Companies:
10,660
total market cap:
$140.341 T
Sign In
๐บ๐ธ
EN
English
$ USD
โฌ
EUR
๐ช๐บ
โน
INR
๐ฎ๐ณ
ยฃ
GBP
๐ฌ๐ง
$
CAD
๐จ๐ฆ
$
AUD
๐ฆ๐บ
$
NZD
๐ณ๐ฟ
$
HKD
๐ญ๐ฐ
$
SGD
๐ธ๐ฌ
Global ranking
Ranking by countries
America
๐บ๐ธ United States
๐จ๐ฆ Canada
๐ฒ๐ฝ Mexico
๐ง๐ท Brazil
๐จ๐ฑ Chile
Europe
๐ช๐บ European Union
๐ฉ๐ช Germany
๐ฌ๐ง United Kingdom
๐ซ๐ท France
๐ช๐ธ Spain
๐ณ๐ฑ Netherlands
๐ธ๐ช Sweden
๐ฎ๐น Italy
๐จ๐ญ Switzerland
๐ต๐ฑ Poland
๐ซ๐ฎ Finland
Asia
๐จ๐ณ China
๐ฏ๐ต Japan
๐ฐ๐ท South Korea
๐ญ๐ฐ Hong Kong
๐ธ๐ฌ Singapore
๐ฎ๐ฉ Indonesia
๐ฎ๐ณ India
๐ฒ๐พ Malaysia
๐น๐ผ Taiwan
๐น๐ญ Thailand
๐ป๐ณ Vietnam
Others
๐ฆ๐บ Australia
๐ณ๐ฟ New Zealand
๐ฎ๐ฑ Israel
๐ธ๐ฆ Saudi Arabia
๐น๐ท Turkey
๐ท๐บ Russia
๐ฟ๐ฆ South Africa
>> All Countries
Ranking by categories
๐ All assets by Market Cap
๐ Automakers
โ๏ธ Airlines
๐ซ Airports
โ๏ธ Aircraft manufacturers
๐ฆ Banks
๐จ Hotels
๐ Pharmaceuticals
๐ E-Commerce
โ๏ธ Healthcare
๐ฆ Courier services
๐ฐ Media/Press
๐ท Alcoholic beverages
๐ฅค Beverages
๐ Clothing
โ๏ธ Mining
๐ Railways
๐ฆ Insurance
๐ Real estate
โ Ports
๐ผ Professional services
๐ด Food
๐ Restaurant chains
โ๐ป Software
๐ Semiconductors
๐ฌ Tobacco
๐ณ Financial services
๐ข Oil&Gas
๐ Electricity
๐งช Chemicals
๐ฐ Investment
๐ก Telecommunication
๐๏ธ Retail
๐ฅ๏ธ Internet
๐ Construction
๐ฎ Video Game
๐ป Tech
๐ฆพ AI
>> All Categories
ETFs
๐ All ETFs
๐๏ธ Bond ETFs
๏ผ Dividend ETFs
โฟ Bitcoin ETFs
โข Ethereum ETFs
๐ช Crypto Currency ETFs
๐ฅ Gold ETFs & ETCs
๐ฅ Silver ETFs & ETCs
๐ข๏ธ Oil ETFs & ETCs
๐ฝ Commodities ETFs & ETNs
๐ Emerging Markets ETFs
๐ Small-Cap ETFs
๐ Low volatility ETFs
๐ Inverse/Bear ETFs
โฌ๏ธ Leveraged ETFs
๐ Global/World ETFs
๐บ๐ธ USA ETFs
๐บ๐ธ S&P 500 ETFs
๐บ๐ธ Dow Jones ETFs
๐ช๐บ Europe ETFs
๐จ๐ณ China ETFs
๐ฏ๐ต Japan ETFs
๐ฎ๐ณ India ETFs
๐ฌ๐ง UK ETFs
๐ฉ๐ช Germany ETFs
๐ซ๐ท France ETFs
โ๏ธ Mining ETFs
โ๏ธ Gold Mining ETFs
โ๏ธ Silver Mining ETFs
๐งฌ Biotech ETFs
๐ฉโ๐ป Tech ETFs
๐ Real Estate ETFs
โ๏ธ Healthcare ETFs
โก Energy ETFs
๐ Renewable Energy ETFs
๐ก๏ธ Insurance ETFs
๐ฐ Water ETFs
๐ด Food & Beverage ETFs
๐ฑ Socially Responsible ETFs
๐ฃ๏ธ Infrastructure ETFs
๐ก Innovation ETFs
๐ Semiconductors ETFs
๐ Aerospace & Defense ETFs
๐ Cybersecurity ETFs
๐ฆพ Artificial Intelligence ETFs
Watchlist
Account
Reinsurance Group of America
RGA
#1492
Rank
$14.80 B
Marketcap
๐บ๐ธ
United States
Country
$225.36
Share price
9.40%
Change (1 day)
9.60%
Change (1 year)
๐ฆ Insurance
Categories
Market cap
Revenue
Earnings
Price history
P/E ratio
P/S ratio
More
Price history
P/E ratio
P/S ratio
P/B ratio
Operating margin
EPS
Dividends
Dividend yield
Shares outstanding
Fails to deliver
Cost to borrow
Total assets
Total liabilities
Total debt
Cash on Hand
Net Assets
Annual Reports (10-K)
Reinsurance Group of America
Quarterly Reports (10-Q)
Financial Year FY2019 Q2
Reinsurance Group of America - 10-Q quarterly report FY2019 Q2
Text size:
Small
Medium
Large
false
--12-31
Q2
2019
0000898174
38882168000
107721000
166159000
4938000
27374000
500
1000
600
1200
0.01
0.01
140000000
140000000
79137758
79137758
62814368
62758491
“A- (excellent)”
0.10
1.00
1.00
0.01
7.5
0.05
0.01
0.01
0.10
0.00
0.00
0.00
5.9
0.00
0.01
0.00
0.03
0.02
0.01
0.01
6.5
0.01
0.01
0.01
0.10
1.00
1.00
0.04
5.9
0.05
0.01
0.01
0.10
0.00
0.00
0.00
5.9
0.00
0.01
0.00
0.03
0.02
0.01
0.01
5.9
0.01
0.01
0.01
0.04
0.05
0.35
1.00
0.05
0.02
0.00
0.00
0.00
0.00
0.02
0.01
0.10
0.02
0.03
0.04
0.05
0.35
1.00
0.05
0.02
0.00
0.00
0.00
0.00
0.02
0.01
0.12
0.02
0.03
0.35
1.00
0.05
0.04
0.05
0.25
0.27
1.00
0.07
0.00
0.00
0.00
0.02
0.00
0.00
0.00
0.00
0.00
0.10
0.02
0.03
0.02
0.01
0.05
0.13
0.01
0.05
0.35
1.00
0.05
0.04
0.05
0.25
0.27
1.00
0.07
0.00
0.00
0.00
0.02
0.00
0.00
0.00
0.00
0.00
0.12
0.02
0.03
0.02
0.01
0.05
0.13
0.01
0.05
12.3
0.04
6.9
0.04
7.9
0.04
12.3
0.04
6.9
0.04
8.2
0.04
55200000
0.01
0.01
10000000
10000000
0
0
0
0
16323390
16379267
0000898174
2019-01-01
2019-06-30
0000898174
2019-07-31
0000898174
exch:XNYS
rga:RZAMember
2019-01-01
2019-06-30
0000898174
exch:XNYS
rga:RGAMember
2019-01-01
2019-06-30
0000898174
exch:XNYS
rga:RZBMember
2019-01-01
2019-06-30
0000898174
2019-06-30
0000898174
2018-12-31
0000898174
2018-04-01
2018-06-30
0000898174
2019-04-01
2019-06-30
0000898174
2018-01-01
2018-06-30
0000898174
us-gaap:CommonStockMember
2017-12-31
0000898174
us-gaap:AdditionalPaidInCapitalMember
2018-06-30
0000898174
us-gaap:AdditionalPaidInCapitalMember
2018-01-01
2018-06-30
0000898174
us-gaap:AdditionalPaidInCapitalMember
2017-12-31
0000898174
us-gaap:TreasuryStockMember
2018-06-30
0000898174
2018-06-30
0000898174
us-gaap:TreasuryStockMember
2018-01-01
2018-06-30
0000898174
us-gaap:RetainedEarningsMember
2017-12-31
0000898174
us-gaap:RetainedEarningsMember
2018-06-30
0000898174
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2018-06-30
0000898174
us-gaap:RetainedEarningsMember
2018-01-01
2018-06-30
0000898174
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2017-12-31
0000898174
us-gaap:CommonStockMember
2018-06-30
0000898174
2017-12-31
0000898174
us-gaap:TreasuryStockMember
2017-12-31
0000898174
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2018-03-31
0000898174
us-gaap:TreasuryStockMember
2018-04-01
2018-06-30
0000898174
us-gaap:RetainedEarningsMember
2018-04-01
2018-06-30
0000898174
us-gaap:AdditionalPaidInCapitalMember
2018-03-31
0000898174
us-gaap:CommonStockMember
2018-03-31
0000898174
us-gaap:RetainedEarningsMember
2018-03-31
0000898174
us-gaap:AdditionalPaidInCapitalMember
2018-04-01
2018-06-30
0000898174
us-gaap:TreasuryStockMember
2018-03-31
0000898174
2018-03-31
0000898174
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2018-12-31
0000898174
us-gaap:RetainedEarningsMember
2019-01-01
2019-06-30
0000898174
us-gaap:TreasuryStockMember
2018-12-31
0000898174
us-gaap:TreasuryStockMember
2019-01-01
2019-06-30
0000898174
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2019-06-30
0000898174
us-gaap:AdditionalPaidInCapitalMember
2019-06-30
0000898174
us-gaap:CommonStockMember
2019-06-30
0000898174
us-gaap:TreasuryStockMember
2019-06-30
0000898174
us-gaap:CommonStockMember
2018-12-31
0000898174
us-gaap:AdditionalPaidInCapitalMember
2019-01-01
2019-06-30
0000898174
us-gaap:RetainedEarningsMember
2018-12-31
0000898174
us-gaap:AdditionalPaidInCapitalMember
2018-12-31
0000898174
us-gaap:RetainedEarningsMember
2019-06-30
0000898174
us-gaap:TreasuryStockMember
2019-03-31
0000898174
us-gaap:AdditionalPaidInCapitalMember
2019-03-31
0000898174
us-gaap:TreasuryStockMember
2019-04-01
2019-06-30
0000898174
2019-03-31
0000898174
us-gaap:CommonStockMember
2019-03-31
0000898174
us-gaap:RetainedEarningsMember
2019-04-01
2019-06-30
0000898174
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2019-03-31
0000898174
us-gaap:RetainedEarningsMember
2019-03-31
0000898174
us-gaap:AdditionalPaidInCapitalMember
2019-04-01
2019-06-30
0000898174
us-gaap:StockCompensationPlanMember
2018-04-01
2018-06-30
0000898174
us-gaap:StockCompensationPlanMember
2019-04-01
2019-06-30
0000898174
us-gaap:EmployeeStockOptionMember
2018-04-01
2018-06-30
0000898174
us-gaap:EmployeeStockOptionMember
2019-01-01
2019-06-30
0000898174
us-gaap:EmployeeStockOptionMember
2018-01-01
2018-06-30
0000898174
us-gaap:StockCompensationPlanMember
2019-01-01
2019-06-30
0000898174
us-gaap:EmployeeStockOptionMember
2019-04-01
2019-06-30
0000898174
us-gaap:StockCompensationPlanMember
2018-01-01
2018-06-30
0000898174
us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember
2019-06-30
0000898174
us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember
2019-01-01
2019-06-30
0000898174
us-gaap:AccumulatedTranslationAdjustmentMember
2019-06-30
0000898174
us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember
2019-06-30
0000898174
us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember
2019-01-01
2019-06-30
0000898174
us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember
2018-12-31
0000898174
us-gaap:AccumulatedTranslationAdjustmentMember
2019-01-01
2019-06-30
0000898174
us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember
2018-12-31
0000898174
us-gaap:AccumulatedTranslationAdjustmentMember
2018-12-31
0000898174
rga:CommonStockOutstandingMember
2018-04-01
2018-06-30
0000898174
rga:CommonStockHeldInTreasuryMember
2017-12-31
0000898174
rga:CommonStockIssuableMember
2018-06-30
0000898174
rga:CommonStockIssuableMember
2017-12-31
0000898174
rga:CommonStockIssuableMember
2018-04-01
2018-06-30
0000898174
rga:CommonStockHeldInTreasuryMember
2018-04-01
2018-06-30
0000898174
rga:CommonStockOutstandingMember
2018-06-30
0000898174
rga:CommonStockHeldInTreasuryMember
2018-06-30
0000898174
rga:CommonStockOutstandingMember
2017-12-31
0000898174
us-gaap:AccumulatedTranslationAdjustmentMember
2018-01-01
2018-06-30
0000898174
us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember
2017-12-31
0000898174
us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember
2017-12-31
0000898174
us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember
2018-01-01
2018-06-30
0000898174
us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember
2018-01-01
2018-06-30
0000898174
us-gaap:AccumulatedTranslationAdjustmentMember
2017-12-31
0000898174
us-gaap:AccumulatedTranslationAdjustmentMember
2018-06-30
0000898174
us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember
2018-06-30
0000898174
us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember
2018-06-30
0000898174
rga:CommonStockHeldInTreasuryMember
2018-12-31
0000898174
rga:CommonStockIssuableMember
2019-04-01
2019-06-30
0000898174
rga:CommonStockOutstandingMember
2019-06-30
0000898174
rga:CommonStockOutstandingMember
2018-12-31
0000898174
rga:CommonStockOutstandingMember
2019-04-01
2019-06-30
0000898174
rga:CommonStockHeldInTreasuryMember
2019-06-30
0000898174
rga:CommonStockHeldInTreasuryMember
2019-04-01
2019-06-30
0000898174
rga:CommonStockIssuableMember
2018-12-31
0000898174
rga:CommonStockIssuableMember
2019-06-30
0000898174
rga:UnrealizedAppreciationDepreciationOfInvestmentsMember
us-gaap:CurrencySwapMember
2019-01-01
2019-06-30
0000898174
rga:UnrealizedAppreciationDepreciationOfInvestmentsMember
rga:DacAttributedToUnrealizedGainsLossesMember
2019-04-01
2019-06-30
0000898174
rga:UnrealizedAppreciationDepreciationOfInvestmentsMember
2019-04-01
2019-06-30
0000898174
rga:UnrealizedAppreciationDepreciationOfInvestmentsMember
rga:UnrealizedGainsLossesOnAvailableForSaleSecuritiesMember
2018-04-01
2018-06-30
0000898174
rga:AmortizationOfUnrealizedPensionAndPostretirementBenefitsMember
2018-04-01
2018-06-30
0000898174
rga:AmountsReclassifiedFromAociMember
2019-01-01
2019-06-30
0000898174
rga:AmortizationOfUnrealizedPensionAndPostretirementBenefitsMember
rga:PriorServiceCostMember
2019-01-01
2019-06-30
0000898174
rga:UnrealizedAppreciationDepreciationOfInvestmentsMember
2019-01-01
2019-06-30
0000898174
rga:UnrealizedAppreciationDepreciationOfInvestmentsMember
2018-04-01
2018-06-30
0000898174
rga:AmortizationOfUnrealizedPensionAndPostretirementBenefitsMember
rga:ActuarialGainsLossesMember
2019-04-01
2019-06-30
0000898174
rga:UnrealizedAppreciationDepreciationOfInvestmentsMember
us-gaap:InterestRateSwapMember
2019-04-01
2019-06-30
0000898174
rga:AmortizationOfUnrealizedPensionAndPostretirementBenefitsMember
rga:ActuarialGainsLossesMember
2018-01-01
2018-06-30
0000898174
rga:UnrealizedAppreciationDepreciationOfInvestmentsMember
rga:DacAttributedToUnrealizedGainsLossesMember
2018-04-01
2018-06-30
0000898174
rga:UnrealizedAppreciationDepreciationOfInvestmentsMember
rga:UnrealizedGainsLossesOnAvailableForSaleSecuritiesMember
2019-04-01
2019-06-30
0000898174
rga:AmortizationOfUnrealizedPensionAndPostretirementBenefitsMember
2019-04-01
2019-06-30
0000898174
rga:AmortizationOfUnrealizedPensionAndPostretirementBenefitsMember
rga:PriorServiceCostMember
2018-01-01
2018-06-30
0000898174
rga:AmountsReclassifiedFromAociMember
2018-04-01
2018-06-30
0000898174
rga:UnrealizedAppreciationDepreciationOfInvestmentsMember
us-gaap:InterestRateSwapMember
2019-01-01
2019-06-30
0000898174
rga:UnrealizedAppreciationDepreciationOfInvestmentsMember
us-gaap:CurrencySwapMember
2018-01-01
2018-06-30
0000898174
rga:UnrealizedAppreciationDepreciationOfInvestmentsMember
us-gaap:InterestRateSwapMember
2018-01-01
2018-06-30
0000898174
rga:AmortizationOfUnrealizedPensionAndPostretirementBenefitsMember
2018-01-01
2018-06-30
0000898174
rga:UnrealizedAppreciationDepreciationOfInvestmentsMember
2018-01-01
2018-06-30
0000898174
rga:UnrealizedAppreciationDepreciationOfInvestmentsMember
rga:DacAttributedToUnrealizedGainsLossesMember
2018-01-01
2018-06-30
0000898174
rga:UnrealizedAppreciationDepreciationOfInvestmentsMember
rga:UnrealizedGainsLossesOnAvailableForSaleSecuritiesMember
2018-01-01
2018-06-30
0000898174
rga:AmountsReclassifiedFromAociMember
2019-04-01
2019-06-30
0000898174
rga:UnrealizedAppreciationDepreciationOfInvestmentsMember
rga:UnrealizedGainsLossesOnAvailableForSaleSecuritiesMember
2019-01-01
2019-06-30
0000898174
rga:UnrealizedAppreciationDepreciationOfInvestmentsMember
rga:DacAttributedToUnrealizedGainsLossesMember
2019-01-01
2019-06-30
0000898174
rga:UnrealizedAppreciationDepreciationOfInvestmentsMember
us-gaap:InterestRateSwapMember
2018-04-01
2018-06-30
0000898174
rga:AmortizationOfUnrealizedPensionAndPostretirementBenefitsMember
rga:PriorServiceCostMember
2019-04-01
2019-06-30
0000898174
rga:AmortizationOfUnrealizedPensionAndPostretirementBenefitsMember
2019-01-01
2019-06-30
0000898174
rga:AmortizationOfUnrealizedPensionAndPostretirementBenefitsMember
rga:PriorServiceCostMember
2018-04-01
2018-06-30
0000898174
rga:AmortizationOfUnrealizedPensionAndPostretirementBenefitsMember
rga:ActuarialGainsLossesMember
2018-04-01
2018-06-30
0000898174
rga:AmountsReclassifiedFromAociMember
2018-01-01
2018-06-30
0000898174
rga:UnrealizedAppreciationDepreciationOfInvestmentsMember
us-gaap:CurrencySwapMember
2019-04-01
2019-06-30
0000898174
rga:UnrealizedAppreciationDepreciationOfInvestmentsMember
us-gaap:CurrencySwapMember
2018-04-01
2018-06-30
0000898174
rga:AmortizationOfUnrealizedPensionAndPostretirementBenefitsMember
rga:ActuarialGainsLossesMember
2019-01-01
2019-06-30
0000898174
us-gaap:CashFlowHedgingMember
2019-01-01
2019-06-30
0000898174
us-gaap:CashFlowHedgingMember
2018-01-01
2018-12-31
0000898174
rga:RGAShareRepurchaseProgramMember
2019-01-01
2019-06-30
0000898174
us-gaap:CashFlowHedgingMember
2018-01-01
2018-06-30
0000898174
rga:RGAShareRepurchaseProgramMember
2018-01-01
2018-06-30
0000898174
us-gaap:CashFlowHedgingMember
2017-01-01
2017-12-31
0000898174
us-gaap:FinancingReceivables30To59DaysPastDueMember
2019-06-30
0000898174
us-gaap:FinancingReceivables30To59DaysPastDueMember
2018-12-31
0000898174
country:GB
2019-06-30
0000898174
stpr:WA
2019-06-30
0000898174
stpr:TX
2019-06-30
0000898174
stpr:CA
2019-06-30
0000898174
country:CA
2019-06-30
0000898174
rga:LTV60To69PercentMember
2019-06-30
0000898174
rga:DebtServiceCoverageRatioRangeTwoMember
rga:LTV70To79PercentMember
2019-06-30
0000898174
rga:DebtServiceCoverageRatioRangeTwoMember
us-gaap:Ltv80To100PercentMember
2019-06-30
0000898174
rga:DebtServiceCoverageRatioRangeTwoMember
rga:LTV0To59PercentMember
2019-06-30
0000898174
us-gaap:Ltv80To100PercentMember
2019-06-30
0000898174
rga:DebtServiceCoverageRatioRangeThreeMember
rga:LTV0To59PercentMember
2019-06-30
0000898174
rga:DebtServiceCoverageRatioRangeOneMember
rga:LTV60To69PercentMember
2019-06-30
0000898174
rga:LTV70To79PercentMember
2019-06-30
0000898174
rga:DebtServiceCoverageRatioRangeThreeMember
2019-06-30
0000898174
rga:DebtServiceCoverageRatioRangeTwoMember
rga:LTV60To69PercentMember
2019-06-30
0000898174
rga:LTV0To59PercentMember
2019-06-30
0000898174
rga:DebtServiceCoverageRatioRangeOneMember
rga:LTV0To59PercentMember
2019-06-30
0000898174
rga:DebtServiceCoverageRatioRangeTwoMember
2019-06-30
0000898174
rga:DebtServiceCoverageRatioRangeOneMember
rga:LTV70To79PercentMember
2019-06-30
0000898174
rga:DebtServiceCoverageRatioRangeThreeMember
rga:LTV60To69PercentMember
2019-06-30
0000898174
rga:DebtServiceCoverageRatioRangeOneMember
2019-06-30
0000898174
rga:DebtServiceCoverageRatioRangeThreeMember
us-gaap:Ltv80To100PercentMember
2019-06-30
0000898174
rga:DebtServiceCoverageRatioRangeOneMember
us-gaap:Ltv80To100PercentMember
2019-06-30
0000898174
rga:DebtServiceCoverageRatioRangeThreeMember
rga:LTV70To79PercentMember
2019-06-30
0000898174
rga:CanadianProvinceOfQuebecSecuritiesMember
2019-06-30
0000898174
rga:CanadianProvinceOfQuebecSecuritiesMember
2018-12-31
0000898174
rga:CanadianProvinceOfOntarioSecuritiesMember
2018-12-31
0000898174
rga:CanadianProvinceOfOntarioSecuritiesMember
2019-06-30
0000898174
rga:CollateralReceivedFixedMaturitySecuritiesMember
2019-06-30
0000898174
us-gaap:CarryingReportedAmountFairValueDisclosureMember
2018-12-31
0000898174
us-gaap:EstimateOfFairValueFairValueDisclosureMember
2018-12-31
0000898174
rga:CollateralFixedMaturitySecuritiesMember
2019-06-30
0000898174
us-gaap:CarryingReportedAmountFairValueDisclosureMember
2019-06-30
0000898174
rga:CollateralFixedMaturitySecuritiesMember
2018-12-31
0000898174
us-gaap:EstimateOfFairValueFairValueDisclosureMember
2019-06-30
0000898174
rga:CollateralReceivedFixedMaturitySecuritiesMember
2018-12-31
0000898174
rga:DebtServiceCoverageRatioRangeOneMember
rga:LTV70To79PercentMember
2018-12-31
0000898174
rga:DebtServiceCoverageRatioRangeTwoMember
rga:LTV70To79PercentMember
2018-12-31
0000898174
rga:LTV0To59PercentMember
2018-12-31
0000898174
rga:DebtServiceCoverageRatioRangeThreeMember
rga:LTV0To59PercentMember
2018-12-31
0000898174
rga:LTV70To79PercentMember
2018-12-31
0000898174
rga:DebtServiceCoverageRatioRangeThreeMember
us-gaap:Ltv80To100PercentMember
2018-12-31
0000898174
rga:LTV60To69PercentMember
2018-12-31
0000898174
rga:DebtServiceCoverageRatioRangeTwoMember
rga:LTV60To69PercentMember
2018-12-31
0000898174
rga:DebtServiceCoverageRatioRangeOneMember
us-gaap:Ltv80To100PercentMember
2018-12-31
0000898174
rga:DebtServiceCoverageRatioRangeOneMember
rga:LTV60To69PercentMember
2018-12-31
0000898174
us-gaap:Ltv80To100PercentMember
2018-12-31
0000898174
rga:DebtServiceCoverageRatioRangeThreeMember
rga:LTV60To69PercentMember
2018-12-31
0000898174
rga:DebtServiceCoverageRatioRangeTwoMember
us-gaap:Ltv80To100PercentMember
2018-12-31
0000898174
rga:DebtServiceCoverageRatioRangeOneMember
rga:LTV0To59PercentMember
2018-12-31
0000898174
rga:DebtServiceCoverageRatioRangeThreeMember
rga:LTV70To79PercentMember
2018-12-31
0000898174
rga:DebtServiceCoverageRatioRangeThreeMember
2018-12-31
0000898174
rga:DebtServiceCoverageRatioRangeTwoMember
rga:LTV0To59PercentMember
2018-12-31
0000898174
rga:DebtServiceCoverageRatioRangeTwoMember
2018-12-31
0000898174
rga:DebtServiceCoverageRatioRangeOneMember
2018-12-31
0000898174
us-gaap:CommercialRealEstatePortfolioSegmentMember
2018-12-31
0000898174
us-gaap:CommercialRealEstatePortfolioSegmentMember
2019-06-30
0000898174
us-gaap:LimitedPartnerMember
2018-12-31
0000898174
us-gaap:OtherCreditDerivativesMember
2018-12-31
0000898174
rga:FairValueOptionContractholderDirectedUnitLinkedInvestmentsMember
2018-12-31
0000898174
us-gaap:DerivativeMember
2019-06-30
0000898174
us-gaap:OtherCreditDerivativesMember
2019-06-30
0000898174
rga:EquityReleaseMortgagesMember
2018-12-31
0000898174
us-gaap:LimitedPartnerMember
2019-06-30
0000898174
rga:FairValueOptionContractholderDirectedUnitLinkedInvestmentsMember
2019-06-30
0000898174
rga:EquityReleaseMortgagesMember
2019-06-30
0000898174
us-gaap:DerivativeMember
2018-12-31
0000898174
rga:MoreThanOrEqualTo20PercentForLessThanSixMonthsMember
2019-01-01
2019-06-30
0000898174
rga:MoreThanOrEqualTo20PercentForLessThanSixMonthsMember
2018-12-31
0000898174
rga:MoreThanOrEqualTo20PercentForSixMonthsOrGreaterMember
2018-01-01
2018-12-31
0000898174
rga:MoreThanOrEqualTo20PercentForLessThanSixMonthsMember
2018-01-01
2018-12-31
0000898174
rga:LessThan20PercentMember
2018-12-31
0000898174
rga:LessThan20PercentMember
2019-01-01
2019-06-30
0000898174
rga:LessThan20PercentMember
2019-06-30
0000898174
rga:MoreThanOrEqualTo20PercentForLessThanSixMonthsMember
2019-06-30
0000898174
rga:LessThan20PercentMember
2018-01-01
2018-12-31
0000898174
rga:MoreThanOrEqualTo20PercentForSixMonthsOrGreaterMember
2019-01-01
2019-06-30
0000898174
rga:MoreThanOrEqualTo20PercentForSixMonthsOrGreaterMember
2019-06-30
0000898174
rga:MoreThanOrEqualTo20PercentForSixMonthsOrGreaterMember
2018-12-31
0000898174
2018-01-01
2018-12-31
0000898174
rga:MortgageLoansOnRealEstateDueOneYearThroughFiveYearsMember
2018-12-31
0000898174
rga:MortgageLoansOnRealEstateDueAfterFiveYearsMember
2018-12-31
0000898174
rga:MortgageLoansOnRealEstateDueOneYearThroughFiveYearsMember
2019-06-30
0000898174
rga:MortgageLoansOnRealEstateDueAfterTenYearsMember
2019-06-30
0000898174
rga:MortgageLoansOnRealEstateDueAfterFiveYearsMember
2019-06-30
0000898174
rga:MortgageLoansOnRealEstateDueAfterTenYearsMember
2018-12-31
0000898174
us-gaap:CommercialMortgageBackedSecuritiesMember
us-gaap:FixedMaturitiesMember
2019-06-30
0000898174
us-gaap:AssetBackedSecuritiesMember
us-gaap:FixedMaturitiesMember
2019-06-30
0000898174
us-gaap:USStatesAndPoliticalSubdivisionsMember
us-gaap:FixedMaturitiesMember
2019-06-30
0000898174
us-gaap:ResidentialMortgageBackedSecuritiesMember
us-gaap:FixedMaturitiesMember
2019-06-30
0000898174
rga:CanadianProvincialGovernmentsMember
us-gaap:FixedMaturitiesMember
2019-06-30
0000898174
us-gaap:USTreasuryAndGovernmentMember
us-gaap:FixedMaturitiesMember
2019-06-30
0000898174
us-gaap:FixedMaturitiesMember
2019-06-30
0000898174
us-gaap:CorporateDebtSecuritiesMember
us-gaap:FixedMaturitiesMember
2019-06-30
0000898174
us-gaap:ForeignGovernmentDebtSecuritiesMember
us-gaap:FixedMaturitiesMember
2019-06-30
0000898174
us-gaap:AssetBackedSecuritiesMember
us-gaap:FixedMaturitiesMember
2018-12-31
0000898174
us-gaap:USStatesAndPoliticalSubdivisionsMember
us-gaap:FixedMaturitiesMember
2018-12-31
0000898174
us-gaap:ResidentialMortgageBackedSecuritiesMember
us-gaap:FixedMaturitiesMember
2018-12-31
0000898174
us-gaap:CommercialMortgageBackedSecuritiesMember
us-gaap:FixedMaturitiesMember
2018-12-31
0000898174
us-gaap:ForeignGovernmentDebtSecuritiesMember
us-gaap:FixedMaturitiesMember
2018-12-31
0000898174
us-gaap:USTreasuryAndGovernmentMember
us-gaap:FixedMaturitiesMember
2018-12-31
0000898174
rga:CanadianProvincialGovernmentsMember
us-gaap:FixedMaturitiesMember
2018-12-31
0000898174
us-gaap:CorporateDebtSecuritiesMember
us-gaap:FixedMaturitiesMember
2018-12-31
0000898174
us-gaap:FixedMaturitiesMember
2018-12-31
0000898174
us-gaap:ShortTermInvestmentsMember
2019-01-01
2019-06-30
0000898174
us-gaap:AvailableforsaleSecuritiesMember
2018-01-01
2018-06-30
0000898174
us-gaap:PolicyLoansMember
2018-04-01
2018-06-30
0000898174
us-gaap:PolicyLoansMember
2019-04-01
2019-06-30
0000898174
us-gaap:AvailableforsaleSecuritiesMember
2019-01-01
2019-06-30
0000898174
rga:FundsWithheldAtInterestMember
2019-01-01
2019-06-30
0000898174
us-gaap:AvailableforsaleSecuritiesMember
2019-04-01
2019-06-30
0000898174
us-gaap:EquitySecuritiesMember
2019-04-01
2019-06-30
0000898174
rga:FundsWithheldAtInterestMember
2018-01-01
2018-06-30
0000898174
rga:FundsWithheldAtInterestMember
2018-04-01
2018-06-30
0000898174
rga:FundsWithheldAtInterestMember
2019-04-01
2019-06-30
0000898174
us-gaap:EquitySecuritiesMember
2018-04-01
2018-06-30
0000898174
us-gaap:MortgagesMember
2019-01-01
2019-06-30
0000898174
us-gaap:EquitySecuritiesMember
2018-01-01
2018-06-30
0000898174
us-gaap:EquitySecuritiesMember
2019-01-01
2019-06-30
0000898174
us-gaap:MortgagesMember
2019-04-01
2019-06-30
0000898174
us-gaap:MortgagesMember
2018-01-01
2018-06-30
0000898174
us-gaap:MortgagesMember
2018-04-01
2018-06-30
0000898174
us-gaap:OtherAggregatedInvestmentsMember
2018-01-01
2018-06-30
0000898174
us-gaap:ShortTermInvestmentsMember
2018-04-01
2018-06-30
0000898174
us-gaap:AvailableforsaleSecuritiesMember
2018-04-01
2018-06-30
0000898174
us-gaap:PolicyLoansMember
2019-01-01
2019-06-30
0000898174
us-gaap:ShortTermInvestmentsMember
2019-04-01
2019-06-30
0000898174
us-gaap:OtherAggregatedInvestmentsMember
2018-04-01
2018-06-30
0000898174
us-gaap:OtherAggregatedInvestmentsMember
2019-01-01
2019-06-30
0000898174
us-gaap:ShortTermInvestmentsMember
2018-01-01
2018-06-30
0000898174
us-gaap:OtherAggregatedInvestmentsMember
2019-04-01
2019-06-30
0000898174
us-gaap:PolicyLoansMember
2018-01-01
2018-06-30
0000898174
us-gaap:CommercialAndIndustrialSectorMember
2018-12-31
0000898174
us-gaap:CommercialAndIndustrialSectorMember
2019-06-30
0000898174
us-gaap:GovernmentSectorMember
2018-12-31
0000898174
us-gaap:GovernmentSectorMember
2019-06-30
0000898174
us-gaap:FinancialServicesSectorMember
2019-06-30
0000898174
us-gaap:FinancialServicesSectorMember
2018-12-31
0000898174
us-gaap:ExternalCreditRatingInvestmentGradeMember
us-gaap:CommercialMortgageBackedSecuritiesMember
us-gaap:FixedMaturitiesMember
2019-06-30
0000898174
us-gaap:ExternalCreditRatingInvestmentGradeMember
us-gaap:ForeignGovernmentDebtSecuritiesMember
us-gaap:FixedMaturitiesMember
2019-06-30
0000898174
us-gaap:ExternalCreditRatingInvestmentGradeMember
us-gaap:USStatesAndPoliticalSubdivisionsMember
us-gaap:FixedMaturitiesMember
2019-06-30
0000898174
us-gaap:ExternalCreditRatingInvestmentGradeMember
us-gaap:FixedMaturitiesMember
2019-06-30
0000898174
us-gaap:ExternalCreditRatingInvestmentGradeMember
us-gaap:AssetBackedSecuritiesMember
us-gaap:FixedMaturitiesMember
2019-06-30
0000898174
us-gaap:ExternalCreditRatingNonInvestmentGradeMember
us-gaap:ResidentialMortgageBackedSecuritiesMember
us-gaap:FixedMaturitiesMember
2019-06-30
0000898174
us-gaap:ExternalCreditRatingInvestmentGradeMember
us-gaap:ResidentialMortgageBackedSecuritiesMember
us-gaap:FixedMaturitiesMember
2019-06-30
0000898174
us-gaap:ExternalCreditRatingNonInvestmentGradeMember
us-gaap:CorporateDebtSecuritiesMember
us-gaap:FixedMaturitiesMember
2019-06-30
0000898174
us-gaap:ExternalCreditRatingInvestmentGradeMember
rga:CanadianProvincialGovernmentsMember
us-gaap:FixedMaturitiesMember
2019-06-30
0000898174
us-gaap:ExternalCreditRatingNonInvestmentGradeMember
us-gaap:FixedMaturitiesMember
2019-06-30
0000898174
us-gaap:ExternalCreditRatingNonInvestmentGradeMember
us-gaap:ForeignGovernmentDebtSecuritiesMember
us-gaap:FixedMaturitiesMember
2019-06-30
0000898174
us-gaap:ExternalCreditRatingInvestmentGradeMember
us-gaap:USGovernmentAgenciesDebtSecuritiesMember
us-gaap:FixedMaturitiesMember
2019-06-30
0000898174
us-gaap:ExternalCreditRatingInvestmentGradeMember
us-gaap:CorporateDebtSecuritiesMember
us-gaap:FixedMaturitiesMember
2019-06-30
0000898174
us-gaap:ExternalCreditRatingNonInvestmentGradeMember
us-gaap:ForeignGovernmentDebtSecuritiesMember
us-gaap:FixedMaturitiesMember
2018-12-31
0000898174
us-gaap:ExternalCreditRatingNonInvestmentGradeMember
rga:CanadianProvincialGovernmentsMember
us-gaap:FixedMaturitiesMember
2018-12-31
0000898174
us-gaap:ExternalCreditRatingInvestmentGradeMember
us-gaap:USGovernmentAgenciesDebtSecuritiesMember
us-gaap:FixedMaturitiesMember
2018-12-31
0000898174
us-gaap:ExternalCreditRatingNonInvestmentGradeMember
us-gaap:AssetBackedSecuritiesMember
us-gaap:FixedMaturitiesMember
2018-12-31
0000898174
us-gaap:ExternalCreditRatingInvestmentGradeMember
us-gaap:CorporateDebtSecuritiesMember
us-gaap:FixedMaturitiesMember
2018-12-31
0000898174
us-gaap:ExternalCreditRatingInvestmentGradeMember
us-gaap:CommercialMortgageBackedSecuritiesMember
us-gaap:FixedMaturitiesMember
2018-12-31
0000898174
us-gaap:ExternalCreditRatingInvestmentGradeMember
rga:CanadianProvincialGovernmentsMember
us-gaap:FixedMaturitiesMember
2018-12-31
0000898174
us-gaap:ExternalCreditRatingNonInvestmentGradeMember
us-gaap:FixedMaturitiesMember
2018-12-31
0000898174
us-gaap:ExternalCreditRatingNonInvestmentGradeMember
us-gaap:ResidentialMortgageBackedSecuritiesMember
us-gaap:FixedMaturitiesMember
2018-12-31
0000898174
us-gaap:ExternalCreditRatingInvestmentGradeMember
us-gaap:AssetBackedSecuritiesMember
us-gaap:FixedMaturitiesMember
2018-12-31
0000898174
us-gaap:ExternalCreditRatingInvestmentGradeMember
us-gaap:FixedMaturitiesMember
2018-12-31
0000898174
us-gaap:ExternalCreditRatingInvestmentGradeMember
us-gaap:ResidentialMortgageBackedSecuritiesMember
us-gaap:FixedMaturitiesMember
2018-12-31
0000898174
us-gaap:ExternalCreditRatingInvestmentGradeMember
us-gaap:ForeignGovernmentDebtSecuritiesMember
us-gaap:FixedMaturitiesMember
2018-12-31
0000898174
us-gaap:ExternalCreditRatingInvestmentGradeMember
us-gaap:USStatesAndPoliticalSubdivisionsMember
us-gaap:FixedMaturitiesMember
2018-12-31
0000898174
us-gaap:ExternalCreditRatingNonInvestmentGradeMember
us-gaap:CorporateDebtSecuritiesMember
us-gaap:FixedMaturitiesMember
2018-12-31
0000898174
srt:ApartmentBuildingMember
2019-06-30
0000898174
srt:IndustrialPropertyMember
2019-06-30
0000898174
srt:OtherPropertyMember
2019-06-30
0000898174
srt:OfficeBuildingMember
2019-06-30
0000898174
srt:RetailSiteMember
2019-06-30
0000898174
srt:IndustrialPropertyMember
2018-12-31
0000898174
srt:OtherPropertyMember
2018-12-31
0000898174
srt:RetailSiteMember
2018-12-31
0000898174
srt:ApartmentBuildingMember
2018-12-31
0000898174
srt:OfficeBuildingMember
2018-12-31
0000898174
us-gaap:MaturityOver90DaysMember
2018-12-31
0000898174
us-gaap:ForeignGovernmentDebtSecuritiesMember
2018-12-31
0000898174
us-gaap:CorporateDebtSecuritiesMember
us-gaap:Maturity30To90DaysMember
2018-12-31
0000898174
us-gaap:USGovernmentAgenciesDebtSecuritiesMember
us-gaap:MaturityOver90DaysMember
2018-12-31
0000898174
us-gaap:MaturityOvernightMember
2018-12-31
0000898174
us-gaap:CorporateDebtSecuritiesMember
2018-12-31
0000898174
us-gaap:MaturityUpTo30DaysMember
2018-12-31
0000898174
us-gaap:ForeignGovernmentDebtSecuritiesMember
us-gaap:Maturity30To90DaysMember
2018-12-31
0000898174
us-gaap:ForeignGovernmentDebtSecuritiesMember
us-gaap:MaturityUpTo30DaysMember
2018-12-31
0000898174
us-gaap:CorporateDebtSecuritiesMember
us-gaap:MaturityUpTo30DaysMember
2018-12-31
0000898174
us-gaap:CorporateDebtSecuritiesMember
us-gaap:MaturityOver90DaysMember
2018-12-31
0000898174
us-gaap:Maturity30To90DaysMember
2018-12-31
0000898174
us-gaap:ForeignGovernmentDebtSecuritiesMember
us-gaap:MaturityOvernightMember
2018-12-31
0000898174
us-gaap:USGovernmentAgenciesDebtSecuritiesMember
2018-12-31
0000898174
us-gaap:CorporateDebtSecuritiesMember
us-gaap:MaturityOvernightMember
2018-12-31
0000898174
us-gaap:ForeignGovernmentDebtSecuritiesMember
us-gaap:MaturityOver90DaysMember
2018-12-31
0000898174
us-gaap:USGovernmentAgenciesDebtSecuritiesMember
us-gaap:MaturityUpTo30DaysMember
2018-12-31
0000898174
us-gaap:USGovernmentAgenciesDebtSecuritiesMember
us-gaap:MaturityOvernightMember
2018-12-31
0000898174
us-gaap:USGovernmentAgenciesDebtSecuritiesMember
us-gaap:Maturity30To90DaysMember
2018-12-31
0000898174
us-gaap:USTreasuryAndGovernmentMember
us-gaap:MaturityOver90DaysMember
2019-06-30
0000898174
us-gaap:MaturityOver90DaysMember
2019-06-30
0000898174
us-gaap:ForeignGovernmentDebtSecuritiesMember
us-gaap:MaturityUpTo30DaysMember
2019-06-30
0000898174
us-gaap:ForeignGovernmentDebtSecuritiesMember
us-gaap:MaturityOvernightMember
2019-06-30
0000898174
us-gaap:CorporateDebtSecuritiesMember
2019-06-30
0000898174
us-gaap:CorporateDebtSecuritiesMember
us-gaap:MaturityUpTo30DaysMember
2019-06-30
0000898174
us-gaap:ForeignGovernmentDebtSecuritiesMember
us-gaap:MaturityOver90DaysMember
2019-06-30
0000898174
us-gaap:MaturityOvernightMember
2019-06-30
0000898174
us-gaap:USTreasuryAndGovernmentMember
us-gaap:MaturityOvernightMember
2019-06-30
0000898174
us-gaap:USTreasuryAndGovernmentMember
us-gaap:MaturityUpTo30DaysMember
2019-06-30
0000898174
us-gaap:USTreasuryAndGovernmentMember
2019-06-30
0000898174
us-gaap:CorporateDebtSecuritiesMember
us-gaap:MaturityOvernightMember
2019-06-30
0000898174
us-gaap:OtherDebtSecuritiesMember
us-gaap:Maturity30To90DaysMember
2019-06-30
0000898174
us-gaap:Maturity30To90DaysMember
2019-06-30
0000898174
us-gaap:CorporateDebtSecuritiesMember
us-gaap:Maturity30To90DaysMember
2019-06-30
0000898174
us-gaap:MaturityUpTo30DaysMember
2019-06-30
0000898174
us-gaap:OtherDebtSecuritiesMember
us-gaap:MaturityOvernightMember
2019-06-30
0000898174
us-gaap:CorporateDebtSecuritiesMember
us-gaap:MaturityOver90DaysMember
2019-06-30
0000898174
us-gaap:OtherDebtSecuritiesMember
2019-06-30
0000898174
us-gaap:ForeignGovernmentDebtSecuritiesMember
2019-06-30
0000898174
us-gaap:OtherDebtSecuritiesMember
us-gaap:MaturityUpTo30DaysMember
2019-06-30
0000898174
us-gaap:OtherDebtSecuritiesMember
us-gaap:MaturityOver90DaysMember
2019-06-30
0000898174
us-gaap:USTreasuryAndGovernmentMember
us-gaap:Maturity30To90DaysMember
2019-06-30
0000898174
us-gaap:ForeignGovernmentDebtSecuritiesMember
us-gaap:Maturity30To90DaysMember
2019-06-30
0000898174
rga:CommercialRealEstateOtherReceivableWithRelatedAllowanceMember
2019-04-01
2019-06-30
0000898174
rga:CommercialRealEstateOtherReceivableWithNoRelatedAllowanceMember
2019-06-30
0000898174
rga:CommercialRealEstateOtherReceivableWithRelatedAllowanceMember
2019-01-01
2019-06-30
0000898174
rga:CommercialRealEstateOtherReceivableWithNoRelatedAllowanceMember
2018-12-31
0000898174
rga:CommercialRealEstateOtherReceivableWithRelatedAllowanceMember
2019-06-30
0000898174
rga:CommercialRealEstateOtherReceivableWithRelatedAllowanceMember
2018-12-31
0000898174
rga:CommercialRealEstateOtherReceivableWithNoRelatedAllowanceMember
2018-04-01
2018-06-30
0000898174
rga:CommercialRealEstateOtherReceivableWithNoRelatedAllowanceMember
2018-01-01
2018-06-30
0000898174
rga:CommercialRealEstateOtherReceivableWithNoRelatedAllowanceMember
2019-04-01
2019-06-30
0000898174
rga:CommercialRealEstateOtherReceivableWithNoRelatedAllowanceMember
2019-01-01
2019-06-30
0000898174
rga:CommercialRealEstateOtherReceivableWithRelatedAllowanceMember
2018-01-01
2018-06-30
0000898174
rga:CommercialRealEstateOtherReceivableWithRelatedAllowanceMember
2018-04-01
2018-06-30
0000898174
us-gaap:CurrencySwapMember
2019-04-01
2019-06-30
0000898174
us-gaap:ForeignExchangeForwardMember
2018-01-01
2018-06-30
0000898174
us-gaap:CurrencySwapMember
2019-01-01
2019-06-30
0000898174
us-gaap:ForeignExchangeForwardMember
2018-04-01
2018-06-30
0000898174
us-gaap:ForeignExchangeForwardMember
2019-04-01
2019-06-30
0000898174
us-gaap:CurrencySwapMember
2018-01-01
2018-06-30
0000898174
us-gaap:CurrencySwapMember
2018-04-01
2018-06-30
0000898174
us-gaap:ForeignExchangeForwardMember
2019-01-01
2019-06-30
0000898174
us-gaap:CashFlowHedgingMember
2019-04-01
2019-06-30
0000898174
us-gaap:CashFlowHedgingMember
2019-01-01
2019-03-31
0000898174
us-gaap:CashFlowHedgingMember
us-gaap:InvestmentIncomeMember
2019-04-01
2019-06-30
0000898174
us-gaap:CashFlowHedgingMember
us-gaap:InterestExpenseMember
2018-04-01
2018-06-30
0000898174
us-gaap:CashFlowHedgingMember
2018-01-01
2018-03-31
0000898174
us-gaap:CashFlowHedgingMember
us-gaap:InvestmentIncomeMember
2019-01-01
2019-06-30
0000898174
us-gaap:CashFlowHedgingMember
us-gaap:InvestmentIncomeMember
2018-04-01
2018-06-30
0000898174
us-gaap:CashFlowHedgingMember
us-gaap:InterestExpenseMember
2019-01-01
2019-06-30
0000898174
us-gaap:CashFlowHedgingMember
us-gaap:InvestmentIncomeMember
2018-01-01
2018-06-30
0000898174
us-gaap:CashFlowHedgingMember
us-gaap:InterestExpenseMember
2019-04-01
2019-06-30
0000898174
us-gaap:CashFlowHedgingMember
2018-04-01
2018-06-30
0000898174
us-gaap:CashFlowHedgingMember
us-gaap:InterestExpenseMember
2018-01-01
2018-06-30
0000898174
rga:EmbeddedDerivativesInIndexedAnnuityMember
us-gaap:NondesignatedMember
2019-06-30
0000898174
us-gaap:EquityMember
us-gaap:NondesignatedMember
2019-06-30
0000898174
us-gaap:InterestRateSwapMember
us-gaap:DesignatedAsHedgingInstrumentMember
2018-12-31
0000898174
us-gaap:CurrencySwapMember
us-gaap:NondesignatedMember
2018-12-31
0000898174
us-gaap:ForeignExchangeForwardMember
us-gaap:NondesignatedMember
2019-06-30
0000898174
us-gaap:DesignatedAsHedgingInstrumentMember
2019-06-30
0000898174
us-gaap:FutureMember
us-gaap:NondesignatedMember
2019-06-30
0000898174
rga:EmbeddedDerivativesInVariableAnnuityMember
us-gaap:NondesignatedMember
2019-06-30
0000898174
us-gaap:CurrencySwapMember
us-gaap:DesignatedAsHedgingInstrumentMember
2018-12-31
0000898174
us-gaap:ForeignExchangeForwardMember
us-gaap:DesignatedAsHedgingInstrumentMember
2018-12-31
0000898174
us-gaap:CreditDefaultSwapMember
us-gaap:NondesignatedMember
2019-06-30
0000898174
rga:LongevitySwapMember
us-gaap:NondesignatedMember
2019-06-30
0000898174
rga:LongevitySwapMember
us-gaap:NondesignatedMember
2018-12-31
0000898174
us-gaap:CreditDefaultSwapMember
us-gaap:NondesignatedMember
2018-12-31
0000898174
us-gaap:ForeignExchangeForwardMember
us-gaap:DesignatedAsHedgingInstrumentMember
2019-06-30
0000898174
us-gaap:ForeignExchangeForwardMember
us-gaap:NondesignatedMember
2018-12-31
0000898174
us-gaap:DesignatedAsHedgingInstrumentMember
2018-12-31
0000898174
us-gaap:InterestRateSwapMember
us-gaap:NondesignatedMember
2018-12-31
0000898174
rga:EmbeddedDerivativesInModifiedCoinsuranceOrFundsWithheldArrangementsMember
us-gaap:NondesignatedMember
2019-06-30
0000898174
us-gaap:CurrencySwapMember
us-gaap:DesignatedAsHedgingInstrumentMember
2019-06-30
0000898174
us-gaap:InterestRateSwapMember
us-gaap:DesignatedAsHedgingInstrumentMember
2019-06-30
0000898174
rga:ConsumerPriceIndexSwapMember
us-gaap:NondesignatedMember
2019-06-30
0000898174
rga:SyntheticGuaranteedInvestmentContractsMember
us-gaap:NondesignatedMember
2019-06-30
0000898174
us-gaap:CurrencySwapMember
us-gaap:NondesignatedMember
2019-06-30
0000898174
rga:EmbeddedDerivativesInVariableAnnuityMember
us-gaap:NondesignatedMember
2018-12-31
0000898174
rga:EmbeddedDerivativesInModifiedCoinsuranceOrFundsWithheldArrangementsMember
us-gaap:NondesignatedMember
2018-12-31
0000898174
us-gaap:FutureMember
us-gaap:NondesignatedMember
2018-12-31
0000898174
rga:ConsumerPriceIndexSwapMember
us-gaap:NondesignatedMember
2018-12-31
0000898174
rga:MortalitySwapMember
us-gaap:NondesignatedMember
2018-12-31
0000898174
rga:MortalitySwapMember
us-gaap:NondesignatedMember
2019-06-30
0000898174
rga:EmbeddedDerivativesInIndexedAnnuityMember
us-gaap:NondesignatedMember
2018-12-31
0000898174
us-gaap:InterestRateSwapMember
us-gaap:NondesignatedMember
2019-06-30
0000898174
us-gaap:EquityMember
us-gaap:NondesignatedMember
2018-12-31
0000898174
rga:SyntheticGuaranteedInvestmentContractsMember
us-gaap:NondesignatedMember
2018-12-31
0000898174
us-gaap:NondesignatedMember
2018-12-31
0000898174
us-gaap:NondesignatedMember
2019-06-30
0000898174
us-gaap:InterestRateSwapMember
us-gaap:CashFlowHedgingMember
us-gaap:InterestExpenseMember
2019-04-01
2019-06-30
0000898174
us-gaap:CurrencySwapMember
us-gaap:CashFlowHedgingMember
us-gaap:InterestExpenseMember
2018-01-01
2018-06-30
0000898174
us-gaap:CurrencySwapMember
us-gaap:CashFlowHedgingMember
2019-04-01
2019-06-30
0000898174
us-gaap:CurrencySwapMember
us-gaap:CashFlowHedgingMember
2018-01-01
2018-06-30
0000898174
us-gaap:InterestRateSwapMember
us-gaap:CashFlowHedgingMember
2019-04-01
2019-06-30
0000898174
us-gaap:CurrencySwapMember
us-gaap:CashFlowHedgingMember
us-gaap:InvestmentIncomeMember
2018-01-01
2018-06-30
0000898174
us-gaap:CurrencySwapMember
us-gaap:CashFlowHedgingMember
us-gaap:InterestExpenseMember
2019-01-01
2019-06-30
0000898174
us-gaap:CurrencySwapMember
us-gaap:CashFlowHedgingMember
us-gaap:InvestmentIncomeMember
2019-04-01
2019-06-30
0000898174
us-gaap:InterestRateSwapMember
us-gaap:CashFlowHedgingMember
us-gaap:InterestExpenseMember
2018-04-01
2018-06-30
0000898174
us-gaap:CurrencySwapMember
us-gaap:CashFlowHedgingMember
us-gaap:InterestExpenseMember
2019-04-01
2019-06-30
0000898174
us-gaap:InterestRateSwapMember
us-gaap:CashFlowHedgingMember
us-gaap:InvestmentIncomeMember
2018-04-01
2018-06-30
0000898174
us-gaap:InterestRateSwapMember
us-gaap:CashFlowHedgingMember
us-gaap:InterestExpenseMember
2019-01-01
2019-06-30
0000898174
us-gaap:CurrencySwapMember
us-gaap:CashFlowHedgingMember
us-gaap:InvestmentIncomeMember
2018-04-01
2018-06-30
0000898174
us-gaap:InterestRateSwapMember
us-gaap:CashFlowHedgingMember
us-gaap:InterestExpenseMember
2018-01-01
2018-06-30
0000898174
us-gaap:CurrencySwapMember
us-gaap:CashFlowHedgingMember
us-gaap:InvestmentIncomeMember
2019-01-01
2019-06-30
0000898174
us-gaap:InterestRateSwapMember
us-gaap:CashFlowHedgingMember
2018-01-01
2018-06-30
0000898174
us-gaap:InterestRateSwapMember
us-gaap:CashFlowHedgingMember
us-gaap:InvestmentIncomeMember
2019-04-01
2019-06-30
0000898174
us-gaap:InterestRateSwapMember
us-gaap:CashFlowHedgingMember
2018-04-01
2018-06-30
0000898174
us-gaap:InterestRateSwapMember
us-gaap:CashFlowHedgingMember
2019-01-01
2019-06-30
0000898174
us-gaap:CurrencySwapMember
us-gaap:CashFlowHedgingMember
us-gaap:InterestExpenseMember
2018-04-01
2018-06-30
0000898174
us-gaap:InterestRateSwapMember
us-gaap:CashFlowHedgingMember
us-gaap:InvestmentIncomeMember
2018-01-01
2018-06-30
0000898174
us-gaap:CurrencySwapMember
us-gaap:CashFlowHedgingMember
2018-04-01
2018-06-30
0000898174
us-gaap:InterestRateSwapMember
us-gaap:CashFlowHedgingMember
us-gaap:InvestmentIncomeMember
2019-01-01
2019-06-30
0000898174
us-gaap:CurrencySwapMember
us-gaap:CashFlowHedgingMember
2019-01-01
2019-06-30
0000898174
rga:ConsumerPriceIndexSwapMember
us-gaap:NondesignatedMember
2019-04-01
2019-06-30
0000898174
us-gaap:EquityMember
us-gaap:NondesignatedMember
2018-04-01
2018-06-30
0000898174
rga:MortalitySwapMember
us-gaap:NondesignatedMember
2019-04-01
2019-06-30
0000898174
us-gaap:InterestRateSwapMember
us-gaap:NondesignatedMember
2018-04-01
2018-06-30
0000898174
rga:EmbeddedDerivativesInVariableAnnuityMember
us-gaap:NondesignatedMember
2018-01-01
2018-06-30
0000898174
us-gaap:NondesignatedMember
2019-01-01
2019-06-30
0000898174
rga:ConsumerPriceIndexSwapMember
us-gaap:NondesignatedMember
2018-04-01
2018-06-30
0000898174
rga:LongevitySwapMember
us-gaap:NondesignatedMember
2019-04-01
2019-06-30
0000898174
rga:ConsumerPriceIndexSwapMember
us-gaap:NondesignatedMember
2019-01-01
2019-06-30
0000898174
us-gaap:CreditDefaultSwapMember
us-gaap:NondesignatedMember
2018-01-01
2018-06-30
0000898174
rga:LongevitySwapMember
us-gaap:NondesignatedMember
2018-04-01
2018-06-30
0000898174
us-gaap:InterestRateSwapMember
us-gaap:NondesignatedMember
2019-01-01
2019-06-30
0000898174
us-gaap:EquityMember
us-gaap:NondesignatedMember
2019-01-01
2019-06-30
0000898174
rga:EmbeddedDerivativesInVariableAnnuityMember
us-gaap:NondesignatedMember
2019-04-01
2019-06-30
0000898174
us-gaap:FutureMember
us-gaap:NondesignatedMember
2019-01-01
2019-06-30
0000898174
us-gaap:CreditDefaultSwapMember
us-gaap:NondesignatedMember
2018-04-01
2018-06-30
0000898174
us-gaap:InterestRateSwapMember
us-gaap:NondesignatedMember
2019-04-01
2019-06-30
0000898174
us-gaap:ForeignExchangeForwardMember
us-gaap:NondesignatedMember
2019-01-01
2019-06-30
0000898174
us-gaap:FutureMember
us-gaap:NondesignatedMember
2018-01-01
2018-06-30
0000898174
us-gaap:CurrencySwapMember
us-gaap:NondesignatedMember
2018-01-01
2018-06-30
0000898174
rga:EmbeddedDerivativesInModifiedCoinsuranceOrFundsWithheldArrangementsMember
us-gaap:NondesignatedMember
2018-01-01
2018-06-30
0000898174
us-gaap:NondesignatedMember
2018-01-01
2018-06-30
0000898174
rga:EmbeddedDerivativesInVariableAnnuityMember
us-gaap:NondesignatedMember
2018-04-01
2018-06-30
0000898174
rga:MortalitySwapMember
us-gaap:NondesignatedMember
2018-04-01
2018-06-30
0000898174
rga:EmbeddedDerivativesInIndexedAnnuityMember
us-gaap:NondesignatedMember
2018-04-01
2018-06-30
0000898174
us-gaap:CurrencySwapMember
us-gaap:NondesignatedMember
2018-04-01
2018-06-30
0000898174
us-gaap:FutureMember
us-gaap:NondesignatedMember
2018-04-01
2018-06-30
0000898174
us-gaap:InterestRateSwapMember
us-gaap:NondesignatedMember
2018-01-01
2018-06-30
0000898174
us-gaap:CreditDefaultSwapMember
us-gaap:NondesignatedMember
2019-01-01
2019-06-30
0000898174
us-gaap:NondesignatedMember
2019-04-01
2019-06-30
0000898174
us-gaap:CurrencySwapMember
us-gaap:NondesignatedMember
2019-01-01
2019-06-30
0000898174
rga:EmbeddedDerivativesInIndexedAnnuityMember
us-gaap:NondesignatedMember
2018-01-01
2018-06-30
0000898174
us-gaap:NondesignatedMember
2018-04-01
2018-06-30
0000898174
rga:EmbeddedDerivativesInIndexedAnnuityMember
us-gaap:NondesignatedMember
2019-04-01
2019-06-30
0000898174
rga:MortalitySwapMember
us-gaap:NondesignatedMember
2018-01-01
2018-06-30
0000898174
us-gaap:FutureMember
us-gaap:NondesignatedMember
2019-04-01
2019-06-30
0000898174
rga:LongevitySwapMember
us-gaap:NondesignatedMember
2018-01-01
2018-06-30
0000898174
rga:MortalitySwapMember
us-gaap:NondesignatedMember
2019-01-01
2019-06-30
0000898174
rga:ConsumerPriceIndexSwapMember
us-gaap:NondesignatedMember
2018-01-01
2018-06-30
0000898174
rga:EmbeddedDerivativesInModifiedCoinsuranceOrFundsWithheldArrangementsMember
us-gaap:NondesignatedMember
2019-04-01
2019-06-30
0000898174
rga:EmbeddedDerivativesInIndexedAnnuityMember
us-gaap:NondesignatedMember
2019-01-01
2019-06-30
0000898174
rga:LongevitySwapMember
us-gaap:NondesignatedMember
2019-01-01
2019-06-30
0000898174
rga:EmbeddedDerivativesInVariableAnnuityMember
us-gaap:NondesignatedMember
2019-01-01
2019-06-30
0000898174
us-gaap:CreditDefaultSwapMember
us-gaap:NondesignatedMember
2019-04-01
2019-06-30
0000898174
us-gaap:ForeignExchangeForwardMember
us-gaap:NondesignatedMember
2018-04-01
2018-06-30
0000898174
rga:EmbeddedDerivativesInModifiedCoinsuranceOrFundsWithheldArrangementsMember
us-gaap:NondesignatedMember
2018-04-01
2018-06-30
0000898174
us-gaap:EquityMember
us-gaap:NondesignatedMember
2018-01-01
2018-06-30
0000898174
us-gaap:ForeignExchangeForwardMember
us-gaap:NondesignatedMember
2018-01-01
2018-06-30
0000898174
us-gaap:ForeignExchangeForwardMember
us-gaap:NondesignatedMember
2019-04-01
2019-06-30
0000898174
us-gaap:EquityMember
us-gaap:NondesignatedMember
2019-04-01
2019-06-30
0000898174
us-gaap:CurrencySwapMember
us-gaap:NondesignatedMember
2019-04-01
2019-06-30
0000898174
rga:EmbeddedDerivativesInModifiedCoinsuranceOrFundsWithheldArrangementsMember
us-gaap:NondesignatedMember
2019-01-01
2019-06-30
0000898174
us-gaap:InvestmentIncomeMember
2019-06-30
0000898174
us-gaap:InterestExpenseMember
2019-06-30
0000898174
rga:CreditDefaultSubtotalMember
srt:StandardPoorsBBBRatingMember
2018-12-31
0000898174
rga:SingleNameCreditDefaultSwapsMember
rga:StandardPoorsAaaToAminusRatingsMember
2019-01-01
2019-06-30
0000898174
rga:SingleNameCreditDefaultSwapsMember
srt:StandardPoorsBBBRatingMember
2019-01-01
2019-06-30
0000898174
rga:CreditDefaultSwapsReferencingIndicesMember
srt:StandardPoorsBBBRatingMember
2018-01-01
2018-12-31
0000898174
rga:CreditDefaultSubtotalMember
rga:StandardPoorsAaaToAminusRatingsMember
2018-12-31
0000898174
rga:CreditDefaultSubtotalMember
rga:StandardPoorsAaaToAminusRatingsMember
2019-06-30
0000898174
rga:SingleNameCreditDefaultSwapsMember
srt:StandardPoorsBBRatingMember
2018-12-31
0000898174
rga:CreditDefaultSubtotalMember
srt:StandardPoorsBBRatingMember
2019-06-30
0000898174
rga:SingleNameCreditDefaultSwapsMember
srt:StandardPoorsBBRatingMember
2019-06-30
0000898174
rga:SingleNameCreditDefaultSwapsMember
srt:StandardPoorsBBBRatingMember
2019-06-30
0000898174
rga:SingleNameCreditDefaultSwapsMember
srt:StandardPoorsBBBRatingMember
2018-01-01
2018-12-31
0000898174
srt:StandardPoorsBBRatingMember
2018-01-01
2018-12-31
0000898174
rga:SingleNameCreditDefaultSwapsMember
srt:StandardPoorsBBBRatingMember
2018-12-31
0000898174
rga:CreditDefaultSwapsReferencingIndicesMember
srt:StandardPoorsBBBRatingMember
2018-12-31
0000898174
rga:SingleNameCreditDefaultSwapsMember
rga:StandardPoorsAaaToAminusRatingsMember
2019-06-30
0000898174
srt:StandardPoorsBBRatingMember
2019-01-01
2019-06-30
0000898174
rga:CreditDefaultSubtotalMember
srt:StandardPoorsBBBRatingMember
2019-01-01
2019-06-30
0000898174
rga:SingleNameCreditDefaultSwapsMember
rga:StandardPoorsAaaToAminusRatingsMember
2018-01-01
2018-12-31
0000898174
rga:CreditDefaultSubtotalMember
srt:StandardPoorsBBRatingMember
2018-12-31
0000898174
rga:CreditDefaultSubtotalMember
rga:StandardPoorsAaaToAminusRatingsMember
2019-01-01
2019-06-30
0000898174
rga:SingleNameCreditDefaultSwapsMember
rga:StandardPoorsAaaToAminusRatingsMember
2018-12-31
0000898174
rga:CreditDefaultSubtotalMember
rga:StandardPoorsAaaToAminusRatingsMember
2018-01-01
2018-12-31
0000898174
rga:CreditDefaultSubtotalMember
srt:StandardPoorsBBBRatingMember
2018-01-01
2018-12-31
0000898174
rga:CreditDefaultSwapsReferencingIndicesMember
srt:StandardPoorsBBBRatingMember
2019-06-30
0000898174
rga:CreditDefaultSwapsReferencingIndicesMember
srt:StandardPoorsBBBRatingMember
2019-01-01
2019-06-30
0000898174
rga:CreditDefaultSubtotalMember
srt:StandardPoorsBBBRatingMember
2019-06-30
0000898174
us-gaap:AssetBackedSecuritiesMember
2018-01-01
2018-06-30
0000898174
rga:CanadianProvincialGovernmentsMember
2018-01-01
2018-06-30
0000898174
us-gaap:AssetBackedSecuritiesMember
us-gaap:GainLossOnInvestmentsMember1
2018-01-01
2018-06-30
0000898174
us-gaap:ResidentialMortgageBackedSecuritiesMember
2018-01-01
2018-06-30
0000898174
us-gaap:AssetBackedSecuritiesMember
2018-06-30
0000898174
us-gaap:ResidentialMortgageBackedSecuritiesMember
2018-06-30
0000898174
us-gaap:CorporateDebtSecuritiesMember
2018-01-01
2018-06-30
0000898174
us-gaap:AssetBackedSecuritiesMember
us-gaap:InvestmentIncomeMember
2018-01-01
2018-06-30
0000898174
rga:CanadianProvincialGovernmentsMember
2017-12-31
0000898174
us-gaap:AssetBackedSecuritiesMember
2017-12-31
0000898174
rga:CanadianProvincialGovernmentsMember
2018-06-30
0000898174
rga:CanadianProvincialGovernmentsMember
us-gaap:GainLossOnInvestmentsMember1
2018-01-01
2018-06-30
0000898174
us-gaap:CorporateDebtSecuritiesMember
us-gaap:GainLossOnInvestmentsMember1
2018-01-01
2018-06-30
0000898174
us-gaap:CorporateDebtSecuritiesMember
us-gaap:InvestmentIncomeMember
2018-01-01
2018-06-30
0000898174
rga:CanadianProvincialGovernmentsMember
us-gaap:InvestmentIncomeMember
2018-01-01
2018-06-30
0000898174
us-gaap:ResidentialMortgageBackedSecuritiesMember
us-gaap:InvestmentIncomeMember
2018-01-01
2018-06-30
0000898174
us-gaap:ResidentialMortgageBackedSecuritiesMember
us-gaap:GainLossOnInvestmentsMember1
2018-01-01
2018-06-30
0000898174
us-gaap:CorporateDebtSecuritiesMember
2018-06-30
0000898174
us-gaap:ResidentialMortgageBackedSecuritiesMember
2017-12-31
0000898174
us-gaap:CorporateDebtSecuritiesMember
2017-12-31
0000898174
rga:EmbeddedDerivativesInIndexedAnnuityMember
us-gaap:IncomeApproachValuationTechniqueMember
2019-06-30
0000898174
us-gaap:EquitySecuritiesMember
us-gaap:MarketApproachValuationTechniqueMember
2019-06-30
0000898174
rga:EmbeddedDerivativesInIndexedAnnuityMember
us-gaap:IncomeApproachValuationTechniqueMember
2018-12-31
0000898174
rga:EmbeddedDerivativesInVariableAnnuityMember
us-gaap:IncomeApproachValuationTechniqueMember
2018-12-31
0000898174
us-gaap:ForeignGovernmentDebtMember
2019-06-30
0000898174
us-gaap:USGovernmentAgenciesDebtSecuritiesMember
2019-06-30
0000898174
rga:FundsWithheldAtInterestEmbeddedDerivativesMember
2019-06-30
0000898174
us-gaap:AssetBackedSecuritiesMember
2018-12-31
0000898174
us-gaap:ForeignGovernmentDebtMember
2018-12-31
0000898174
rga:FundsWithheldAtInterestEmbeddedDerivativesMember
2018-12-31
0000898174
us-gaap:EquitySecuritiesMember
us-gaap:MarketApproachValuationTechniqueMember
2018-12-31
0000898174
rga:EmbeddedDerivativesInVariableAnnuityMember
us-gaap:IncomeApproachValuationTechniqueMember
2019-06-30
0000898174
rga:MortalitySwapMember
us-gaap:IncomeApproachValuationTechniqueMember
2018-12-31
0000898174
us-gaap:CorporateDebtSecuritiesMember
us-gaap:MarketApproachValuationTechniqueMember
2019-06-30
0000898174
us-gaap:USGovernmentAgenciesDebtSecuritiesMember
2018-12-31
0000898174
us-gaap:CorporateDebtSecuritiesMember
us-gaap:MarketApproachValuationTechniqueMember
2018-12-31
0000898174
rga:MortalitySwapMember
us-gaap:IncomeApproachValuationTechniqueMember
2019-06-30
0000898174
rga:LongevitySwapMember
us-gaap:IncomeApproachValuationTechniqueMember
2018-12-31
0000898174
us-gaap:AssetBackedSecuritiesMember
2019-06-30
0000898174
rga:LongevitySwapMember
us-gaap:IncomeApproachValuationTechniqueMember
2019-06-30
0000898174
us-gaap:EquitySecuritiesMember
2018-01-01
2018-06-30
0000898174
us-gaap:CorporateDebtSecuritiesMember
2018-04-01
2018-06-30
0000898174
rga:CanadianProvincialGovernmentsMember
2018-04-01
2018-06-30
0000898174
us-gaap:CorporateDebtSecuritiesMember
us-gaap:InvestmentIncomeMember
2018-04-01
2018-06-30
0000898174
us-gaap:AssetBackedSecuritiesMember
us-gaap:GainLossOnInvestmentsMember1
2018-04-01
2018-06-30
0000898174
us-gaap:AssetBackedSecuritiesMember
us-gaap:InvestmentIncomeMember
2018-04-01
2018-06-30
0000898174
us-gaap:CorporateDebtSecuritiesMember
us-gaap:GainLossOnInvestmentsMember1
2018-04-01
2018-06-30
0000898174
us-gaap:AssetBackedSecuritiesMember
2018-04-01
2018-06-30
0000898174
us-gaap:ResidentialMortgageBackedSecuritiesMember
2018-04-01
2018-06-30
0000898174
us-gaap:CorporateDebtSecuritiesMember
2018-03-31
0000898174
us-gaap:ResidentialMortgageBackedSecuritiesMember
us-gaap:GainLossOnInvestmentsMember1
2018-04-01
2018-06-30
0000898174
us-gaap:ResidentialMortgageBackedSecuritiesMember
us-gaap:InvestmentIncomeMember
2018-04-01
2018-06-30
0000898174
us-gaap:AssetBackedSecuritiesMember
2018-03-31
0000898174
rga:CanadianProvincialGovernmentsMember
us-gaap:GainLossOnInvestmentsMember1
2018-04-01
2018-06-30
0000898174
rga:CanadianProvincialGovernmentsMember
us-gaap:InvestmentIncomeMember
2018-04-01
2018-06-30
0000898174
us-gaap:ResidentialMortgageBackedSecuritiesMember
2018-03-31
0000898174
rga:CanadianProvincialGovernmentsMember
2018-03-31
0000898174
us-gaap:AssetBackedSecuritiesMember
us-gaap:InvestmentIncomeMember
2019-01-01
2019-06-30
0000898174
us-gaap:ResidentialMortgageBackedSecuritiesMember
2019-01-01
2019-06-30
0000898174
rga:CanadianProvincialGovernmentsMember
2019-06-30
0000898174
us-gaap:CorporateDebtSecuritiesMember
2019-06-30
0000898174
rga:CanadianProvincialGovernmentsMember
us-gaap:GainLossOnInvestmentsMember1
2019-01-01
2019-06-30
0000898174
rga:CanadianProvincialGovernmentsMember
2019-01-01
2019-06-30
0000898174
rga:CanadianProvincialGovernmentsMember
us-gaap:InvestmentIncomeMember
2019-01-01
2019-06-30
0000898174
us-gaap:CorporateDebtSecuritiesMember
us-gaap:InvestmentIncomeMember
2019-01-01
2019-06-30
0000898174
us-gaap:AssetBackedSecuritiesMember
us-gaap:GainLossOnInvestmentsMember1
2019-01-01
2019-06-30
0000898174
us-gaap:CorporateDebtSecuritiesMember
2019-01-01
2019-06-30
0000898174
us-gaap:ResidentialMortgageBackedSecuritiesMember
2018-12-31
0000898174
us-gaap:ResidentialMortgageBackedSecuritiesMember
us-gaap:GainLossOnInvestmentsMember1
2019-01-01
2019-06-30
0000898174
us-gaap:ResidentialMortgageBackedSecuritiesMember
us-gaap:InvestmentIncomeMember
2019-01-01
2019-06-30
0000898174
us-gaap:ResidentialMortgageBackedSecuritiesMember
2019-06-30
0000898174
us-gaap:AssetBackedSecuritiesMember
2019-01-01
2019-06-30
0000898174
rga:CanadianProvincialGovernmentsMember
2018-12-31
0000898174
us-gaap:CorporateDebtSecuritiesMember
2018-12-31
0000898174
us-gaap:CorporateDebtSecuritiesMember
us-gaap:GainLossOnInvestmentsMember1
2019-01-01
2019-06-30
0000898174
us-gaap:ForeignGovernmentDebtMember
2018-01-01
2018-06-30
0000898174
us-gaap:CommercialMortgageBackedSecuritiesMember
2018-06-30
0000898174
us-gaap:USStatesAndPoliticalSubdivisionsMember
2018-01-01
2018-06-30
0000898174
us-gaap:CommercialMortgageBackedSecuritiesMember
2018-01-01
2018-06-30
0000898174
us-gaap:ForeignGovernmentDebtMember
us-gaap:InvestmentIncomeMember
2018-01-01
2018-06-30
0000898174
us-gaap:USStatesAndPoliticalSubdivisionsMember
2018-06-30
0000898174
us-gaap:USStatesAndPoliticalSubdivisionsMember
2017-12-31
0000898174
us-gaap:USStatesAndPoliticalSubdivisionsMember
us-gaap:InvestmentIncomeMember
2018-01-01
2018-06-30
0000898174
us-gaap:USGovernmentAgenciesDebtSecuritiesMember
us-gaap:InvestmentIncomeMember
2018-01-01
2018-06-30
0000898174
us-gaap:ForeignGovernmentDebtMember
2018-06-30
0000898174
us-gaap:CommercialMortgageBackedSecuritiesMember
2017-12-31
0000898174
us-gaap:CommercialMortgageBackedSecuritiesMember
us-gaap:InvestmentIncomeMember
2018-01-01
2018-06-30
0000898174
us-gaap:USGovernmentAgenciesDebtSecuritiesMember
2017-12-31
0000898174
us-gaap:USGovernmentAgenciesDebtSecuritiesMember
2018-01-01
2018-06-30
0000898174
us-gaap:USGovernmentAgenciesDebtSecuritiesMember
2018-06-30
0000898174
us-gaap:ForeignGovernmentDebtMember
2017-12-31
0000898174
us-gaap:EquitySecuritiesMember
us-gaap:GainLossOnInvestmentsMember1
2019-01-01
2019-06-30
0000898174
us-gaap:USGovernmentAgenciesDebtSecuritiesMember
us-gaap:InvestmentIncomeMember
2019-01-01
2019-06-30
0000898174
us-gaap:USStatesAndPoliticalSubdivisionsMember
us-gaap:GainLossOnInvestmentsMember1
2019-01-01
2019-06-30
0000898174
us-gaap:CommercialMortgageBackedSecuritiesMember
us-gaap:InvestmentIncomeMember
2019-01-01
2019-06-30
0000898174
us-gaap:ForeignGovernmentDebtSecuritiesMember
us-gaap:InvestmentIncomeMember
2019-01-01
2019-06-30
0000898174
us-gaap:USGovernmentAgenciesDebtSecuritiesMember
2019-01-01
2019-06-30
0000898174
us-gaap:USStatesAndPoliticalSubdivisionsMember
us-gaap:InvestmentIncomeMember
2019-01-01
2019-06-30
0000898174
us-gaap:ForeignGovernmentDebtSecuritiesMember
us-gaap:GainLossOnInvestmentsMember1
2019-01-01
2019-06-30
0000898174
us-gaap:CommercialMortgageBackedSecuritiesMember
2019-01-01
2019-06-30
0000898174
us-gaap:EquitySecuritiesMember
2019-01-01
2019-06-30
0000898174
us-gaap:USStatesAndPoliticalSubdivisionsMember
2019-01-01
2019-06-30
0000898174
us-gaap:ForeignGovernmentDebtSecuritiesMember
2019-06-30
0000898174
us-gaap:USGovernmentAgenciesDebtSecuritiesMember
us-gaap:GainLossOnInvestmentsMember1
2019-01-01
2019-06-30
0000898174
us-gaap:ForeignGovernmentDebtSecuritiesMember
2019-01-01
2019-06-30
0000898174
us-gaap:USStatesAndPoliticalSubdivisionsMember
2018-12-31
0000898174
us-gaap:ForeignGovernmentDebtSecuritiesMember
2018-12-31
0000898174
us-gaap:USStatesAndPoliticalSubdivisionsMember
2019-06-30
0000898174
us-gaap:EquitySecuritiesMember
2019-06-30
0000898174
us-gaap:EquitySecuritiesMember
us-gaap:InvestmentIncomeMember
2019-01-01
2019-06-30
0000898174
us-gaap:EquitySecuritiesMember
2018-12-31
0000898174
us-gaap:CommercialMortgageBackedSecuritiesMember
2018-12-31
0000898174
us-gaap:CommercialMortgageBackedSecuritiesMember
us-gaap:GainLossOnInvestmentsMember1
2019-01-01
2019-06-30
0000898174
us-gaap:CommercialMortgageBackedSecuritiesMember
2019-06-30
0000898174
rga:MortalitySwapMember
2018-03-31
0000898174
rga:FundsWithheldAtInterestEmbeddedDerivativesMember
2018-04-01
2018-06-30
0000898174
us-gaap:ShortTermInvestmentsMember
us-gaap:GainLossOnInvestmentsMember1
2018-04-01
2018-06-30
0000898174
rga:FundsWithheldAtInterestEmbeddedDerivativesMember
us-gaap:InterestIncomeMember
2018-04-01
2018-06-30
0000898174
rga:InterestSensitiveContractLiabilitiesEmbeddedDerivativesMember
2018-03-31
0000898174
rga:MortalitySwapMember
us-gaap:InterestIncomeMember
2018-04-01
2018-06-30
0000898174
us-gaap:EquitySecuritiesMember
us-gaap:GainLossOnInvestmentsMember1
2018-04-01
2018-06-30
0000898174
us-gaap:ShortTermInvestmentsMember
us-gaap:InterestIncomeMember
2018-04-01
2018-06-30
0000898174
rga:InterestSensitiveContractLiabilitiesEmbeddedDerivativesMember
us-gaap:GainLossOnInvestmentsMember1
2018-04-01
2018-06-30
0000898174
rga:LongevitySwapMember
2018-04-01
2018-06-30
0000898174
us-gaap:ShortTermInvestmentsMember
us-gaap:OtherIncomeMember
2018-04-01
2018-06-30
0000898174
rga:LongevitySwapMember
us-gaap:GainLossOnInvestmentsMember1
2018-04-01
2018-06-30
0000898174
rga:InterestSensitiveContractLiabilitiesEmbeddedDerivativesMember
2018-04-01
2018-06-30
0000898174
rga:MortalitySwapMember
2018-04-01
2018-06-30
0000898174
rga:MortalitySwapMember
us-gaap:OtherIncomeMember
2018-04-01
2018-06-30
0000898174
rga:InterestSensitiveContractLiabilitiesEmbeddedDerivativesMember
us-gaap:InterestIncomeMember
2018-04-01
2018-06-30
0000898174
us-gaap:EquitySecuritiesMember
us-gaap:InterestIncomeMember
2018-04-01
2018-06-30
0000898174
us-gaap:EquitySecuritiesMember
2018-04-01
2018-06-30
0000898174
us-gaap:EquitySecuritiesMember
2018-03-31
0000898174
rga:LongevitySwapMember
us-gaap:OtherIncomeMember
2018-04-01
2018-06-30
0000898174
rga:FundsWithheldAtInterestEmbeddedDerivativesMember
us-gaap:GainLossOnInvestmentsMember1
2018-04-01
2018-06-30
0000898174
us-gaap:ShortTermInvestmentsMember
2018-04-01
2018-06-30
0000898174
rga:LongevitySwapMember
us-gaap:InterestIncomeMember
2018-04-01
2018-06-30
0000898174
rga:FundsWithheldAtInterestEmbeddedDerivativesMember
2018-06-30
0000898174
rga:MortalitySwapMember
2018-06-30
0000898174
rga:InterestSensitiveContractLiabilitiesEmbeddedDerivativesMember
2018-06-30
0000898174
rga:FundsWithheldAtInterestEmbeddedDerivativesMember
2018-03-31
0000898174
rga:MortalitySwapMember
us-gaap:GainLossOnInvestmentsMember1
2018-04-01
2018-06-30
0000898174
rga:InterestSensitiveContractLiabilitiesEmbeddedDerivativesMember
us-gaap:OtherIncomeMember
2018-04-01
2018-06-30
0000898174
us-gaap:EquitySecuritiesMember
2018-06-30
0000898174
rga:FundsWithheldAtInterestEmbeddedDerivativesMember
us-gaap:OtherIncomeMember
2018-04-01
2018-06-30
0000898174
us-gaap:ShortTermInvestmentsMember
2018-06-30
0000898174
us-gaap:ShortTermInvestmentsMember
2018-03-31
0000898174
us-gaap:EquitySecuritiesMember
us-gaap:OtherIncomeMember
2018-04-01
2018-06-30
0000898174
rga:LongevitySwapMember
2018-03-31
0000898174
rga:LongevitySwapMember
2018-06-30
0000898174
rga:LongevitySwapMember
2018-12-31
0000898174
rga:LongevitySwapMember
2019-01-01
2019-06-30
0000898174
us-gaap:CashAndCashEquivalentsMember
2019-06-30
0000898174
rga:MortalitySwapMember
2018-12-31
0000898174
rga:FundsWithheldAtInterestEmbeddedDerivativesMember
us-gaap:OtherIncomeMember
2019-01-01
2019-06-30
0000898174
us-gaap:ShortTermInvestmentsMember
us-gaap:OtherIncomeMember
2019-01-01
2019-06-30
0000898174
rga:InterestSensitiveContractLiabilitiesEmbeddedDerivativesMember
us-gaap:InvestmentIncomeMember
2019-01-01
2019-06-30
0000898174
us-gaap:ShortTermInvestmentsMember
us-gaap:GainLossOnInvestmentsMember1
2019-01-01
2019-06-30
0000898174
rga:InterestSensitiveContractLiabilitiesEmbeddedDerivativesMember
us-gaap:GainLossOnInvestmentsMember1
2019-01-01
2019-06-30
0000898174
rga:LongevitySwapMember
2019-06-30
0000898174
rga:InterestSensitiveContractLiabilitiesEmbeddedDerivativesMember
us-gaap:InterestIncomeMember
2019-01-01
2019-06-30
0000898174
rga:InterestSensitiveContractLiabilitiesEmbeddedDerivativesMember
2018-12-31
0000898174
rga:InterestSensitiveContractLiabilitiesEmbeddedDerivativesMember
2019-01-01
2019-06-30
0000898174
rga:MortalitySwapMember
2019-01-01
2019-06-30
0000898174
rga:LongevitySwapMember
us-gaap:GainLossOnInvestmentsMember1
2019-01-01
2019-06-30
0000898174
rga:FundsWithheldAtInterestEmbeddedDerivativesMember
us-gaap:GainLossOnInvestmentsMember1
2019-01-01
2019-06-30
0000898174
rga:FundsWithheldAtInterestEmbeddedDerivativesMember
us-gaap:InvestmentIncomeMember
2019-01-01
2019-06-30
0000898174
us-gaap:CashAndCashEquivalentsMember
us-gaap:InvestmentIncomeMember
2019-01-01
2019-06-30
0000898174
us-gaap:CashAndCashEquivalentsMember
2019-01-01
2019-06-30
0000898174
us-gaap:ShortTermInvestmentsMember
us-gaap:InterestIncomeMember
2019-01-01
2019-06-30
0000898174
rga:MortalitySwapMember
2019-06-30
0000898174
rga:FundsWithheldAtInterestEmbeddedDerivativesMember
us-gaap:InterestIncomeMember
2019-01-01
2019-06-30
0000898174
rga:MortalitySwapMember
us-gaap:GainLossOnInvestmentsMember1
2019-01-01
2019-06-30
0000898174
rga:MortalitySwapMember
us-gaap:InvestmentIncomeMember
2019-01-01
2019-06-30
0000898174
us-gaap:ShortTermInvestmentsMember
2019-06-30
0000898174
us-gaap:ShortTermInvestmentsMember
2019-01-01
2019-06-30
0000898174
rga:LongevitySwapMember
us-gaap:OtherIncomeMember
2019-01-01
2019-06-30
0000898174
rga:MortalitySwapMember
us-gaap:InterestIncomeMember
2019-01-01
2019-06-30
0000898174
rga:LongevitySwapMember
us-gaap:InterestIncomeMember
2019-01-01
2019-06-30
0000898174
us-gaap:CashAndCashEquivalentsMember
us-gaap:OtherIncomeMember
2019-01-01
2019-06-30
0000898174
rga:InterestSensitiveContractLiabilitiesEmbeddedDerivativesMember
us-gaap:OtherIncomeMember
2019-01-01
2019-06-30
0000898174
us-gaap:ShortTermInvestmentsMember
2018-12-31
0000898174
us-gaap:ShortTermInvestmentsMember
us-gaap:InvestmentIncomeMember
2019-01-01
2019-06-30
0000898174
rga:FundsWithheldAtInterestEmbeddedDerivativesMember
2019-01-01
2019-06-30
0000898174
rga:LongevitySwapMember
us-gaap:InvestmentIncomeMember
2019-01-01
2019-06-30
0000898174
us-gaap:CashAndCashEquivalentsMember
us-gaap:InterestIncomeMember
2019-01-01
2019-06-30
0000898174
us-gaap:CashAndCashEquivalentsMember
us-gaap:GainLossOnInvestmentsMember1
2019-01-01
2019-06-30
0000898174
rga:InterestSensitiveContractLiabilitiesEmbeddedDerivativesMember
2019-06-30
0000898174
rga:MortalitySwapMember
us-gaap:OtherIncomeMember
2019-01-01
2019-06-30
0000898174
us-gaap:CashAndCashEquivalentsMember
2018-12-31
0000898174
us-gaap:EquitySecuritiesMember
2019-03-31
0000898174
us-gaap:USStatesAndPoliticalSubdivisionsMember
us-gaap:GainLossOnInvestmentsMember1
2019-04-01
2019-06-30
0000898174
us-gaap:EquitySecuritiesMember
us-gaap:GainLossOnInvestmentsMember1
2019-04-01
2019-06-30
0000898174
us-gaap:USGovernmentAgenciesDebtSecuritiesMember
2019-03-31
0000898174
us-gaap:CommercialMortgageBackedSecuritiesMember
us-gaap:GainLossOnInvestmentsMember1
2019-04-01
2019-06-30
0000898174
us-gaap:USGovernmentAgenciesDebtSecuritiesMember
us-gaap:GainLossOnInvestmentsMember1
2019-04-01
2019-06-30
0000898174
us-gaap:USGovernmentAgenciesDebtSecuritiesMember
2019-04-01
2019-06-30
0000898174
us-gaap:EquitySecuritiesMember
us-gaap:InvestmentIncomeMember
2019-04-01
2019-06-30
0000898174
us-gaap:USGovernmentAgenciesDebtSecuritiesMember
us-gaap:InvestmentIncomeMember
2019-04-01
2019-06-30
0000898174
us-gaap:CommercialMortgageBackedSecuritiesMember
us-gaap:InvestmentIncomeMember
2019-04-01
2019-06-30
0000898174
us-gaap:ForeignGovernmentDebtSecuritiesMember
2019-04-01
2019-06-30
0000898174
us-gaap:USStatesAndPoliticalSubdivisionsMember
2019-04-01
2019-06-30
0000898174
us-gaap:ForeignGovernmentDebtSecuritiesMember
us-gaap:GainLossOnInvestmentsMember1
2019-04-01
2019-06-30
0000898174
us-gaap:CommercialMortgageBackedSecuritiesMember
2019-03-31
0000898174
us-gaap:ForeignGovernmentDebtSecuritiesMember
2019-03-31
0000898174
us-gaap:ForeignGovernmentDebtSecuritiesMember
us-gaap:InvestmentIncomeMember
2019-04-01
2019-06-30
0000898174
us-gaap:USStatesAndPoliticalSubdivisionsMember
us-gaap:InvestmentIncomeMember
2019-04-01
2019-06-30
0000898174
us-gaap:EquitySecuritiesMember
2019-04-01
2019-06-30
0000898174
us-gaap:CommercialMortgageBackedSecuritiesMember
2019-04-01
2019-06-30
0000898174
us-gaap:USStatesAndPoliticalSubdivisionsMember
2019-03-31
0000898174
us-gaap:FairValueInputsLevel1Member
us-gaap:CommercialMortgageBackedSecuritiesMember
2018-12-31
0000898174
us-gaap:StockOptionMember
us-gaap:FairValueInputsLevel3Member
2018-12-31
0000898174
rga:ConsumerPriceIndexSwapMember
us-gaap:FairValueInputsLevel2Member
2018-12-31
0000898174
us-gaap:InterestRateSwapMember
us-gaap:FairValueInputsLevel3Member
2018-12-31
0000898174
us-gaap:FairValueInputsLevel1Member
2018-12-31
0000898174
us-gaap:FairValueInputsLevel2Member
2018-12-31
0000898174
us-gaap:FairValueInputsLevel3Member
2018-12-31
0000898174
us-gaap:CurrencySwapMember
us-gaap:FairValueInputsLevel1Member
2018-12-31
0000898174
us-gaap:CurrencySwapMember
2018-12-31
0000898174
us-gaap:CreditDefaultSwapMember
us-gaap:FairValueInputsLevel2Member
2018-12-31
0000898174
us-gaap:ForeignExchangeForwardMember
us-gaap:FairValueInputsLevel2Member
2018-12-31
0000898174
us-gaap:StockOptionMember
us-gaap:FairValueInputsLevel2Member
2018-12-31
0000898174
us-gaap:InterestRateSwapMember
us-gaap:FairValueInputsLevel2Member
2018-12-31
0000898174
us-gaap:CreditDefaultSwapMember
us-gaap:FairValueInputsLevel3Member
2018-12-31
0000898174
us-gaap:FairValueInputsLevel1Member
us-gaap:ForeignGovernmentDebtSecuritiesMember
2018-12-31
0000898174
us-gaap:FairValueInputsLevel3Member
us-gaap:USStatesAndPoliticalSubdivisionsMember
2018-12-31
0000898174
us-gaap:FairValueInputsLevel2Member
us-gaap:ResidentialMortgageBackedSecuritiesMember
2018-12-31
0000898174
us-gaap:CurrencySwapMember
us-gaap:FairValueInputsLevel2Member
2018-12-31
0000898174
rga:FairValueOptionContractholderDirectedUnitLinkedInvestmentsMember
us-gaap:FairValueInputsLevel1Member
2018-12-31
0000898174
us-gaap:StockOptionMember
2018-12-31
0000898174
us-gaap:FairValueInputsLevel3Member
us-gaap:AssetBackedSecuritiesMember
2018-12-31
0000898174
us-gaap:FairValueInputsLevel2Member
us-gaap:ForeignGovernmentDebtSecuritiesMember
2018-12-31
0000898174
us-gaap:ForeignExchangeForwardMember
us-gaap:FairValueInputsLevel1Member
2018-12-31
0000898174
rga:MortalitySwapMember
2018-12-31
0000898174
us-gaap:StockOptionMember
us-gaap:FairValueInputsLevel1Member
2018-12-31
0000898174
us-gaap:InterestRateSwapMember
2018-12-31
0000898174
rga:FairValueOptionContractholderDirectedUnitLinkedInvestmentsMember
2018-12-31
0000898174
rga:MortalitySwapMember
us-gaap:FairValueInputsLevel2Member
2018-12-31
0000898174
us-gaap:CreditDefaultSwapMember
us-gaap:FairValueInputsLevel1Member
2018-12-31
0000898174
rga:ConsumerPriceIndexSwapMember
us-gaap:FairValueInputsLevel3Member
2018-12-31
0000898174
us-gaap:FairValueInputsLevel3Member
us-gaap:USGovernmentAgenciesDebtSecuritiesMember
2018-12-31
0000898174
us-gaap:FairValueInputsLevel1Member
rga:CanadianProvincialGovernmentsMember
2018-12-31
0000898174
us-gaap:FairValueInputsLevel3Member
us-gaap:CorporateDebtSecuritiesMember
2018-12-31
0000898174
us-gaap:FairValueInputsLevel2Member
us-gaap:CommercialMortgageBackedSecuritiesMember
2018-12-31
0000898174
us-gaap:FairValueInputsLevel2Member
us-gaap:AssetBackedSecuritiesMember
2018-12-31
0000898174
us-gaap:CurrencySwapMember
us-gaap:FairValueInputsLevel3Member
2018-12-31
0000898174
rga:ConsumerPriceIndexSwapMember
2018-12-31
0000898174
us-gaap:InterestRateSwapMember
us-gaap:FairValueInputsLevel1Member
2018-12-31
0000898174
us-gaap:FairValueInputsLevel3Member
us-gaap:ForeignGovernmentDebtSecuritiesMember
2018-12-31
0000898174
us-gaap:FairValueInputsLevel1Member
us-gaap:ResidentialMortgageBackedSecuritiesMember
2018-12-31
0000898174
us-gaap:CreditDefaultSwapMember
2018-12-31
0000898174
us-gaap:FairValueInputsLevel2Member
us-gaap:USGovernmentAgenciesDebtSecuritiesMember
2018-12-31
0000898174
rga:ConsumerPriceIndexSwapMember
us-gaap:FairValueInputsLevel1Member
2018-12-31
0000898174
rga:MortalitySwapMember
us-gaap:FairValueInputsLevel3Member
2018-12-31
0000898174
us-gaap:ForeignExchangeForwardMember
2018-12-31
0000898174
us-gaap:FairValueInputsLevel2Member
rga:CanadianProvincialGovernmentsMember
2018-12-31
0000898174
us-gaap:FairValueInputsLevel1Member
us-gaap:AssetBackedSecuritiesMember
2018-12-31
0000898174
us-gaap:FairValueInputsLevel1Member
us-gaap:USStatesAndPoliticalSubdivisionsMember
2018-12-31
0000898174
us-gaap:FairValueInputsLevel3Member
rga:CanadianProvincialGovernmentsMember
2018-12-31
0000898174
us-gaap:FairValueInputsLevel2Member
us-gaap:USStatesAndPoliticalSubdivisionsMember
2018-12-31
0000898174
us-gaap:FairValueInputsLevel1Member
us-gaap:CorporateDebtSecuritiesMember
2018-12-31
0000898174
us-gaap:FairValueInputsLevel3Member
us-gaap:ResidentialMortgageBackedSecuritiesMember
2018-12-31
0000898174
us-gaap:FairValueInputsLevel1Member
us-gaap:USGovernmentAgenciesDebtSecuritiesMember
2018-12-31
0000898174
rga:FairValueOptionContractholderDirectedUnitLinkedInvestmentsMember
us-gaap:FairValueInputsLevel3Member
2018-12-31
0000898174
us-gaap:FairValueInputsLevel3Member
us-gaap:CommercialMortgageBackedSecuritiesMember
2018-12-31
0000898174
rga:FairValueOptionContractholderDirectedUnitLinkedInvestmentsMember
us-gaap:FairValueInputsLevel2Member
2018-12-31
0000898174
us-gaap:FairValueInputsLevel2Member
us-gaap:CorporateDebtSecuritiesMember
2018-12-31
0000898174
rga:MortalitySwapMember
us-gaap:FairValueInputsLevel1Member
2018-12-31
0000898174
us-gaap:ForeignExchangeForwardMember
us-gaap:FairValueInputsLevel3Member
2018-12-31
0000898174
us-gaap:ResidentialMortgageBackedSecuritiesMember
us-gaap:InvestmentIncomeMember
2019-04-01
2019-06-30
0000898174
us-gaap:AssetBackedSecuritiesMember
us-gaap:InvestmentIncomeMember
2019-04-01
2019-06-30
0000898174
us-gaap:ResidentialMortgageBackedSecuritiesMember
2019-03-31
0000898174
us-gaap:CorporateDebtSecuritiesMember
2019-04-01
2019-06-30
0000898174
us-gaap:ResidentialMortgageBackedSecuritiesMember
2019-04-01
2019-06-30
0000898174
rga:CanadianProvincialGovernmentsMember
2019-03-31
0000898174
us-gaap:AssetBackedSecuritiesMember
us-gaap:GainLossOnInvestmentsMember1
2019-04-01
2019-06-30
0000898174
rga:CanadianProvincialGovernmentsMember
2019-04-01
2019-06-30
0000898174
us-gaap:CorporateDebtSecuritiesMember
2019-03-31
0000898174
us-gaap:AssetBackedSecuritiesMember
2019-04-01
2019-06-30
0000898174
us-gaap:CorporateDebtSecuritiesMember
us-gaap:GainLossOnInvestmentsMember1
2019-04-01
2019-06-30
0000898174
rga:CanadianProvincialGovernmentsMember
us-gaap:InvestmentIncomeMember
2019-04-01
2019-06-30
0000898174
us-gaap:CorporateDebtSecuritiesMember
us-gaap:InvestmentIncomeMember
2019-04-01
2019-06-30
0000898174
rga:CanadianProvincialGovernmentsMember
us-gaap:GainLossOnInvestmentsMember1
2019-04-01
2019-06-30
0000898174
us-gaap:AssetBackedSecuritiesMember
2019-03-31
0000898174
us-gaap:ResidentialMortgageBackedSecuritiesMember
us-gaap:GainLossOnInvestmentsMember1
2019-04-01
2019-06-30
0000898174
us-gaap:CarryingReportedAmountFairValueDisclosureMember
2018-12-31
0000898174
us-gaap:FairValueInputsLevel1Member
us-gaap:EstimateOfFairValueFairValueDisclosureMember
2018-12-31
0000898174
us-gaap:FairValueInputsLevel1Member
us-gaap:EstimateOfFairValueFairValueDisclosureMember
2019-06-30
0000898174
us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember
us-gaap:EstimateOfFairValueFairValueDisclosureMember
2019-06-30
0000898174
us-gaap:FairValueInputsLevel2Member
us-gaap:EstimateOfFairValueFairValueDisclosureMember
2019-06-30
0000898174
us-gaap:FairValueInputsLevel3Member
us-gaap:EstimateOfFairValueFairValueDisclosureMember
2018-12-31
0000898174
us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember
us-gaap:EstimateOfFairValueFairValueDisclosureMember
2018-12-31
0000898174
us-gaap:FairValueInputsLevel3Member
us-gaap:EstimateOfFairValueFairValueDisclosureMember
2019-06-30
0000898174
us-gaap:FairValueInputsLevel2Member
us-gaap:EstimateOfFairValueFairValueDisclosureMember
2018-12-31
0000898174
us-gaap:EstimateOfFairValueFairValueDisclosureMember
2019-06-30
0000898174
us-gaap:CarryingReportedAmountFairValueDisclosureMember
2019-06-30
0000898174
us-gaap:EstimateOfFairValueFairValueDisclosureMember
2018-12-31
0000898174
rga:LongevitySwapMember
2017-12-31
0000898174
rga:LongevitySwapMember
us-gaap:OtherIncomeMember
2018-01-01
2018-06-30
0000898174
rga:InterestSensitiveContractLiabilitiesEmbeddedDerivativesMember
2018-01-01
2018-06-30
0000898174
rga:InterestSensitiveContractLiabilitiesEmbeddedDerivativesMember
2017-12-31
0000898174
rga:FundsWithheldAtInterestEmbeddedDerivativesMember
2017-12-31
0000898174
us-gaap:ShortTermInvestmentsMember
2018-01-01
2018-06-30
0000898174
us-gaap:EquitySecuritiesMember
us-gaap:InterestIncomeMember
2018-01-01
2018-06-30
0000898174
rga:MortalitySwapMember
2018-01-01
2018-06-30
0000898174
us-gaap:ShortTermInvestmentsMember
2017-12-31
0000898174
rga:LongevitySwapMember
2018-01-01
2018-06-30
0000898174
rga:MortalitySwapMember
us-gaap:OtherIncomeMember
2018-01-01
2018-06-30
0000898174
rga:MortalitySwapMember
us-gaap:GainLossOnInvestmentsMember1
2018-01-01
2018-06-30
0000898174
rga:FundsWithheldAtInterestEmbeddedDerivativesMember
us-gaap:InterestIncomeMember
2018-01-01
2018-06-30
0000898174
rga:InterestSensitiveContractLiabilitiesEmbeddedDerivativesMember
us-gaap:InterestIncomeMember
2018-01-01
2018-06-30
0000898174
rga:InterestSensitiveContractLiabilitiesEmbeddedDerivativesMember
us-gaap:OtherIncomeMember
2018-01-01
2018-06-30
0000898174
us-gaap:EquitySecuritiesMember
us-gaap:OtherIncomeMember
2018-01-01
2018-06-30
0000898174
rga:FundsWithheldAtInterestEmbeddedDerivativesMember
us-gaap:GainLossOnInvestmentsMember1
2018-01-01
2018-06-30
0000898174
us-gaap:ShortTermInvestmentsMember
us-gaap:InterestIncomeMember
2018-01-01
2018-06-30
0000898174
us-gaap:EquitySecuritiesMember
us-gaap:GainLossOnInvestmentsMember1
2018-01-01
2018-06-30
0000898174
us-gaap:ShortTermInvestmentsMember
us-gaap:GainLossOnInvestmentsMember1
2018-01-01
2018-06-30
0000898174
rga:FundsWithheldAtInterestEmbeddedDerivativesMember
2018-01-01
2018-06-30
0000898174
rga:MortalitySwapMember
us-gaap:InterestIncomeMember
2018-01-01
2018-06-30
0000898174
rga:LongevitySwapMember
us-gaap:InterestIncomeMember
2018-01-01
2018-06-30
0000898174
rga:LongevitySwapMember
us-gaap:GainLossOnInvestmentsMember1
2018-01-01
2018-06-30
0000898174
rga:FundsWithheldAtInterestEmbeddedDerivativesMember
us-gaap:OtherIncomeMember
2018-01-01
2018-06-30
0000898174
rga:InterestSensitiveContractLiabilitiesEmbeddedDerivativesMember
us-gaap:GainLossOnInvestmentsMember1
2018-01-01
2018-06-30
0000898174
rga:MortalitySwapMember
2017-12-31
0000898174
us-gaap:ShortTermInvestmentsMember
us-gaap:OtherIncomeMember
2018-01-01
2018-06-30
0000898174
us-gaap:EquitySecuritiesMember
2017-12-31
0000898174
rga:LongevitySwapMember
2019-04-01
2019-06-30
0000898174
rga:LongevitySwapMember
us-gaap:InsuranceClaimsMember
2019-04-01
2019-06-30
0000898174
us-gaap:CashEquivalentsMember
us-gaap:InvestmentIncomeMember
2019-04-01
2019-06-30
0000898174
us-gaap:CashEquivalentsMember
2019-04-01
2019-06-30
0000898174
rga:MortalitySwapMember
us-gaap:InvestmentIncomeMember
2019-04-01
2019-06-30
0000898174
rga:LongevitySwapMember
2019-03-31
0000898174
rga:InterestSensitiveContractLiabilitiesEmbeddedDerivativesMember
us-gaap:InvestmentIncomeMember
2019-04-01
2019-06-30
0000898174
rga:MortalitySwapMember
rga:PolicyAcquisitionCostsAndOtherInsuranceExpensesMember
2019-04-01
2019-06-30
0000898174
rga:LongevitySwapMember
us-gaap:GainLossOnInvestmentsMember1
2019-04-01
2019-06-30
0000898174
rga:FundsWithheldAtInterestEmbeddedDerivativesMember
2019-04-01
2019-06-30
0000898174
us-gaap:CashEquivalentsMember
us-gaap:InsuranceClaimsMember
2019-04-01
2019-06-30
0000898174
rga:FundsWithheldAtInterestEmbeddedDerivativesMember
us-gaap:GainLossOnInvestmentsMember1
2019-04-01
2019-06-30
0000898174
us-gaap:ShortTermInvestmentsMember
us-gaap:GainLossOnInvestmentsMember1
2019-04-01
2019-06-30
0000898174
us-gaap:ShortTermInvestmentsMember
us-gaap:InsuranceClaimsMember
2019-04-01
2019-06-30
0000898174
us-gaap:CashEquivalentsMember
us-gaap:GainLossOnInvestmentsMember1
2019-04-01
2019-06-30
0000898174
us-gaap:ShortTermInvestmentsMember
us-gaap:InvestmentIncomeMember
2019-04-01
2019-06-30
0000898174
us-gaap:ShortTermInvestmentsMember
2019-04-01
2019-06-30
0000898174
rga:InterestSensitiveContractLiabilitiesEmbeddedDerivativesMember
2019-04-01
2019-06-30
0000898174
rga:FundsWithheldAtInterestEmbeddedDerivativesMember
us-gaap:InvestmentIncomeMember
2019-04-01
2019-06-30
0000898174
rga:LongevitySwapMember
us-gaap:OtherIncomeMember
2019-04-01
2019-06-30
0000898174
rga:InterestSensitiveContractLiabilitiesEmbeddedDerivativesMember
us-gaap:InterestIncomeMember
2019-04-01
2019-06-30
0000898174
rga:MortalitySwapMember
us-gaap:InterestIncomeMember
2019-04-01
2019-06-30
0000898174
rga:MortalitySwapMember
2019-04-01
2019-06-30
0000898174
us-gaap:CashEquivalentsMember
rga:PolicyAcquisitionCostsAndOtherInsuranceExpensesMember
2019-04-01
2019-06-30
0000898174
rga:MortalitySwapMember
us-gaap:OtherIncomeMember
2019-04-01
2019-06-30
0000898174
rga:FundsWithheldAtInterestEmbeddedDerivativesMember
us-gaap:InterestIncomeMember
2019-04-01
2019-06-30
0000898174
rga:InterestSensitiveContractLiabilitiesEmbeddedDerivativesMember
us-gaap:InsuranceClaimsMember
2019-04-01
2019-06-30
0000898174
rga:MortalitySwapMember
us-gaap:GainLossOnInvestmentsMember1
2019-04-01
2019-06-30
0000898174
rga:MortalitySwapMember
us-gaap:InsuranceClaimsMember
2019-04-01
2019-06-30
0000898174
us-gaap:CashEquivalentsMember
2019-03-31
0000898174
rga:LongevitySwapMember
us-gaap:InterestIncomeMember
2019-04-01
2019-06-30
0000898174
rga:FundsWithheldAtInterestEmbeddedDerivativesMember
us-gaap:InsuranceClaimsMember
2019-04-01
2019-06-30
0000898174
us-gaap:ShortTermInvestmentsMember
us-gaap:OtherIncomeMember
2019-04-01
2019-06-30
0000898174
rga:FundsWithheldAtInterestEmbeddedDerivativesMember
us-gaap:OtherIncomeMember
2019-04-01
2019-06-30
0000898174
us-gaap:CashEquivalentsMember
us-gaap:OtherIncomeMember
2019-04-01
2019-06-30
0000898174
rga:InterestSensitiveContractLiabilitiesEmbeddedDerivativesMember
2019-03-31
0000898174
us-gaap:CashEquivalentsMember
us-gaap:InterestIncomeMember
2019-04-01
2019-06-30
0000898174
rga:LongevitySwapMember
rga:PolicyAcquisitionCostsAndOtherInsuranceExpensesMember
2019-04-01
2019-06-30
0000898174
rga:InterestSensitiveContractLiabilitiesEmbeddedDerivativesMember
us-gaap:GainLossOnInvestmentsMember1
2019-04-01
2019-06-30
0000898174
rga:FundsWithheldAtInterestEmbeddedDerivativesMember
2019-03-31
0000898174
us-gaap:ShortTermInvestmentsMember
2019-03-31
0000898174
us-gaap:CashEquivalentsMember
2019-06-30
0000898174
rga:MortalitySwapMember
2019-03-31
0000898174
us-gaap:ShortTermInvestmentsMember
us-gaap:InterestIncomeMember
2019-04-01
2019-06-30
0000898174
rga:LongevitySwapMember
us-gaap:InvestmentIncomeMember
2019-04-01
2019-06-30
0000898174
rga:InterestSensitiveContractLiabilitiesEmbeddedDerivativesMember
rga:PolicyAcquisitionCostsAndOtherInsuranceExpensesMember
2019-04-01
2019-06-30
0000898174
rga:InterestSensitiveContractLiabilitiesEmbeddedDerivativesMember
us-gaap:OtherIncomeMember
2019-04-01
2019-06-30
0000898174
rga:FundsWithheldAtInterestEmbeddedDerivativesMember
rga:PolicyAcquisitionCostsAndOtherInsuranceExpensesMember
2019-04-01
2019-06-30
0000898174
us-gaap:ShortTermInvestmentsMember
rga:PolicyAcquisitionCostsAndOtherInsuranceExpensesMember
2019-04-01
2019-06-30
0000898174
rga:ConsumerPriceIndexSwapMember
2019-06-30
0000898174
us-gaap:StockOptionMember
us-gaap:FairValueInputsLevel2Member
2019-06-30
0000898174
us-gaap:FairValueInputsLevel1Member
2019-06-30
0000898174
us-gaap:FairValueInputsLevel1Member
us-gaap:ForeignGovernmentDebtSecuritiesMember
2019-06-30
0000898174
us-gaap:InterestRateSwapMember
us-gaap:FairValueInputsLevel3Member
2019-06-30
0000898174
us-gaap:FairValueInputsLevel2Member
2019-06-30
0000898174
us-gaap:CurrencySwapMember
2019-06-30
0000898174
us-gaap:FairValueInputsLevel3Member
us-gaap:USStatesAndPoliticalSubdivisionsMember
2019-06-30
0000898174
us-gaap:CreditDefaultSwapMember
us-gaap:FairValueInputsLevel1Member
2019-06-30
0000898174
us-gaap:FairValueInputsLevel3Member
2019-06-30
0000898174
us-gaap:ForeignExchangeForwardMember
2019-06-30
0000898174
us-gaap:StockOptionMember
us-gaap:FairValueInputsLevel1Member
2019-06-30
0000898174
us-gaap:FairValueInputsLevel1Member
us-gaap:ResidentialMortgageBackedSecuritiesMember
2019-06-30
0000898174
rga:MortalitySwapMember
2019-06-30
0000898174
us-gaap:CurrencySwapMember
us-gaap:FairValueInputsLevel1Member
2019-06-30
0000898174
us-gaap:FairValueInputsLevel3Member
rga:CanadianProvincialGovernmentsMember
2019-06-30
0000898174
us-gaap:FairValueInputsLevel2Member
us-gaap:ResidentialMortgageBackedSecuritiesMember
2019-06-30
0000898174
rga:FairValueOptionContractholderDirectedUnitLinkedInvestmentsMember
us-gaap:FairValueInputsLevel3Member
2019-06-30
0000898174
us-gaap:FairValueInputsLevel3Member
us-gaap:CorporateDebtSecuritiesMember
2019-06-30
0000898174
us-gaap:FairValueInputsLevel3Member
us-gaap:AssetBackedSecuritiesMember
2019-06-30
0000898174
us-gaap:ForeignExchangeForwardMember
us-gaap:FairValueInputsLevel1Member
2019-06-30
0000898174
rga:MortalitySwapMember
us-gaap:FairValueInputsLevel1Member
2019-06-30
0000898174
us-gaap:CurrencySwapMember
us-gaap:FairValueInputsLevel3Member
2019-06-30
0000898174
us-gaap:InterestRateSwapMember
2019-06-30
0000898174
us-gaap:FairValueInputsLevel2Member
us-gaap:USGovernmentAgenciesDebtSecuritiesMember
2019-06-30
0000898174
rga:MortalitySwapMember
us-gaap:FairValueInputsLevel3Member
2019-06-30
0000898174
rga:ConsumerPriceIndexSwapMember
us-gaap:FairValueInputsLevel1Member
2019-06-30
0000898174
us-gaap:FairValueInputsLevel2Member
us-gaap:CorporateDebtSecuritiesMember
2019-06-30
0000898174
us-gaap:FairValueInputsLevel2Member
us-gaap:USStatesAndPoliticalSubdivisionsMember
2019-06-30
0000898174
rga:FairValueOptionContractholderDirectedUnitLinkedInvestmentsMember
2019-06-30
0000898174
rga:FairValueOptionContractholderDirectedUnitLinkedInvestmentsMember
us-gaap:FairValueInputsLevel2Member
2019-06-30
0000898174
us-gaap:StockOptionMember
us-gaap:FairValueInputsLevel3Member
2019-06-30
0000898174
us-gaap:CreditDefaultSwapMember
us-gaap:FairValueInputsLevel3Member
2019-06-30
0000898174
us-gaap:FairValueInputsLevel1Member
us-gaap:USStatesAndPoliticalSubdivisionsMember
2019-06-30
0000898174
us-gaap:ForeignExchangeForwardMember
us-gaap:FairValueInputsLevel3Member
2019-06-30
0000898174
us-gaap:FairValueInputsLevel1Member
us-gaap:CorporateDebtSecuritiesMember
2019-06-30
0000898174
us-gaap:FairValueInputsLevel2Member
rga:CanadianProvincialGovernmentsMember
2019-06-30
0000898174
us-gaap:FairValueInputsLevel3Member
us-gaap:ResidentialMortgageBackedSecuritiesMember
2019-06-30
0000898174
us-gaap:FairValueInputsLevel1Member
us-gaap:AssetBackedSecuritiesMember
2019-06-30
0000898174
us-gaap:CreditDefaultSwapMember
us-gaap:FairValueInputsLevel2Member
2019-06-30
0000898174
us-gaap:CurrencySwapMember
us-gaap:FairValueInputsLevel2Member
2019-06-30
0000898174
us-gaap:InterestRateSwapMember
us-gaap:FairValueInputsLevel2Member
2019-06-30
0000898174
us-gaap:FairValueInputsLevel3Member
us-gaap:CommercialMortgageBackedSecuritiesMember
2019-06-30
0000898174
us-gaap:StockOptionMember
2019-06-30
0000898174
us-gaap:ForeignExchangeForwardMember
us-gaap:FairValueInputsLevel2Member
2019-06-30
0000898174
us-gaap:FairValueInputsLevel1Member
us-gaap:USGovernmentAgenciesDebtSecuritiesMember
2019-06-30
0000898174
us-gaap:FairValueInputsLevel1Member
rga:CanadianProvincialGovernmentsMember
2019-06-30
0000898174
us-gaap:FairValueInputsLevel2Member
us-gaap:AssetBackedSecuritiesMember
2019-06-30
0000898174
us-gaap:CreditDefaultSwapMember
2019-06-30
0000898174
us-gaap:InterestRateSwapMember
us-gaap:FairValueInputsLevel1Member
2019-06-30
0000898174
rga:FairValueOptionContractholderDirectedUnitLinkedInvestmentsMember
us-gaap:FairValueInputsLevel1Member
2019-06-30
0000898174
us-gaap:FairValueInputsLevel2Member
us-gaap:ForeignGovernmentDebtSecuritiesMember
2019-06-30
0000898174
us-gaap:FairValueInputsLevel3Member
us-gaap:USGovernmentAgenciesDebtSecuritiesMember
2019-06-30
0000898174
rga:MortalitySwapMember
us-gaap:FairValueInputsLevel2Member
2019-06-30
0000898174
us-gaap:FairValueInputsLevel3Member
us-gaap:ForeignGovernmentDebtSecuritiesMember
2019-06-30
0000898174
rga:ConsumerPriceIndexSwapMember
us-gaap:FairValueInputsLevel3Member
2019-06-30
0000898174
rga:ConsumerPriceIndexSwapMember
us-gaap:FairValueInputsLevel2Member
2019-06-30
0000898174
us-gaap:FairValueInputsLevel2Member
us-gaap:CommercialMortgageBackedSecuritiesMember
2019-06-30
0000898174
us-gaap:FairValueInputsLevel1Member
us-gaap:CommercialMortgageBackedSecuritiesMember
2019-06-30
0000898174
us-gaap:USStatesAndPoliticalSubdivisionsMember
2018-04-01
2018-06-30
0000898174
us-gaap:USStatesAndPoliticalSubdivisionsMember
us-gaap:InvestmentIncomeMember
2018-04-01
2018-06-30
0000898174
us-gaap:CommercialMortgageBackedSecuritiesMember
2018-04-01
2018-06-30
0000898174
us-gaap:ForeignGovernmentDebtMember
us-gaap:InvestmentIncomeMember
2018-04-01
2018-06-30
0000898174
us-gaap:USStatesAndPoliticalSubdivisionsMember
2018-03-31
0000898174
us-gaap:ForeignGovernmentDebtMember
2018-04-01
2018-06-30
0000898174
us-gaap:USGovernmentAgenciesDebtSecuritiesMember
us-gaap:InvestmentIncomeMember
2018-04-01
2018-06-30
0000898174
us-gaap:CommercialMortgageBackedSecuritiesMember
2018-03-31
0000898174
us-gaap:USGovernmentAgenciesDebtSecuritiesMember
2018-03-31
0000898174
us-gaap:USGovernmentAgenciesDebtSecuritiesMember
2018-04-01
2018-06-30
0000898174
us-gaap:ForeignGovernmentDebtMember
2018-03-31
0000898174
us-gaap:CommercialMortgageBackedSecuritiesMember
us-gaap:InvestmentIncomeMember
2018-04-01
2018-06-30
0000898174
srt:PartnershipInterestMember
2019-01-01
2019-06-30
0000898174
srt:PartnershipInterestMember
2019-04-01
2019-06-30
0000898174
srt:PartnershipInterestMember
2019-06-30
0000898174
srt:MinimumMember
rga:EmbeddedDerivativesInVariableAnnuityMember
us-gaap:MeasurementInputCounterpartyCreditRiskMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2019-06-30
0000898174
srt:MinimumMember
rga:LongevitySwapMember
us-gaap:MeasurementInputMortalityRateMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2019-06-30
0000898174
srt:MaximumMember
rga:LongevitySwapMember
rga:MeasurementInputMortalityImprovementMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2019-06-30
0000898174
srt:WeightedAverageMember
rga:LongevitySwapMember
us-gaap:MeasurementInputMortalityRateMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2019-06-30
0000898174
srt:WeightedAverageMember
us-gaap:AssetBackedSecuritiesMember
us-gaap:MarketApproachValuationTechniqueMember
2019-06-30
0000898174
srt:MinimumMember
us-gaap:EquitySecuritiesMember
us-gaap:MeasurementInputEbitdaMultipleMember
us-gaap:MarketApproachValuationTechniqueMember
2019-06-30
0000898174
srt:WeightedAverageMember
us-gaap:EquitySecuritiesMember
us-gaap:MarketApproachValuationTechniqueMember
2018-12-31
0000898174
srt:WeightedAverageMember
rga:EmbeddedDerivativesInIndexedAnnuityMember
us-gaap:MeasurementInputLapseRateMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2018-12-31
0000898174
srt:MaximumMember
rga:FundsWithheldAtInterestEmbeddedDerivativesMember
us-gaap:MeasurementInputCounterpartyCreditRiskMember
us-gaap:IncomeApproachValuationTechniqueMember
2019-06-30
0000898174
srt:MinimumMember
us-gaap:USGovernmentAgenciesDebtSecuritiesMember
us-gaap:MarketApproachValuationTechniqueMember
2018-12-31
0000898174
srt:WeightedAverageMember
rga:LongevitySwapMember
rga:MeasurementInputMortalityImprovementMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2018-12-31
0000898174
srt:MinimumMember
rga:FundsWithheldAtInterestEmbeddedDerivativesMember
us-gaap:MeasurementInputCounterpartyCreditRiskMember
us-gaap:IncomeApproachValuationTechniqueMember
2018-12-31
0000898174
srt:MinimumMember
rga:LongevitySwapMember
us-gaap:MeasurementInputMortalityRateMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2018-12-31
0000898174
srt:WeightedAverageMember
us-gaap:CorporateDebtSecuritiesMember
us-gaap:MarketApproachValuationTechniqueMember
2019-06-30
0000898174
srt:WeightedAverageMember
rga:EmbeddedDerivativesInVariableAnnuityMember
us-gaap:MeasurementInputMortalityRateMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2018-12-31
0000898174
srt:MinimumMember
rga:EmbeddedDerivativesInVariableAnnuityMember
us-gaap:MeasurementInputMortalityRateMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2019-06-30
0000898174
srt:MinimumMember
rga:FundsWithheldAtInterestEmbeddedDerivativesMember
us-gaap:MeasurementInputMortalityRateMember
us-gaap:IncomeApproachValuationTechniqueMember
2018-12-31
0000898174
srt:MaximumMember
rga:EmbeddedDerivativesInIndexedAnnuityMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2018-12-31
0000898174
srt:WeightedAverageMember
rga:EmbeddedDerivativesInIndexedAnnuityMember
us-gaap:MeasurementInputWithdrawalRateMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2018-12-31
0000898174
srt:MaximumMember
rga:EmbeddedDerivativesInVariableAnnuityMember
us-gaap:MeasurementInputCounterpartyCreditRiskMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2018-12-31
0000898174
srt:WeightedAverageMember
rga:EmbeddedDerivativesInVariableAnnuityMember
us-gaap:MeasurementInputLongTermRevenueGrowthRateMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2018-12-31
0000898174
srt:MinimumMember
rga:EmbeddedDerivativesInVariableAnnuityMember
us-gaap:MeasurementInputLongTermRevenueGrowthRateMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2019-06-30
0000898174
srt:MinimumMember
us-gaap:EquitySecuritiesMember
us-gaap:MeasurementInputEbitdaMultipleMember
us-gaap:MarketApproachValuationTechniqueMember
2018-12-31
0000898174
srt:MaximumMember
rga:EmbeddedDerivativesInIndexedAnnuityMember
us-gaap:MeasurementInputWithdrawalRateMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2018-12-31
0000898174
srt:MinimumMember
us-gaap:USGovernmentAgenciesDebtSecuritiesMember
us-gaap:MarketApproachValuationTechniqueMember
2019-06-30
0000898174
srt:MinimumMember
rga:FundsWithheldAtInterestEmbeddedDerivativesMember
us-gaap:MeasurementInputLapseRateMember
us-gaap:IncomeApproachValuationTechniqueMember
2019-06-30
0000898174
srt:WeightedAverageMember
rga:EmbeddedDerivativesInIndexedAnnuityMember
us-gaap:MeasurementInputWithdrawalRateMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2019-06-30
0000898174
srt:MaximumMember
us-gaap:USGovernmentAgenciesDebtSecuritiesMember
us-gaap:MarketApproachValuationTechniqueMember
2019-06-30
0000898174
srt:WeightedAverageMember
rga:EmbeddedDerivativesInIndexedAnnuityMember
us-gaap:MeasurementInputLapseRateMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2019-06-30
0000898174
srt:WeightedAverageMember
rga:FundsWithheldAtInterestEmbeddedDerivativesMember
us-gaap:MeasurementInputWithdrawalRateMember
us-gaap:IncomeApproachValuationTechniqueMember
2019-06-30
0000898174
srt:MaximumMember
us-gaap:CorporateDebtSecuritiesMember
us-gaap:MarketApproachValuationTechniqueMember
2019-06-30
0000898174
srt:MaximumMember
rga:FundsWithheldAtInterestEmbeddedDerivativesMember
us-gaap:MeasurementInputLapseRateMember
us-gaap:IncomeApproachValuationTechniqueMember
2019-06-30
0000898174
srt:MinimumMember
rga:LongevitySwapMember
rga:MeasurementInputMortalityImprovementMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2018-12-31
0000898174
srt:MaximumMember
us-gaap:CorporateDebtSecuritiesMember
us-gaap:MarketApproachValuationTechniqueMember
2018-12-31
0000898174
srt:MinimumMember
us-gaap:CorporateDebtSecuritiesMember
us-gaap:MeasurementInputEbitdaMultipleMember
us-gaap:MarketApproachValuationTechniqueMember
2019-06-30
0000898174
srt:MinimumMember
us-gaap:EquitySecuritiesMember
us-gaap:MarketApproachValuationTechniqueMember
2019-06-30
0000898174
srt:WeightedAverageMember
us-gaap:EquitySecuritiesMember
us-gaap:MeasurementInputEbitdaMultipleMember
us-gaap:MarketApproachValuationTechniqueMember
2018-12-31
0000898174
srt:MaximumMember
rga:EmbeddedDerivativesInVariableAnnuityMember
us-gaap:MeasurementInputCounterpartyCreditRiskMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2019-06-30
0000898174
srt:MinimumMember
rga:FundsWithheldAtInterestEmbeddedDerivativesMember
us-gaap:MeasurementInputWithdrawalRateMember
us-gaap:IncomeApproachValuationTechniqueMember
2018-12-31
0000898174
srt:WeightedAverageMember
us-gaap:EquitySecuritiesMember
us-gaap:MeasurementInputEbitdaMultipleMember
us-gaap:MarketApproachValuationTechniqueMember
2019-06-30
0000898174
srt:WeightedAverageMember
rga:EmbeddedDerivativesInVariableAnnuityMember
us-gaap:MeasurementInputLapseRateMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2019-06-30
0000898174
srt:MinimumMember
rga:MortalitySwapMember
us-gaap:MeasurementInputMortalityRateMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2019-06-30
0000898174
srt:WeightedAverageMember
rga:FundsWithheldAtInterestEmbeddedDerivativesMember
us-gaap:MeasurementInputCounterpartyCreditRiskMember
us-gaap:IncomeApproachValuationTechniqueMember
2019-06-30
0000898174
srt:MaximumMember
rga:FundsWithheldAtInterestEmbeddedDerivativesMember
us-gaap:MeasurementInputLapseRateMember
us-gaap:IncomeApproachValuationTechniqueMember
2018-12-31
0000898174
srt:MinimumMember
rga:EmbeddedDerivativesInIndexedAnnuityMember
us-gaap:MeasurementInputLapseRateMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2019-06-30
0000898174
srt:WeightedAverageMember
rga:EmbeddedDerivativesInIndexedAnnuityMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2018-12-31
0000898174
srt:MinimumMember
rga:EmbeddedDerivativesInIndexedAnnuityMember
us-gaap:MeasurementInputWithdrawalRateMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2018-12-31
0000898174
srt:WeightedAverageMember
rga:EmbeddedDerivativesInVariableAnnuityMember
us-gaap:MeasurementInputWithdrawalRateMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2018-12-31
0000898174
srt:MaximumMember
rga:FundsWithheldAtInterestEmbeddedDerivativesMember
us-gaap:MeasurementInputMortalityRateMember
us-gaap:IncomeApproachValuationTechniqueMember
2019-06-30
0000898174
srt:MinimumMember
rga:FundsWithheldAtInterestEmbeddedDerivativesMember
us-gaap:MeasurementInputMortalityRateMember
us-gaap:IncomeApproachValuationTechniqueMember
2019-06-30
0000898174
srt:MaximumMember
rga:EmbeddedDerivativesInVariableAnnuityMember
us-gaap:MeasurementInputLapseRateMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2018-12-31
0000898174
srt:WeightedAverageMember
rga:EmbeddedDerivativesInVariableAnnuityMember
us-gaap:MeasurementInputLongTermRevenueGrowthRateMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2019-06-30
0000898174
srt:MaximumMember
rga:EmbeddedDerivativesInVariableAnnuityMember
us-gaap:MeasurementInputLapseRateMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2019-06-30
0000898174
srt:WeightedAverageMember
us-gaap:EquitySecuritiesMember
us-gaap:MarketApproachValuationTechniqueMember
2019-06-30
0000898174
srt:WeightedAverageMember
rga:LongevitySwapMember
rga:MeasurementInputMortalityImprovementMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2019-06-30
0000898174
srt:MinimumMember
us-gaap:ForeignCorporateDebtSecuritiesMember
us-gaap:MarketApproachValuationTechniqueMember
2019-06-30
0000898174
srt:MaximumMember
rga:EmbeddedDerivativesInVariableAnnuityMember
us-gaap:MeasurementInputLongTermRevenueGrowthRateMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2019-06-30
0000898174
srt:WeightedAverageMember
rga:EmbeddedDerivativesInIndexedAnnuityMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2019-06-30
0000898174
srt:MinimumMember
rga:FundsWithheldAtInterestEmbeddedDerivativesMember
us-gaap:MeasurementInputCounterpartyCreditRiskMember
us-gaap:IncomeApproachValuationTechniqueMember
2019-06-30
0000898174
srt:WeightedAverageMember
rga:EmbeddedDerivativesInIndexedAnnuityMember
us-gaap:MeasurementInputMortalityRateMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2018-12-31
0000898174
srt:MaximumMember
us-gaap:AssetBackedSecuritiesMember
us-gaap:MarketApproachValuationTechniqueMember
2018-12-31
0000898174
srt:WeightedAverageMember
rga:FundsWithheldAtInterestEmbeddedDerivativesMember
us-gaap:MeasurementInputCounterpartyCreditRiskMember
us-gaap:IncomeApproachValuationTechniqueMember
2018-12-31
0000898174
srt:MaximumMember
rga:EmbeddedDerivativesInVariableAnnuityMember
us-gaap:MeasurementInputWithdrawalRateMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2019-06-30
0000898174
srt:MaximumMember
us-gaap:ForeignCorporateDebtSecuritiesMember
us-gaap:MarketApproachValuationTechniqueMember
2019-06-30
0000898174
srt:MaximumMember
rga:FundsWithheldAtInterestEmbeddedDerivativesMember
rga:MeasurementInputCreditingRateMember
us-gaap:IncomeApproachValuationTechniqueMember
2019-06-30
0000898174
srt:MaximumMember
rga:FundsWithheldAtInterestEmbeddedDerivativesMember
us-gaap:MeasurementInputMortalityRateMember
us-gaap:IncomeApproachValuationTechniqueMember
2018-12-31
0000898174
srt:MaximumMember
us-gaap:EquitySecuritiesMember
us-gaap:MarketApproachValuationTechniqueMember
2018-12-31
0000898174
srt:MinimumMember
rga:EmbeddedDerivativesInVariableAnnuityMember
us-gaap:MeasurementInputLapseRateMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2018-12-31
0000898174
srt:WeightedAverageMember
rga:MortalitySwapMember
us-gaap:MeasurementInputMortalityRateMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2018-12-31
0000898174
srt:MinimumMember
us-gaap:AssetBackedSecuritiesMember
us-gaap:MarketApproachValuationTechniqueMember
2019-06-30
0000898174
srt:WeightedAverageMember
rga:MortalitySwapMember
us-gaap:MeasurementInputMortalityRateMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2019-06-30
0000898174
srt:MaximumMember
rga:EmbeddedDerivativesInIndexedAnnuityMember
us-gaap:MeasurementInputMortalityRateMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2018-12-31
0000898174
srt:WeightedAverageMember
rga:FundsWithheldAtInterestEmbeddedDerivativesMember
us-gaap:MeasurementInputMortalityRateMember
us-gaap:IncomeApproachValuationTechniqueMember
2018-12-31
0000898174
srt:MaximumMember
rga:EmbeddedDerivativesInIndexedAnnuityMember
us-gaap:MeasurementInputWithdrawalRateMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2019-06-30
0000898174
srt:MinimumMember
rga:FundsWithheldAtInterestEmbeddedDerivativesMember
us-gaap:MeasurementInputWithdrawalRateMember
us-gaap:IncomeApproachValuationTechniqueMember
2019-06-30
0000898174
srt:MaximumMember
us-gaap:EquitySecuritiesMember
us-gaap:MeasurementInputEbitdaMultipleMember
us-gaap:MarketApproachValuationTechniqueMember
2018-12-31
0000898174
srt:MinimumMember
rga:FundsWithheldAtInterestEmbeddedDerivativesMember
rga:MeasurementInputCreditingRateMember
us-gaap:IncomeApproachValuationTechniqueMember
2019-06-30
0000898174
srt:MinimumMember
us-gaap:ForeignCorporateDebtSecuritiesMember
us-gaap:MarketApproachValuationTechniqueMember
2018-12-31
0000898174
srt:MaximumMember
rga:EmbeddedDerivativesInVariableAnnuityMember
us-gaap:MeasurementInputMortalityRateMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2019-06-30
0000898174
srt:MinimumMember
rga:EmbeddedDerivativesInVariableAnnuityMember
us-gaap:MeasurementInputLapseRateMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2019-06-30
0000898174
srt:MinimumMember
rga:MortalitySwapMember
us-gaap:MeasurementInputMortalityRateMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2018-12-31
0000898174
srt:MaximumMember
rga:EmbeddedDerivativesInVariableAnnuityMember
us-gaap:MeasurementInputMortalityRateMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2018-12-31
0000898174
srt:MaximumMember
rga:EmbeddedDerivativesInVariableAnnuityMember
us-gaap:MeasurementInputLongTermRevenueGrowthRateMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2018-12-31
0000898174
srt:MaximumMember
rga:EmbeddedDerivativesInIndexedAnnuityMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2019-06-30
0000898174
srt:WeightedAverageMember
rga:EmbeddedDerivativesInVariableAnnuityMember
us-gaap:MeasurementInputCounterpartyCreditRiskMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2018-12-31
0000898174
srt:MaximumMember
rga:EmbeddedDerivativesInVariableAnnuityMember
us-gaap:MeasurementInputWithdrawalRateMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2018-12-31
0000898174
srt:MinimumMember
rga:EmbeddedDerivativesInVariableAnnuityMember
us-gaap:MeasurementInputWithdrawalRateMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2019-06-30
0000898174
srt:WeightedAverageMember
us-gaap:CorporateDebtSecuritiesMember
us-gaap:MarketApproachValuationTechniqueMember
2018-12-31
0000898174
srt:MinimumMember
rga:EmbeddedDerivativesInVariableAnnuityMember
us-gaap:MeasurementInputWithdrawalRateMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2018-12-31
0000898174
srt:WeightedAverageMember
rga:FundsWithheldAtInterestEmbeddedDerivativesMember
rga:MeasurementInputCreditingRateMember
us-gaap:IncomeApproachValuationTechniqueMember
2019-06-30
0000898174
srt:MaximumMember
us-gaap:EquitySecuritiesMember
us-gaap:MarketApproachValuationTechniqueMember
2019-06-30
0000898174
srt:MinimumMember
rga:EmbeddedDerivativesInIndexedAnnuityMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2018-12-31
0000898174
srt:MaximumMember
rga:FundsWithheldAtInterestEmbeddedDerivativesMember
rga:MeasurementInputCreditingRateMember
us-gaap:IncomeApproachValuationTechniqueMember
2018-12-31
0000898174
srt:MaximumMember
rga:LongevitySwapMember
us-gaap:MeasurementInputMortalityRateMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2019-06-30
0000898174
srt:MinimumMember
rga:EmbeddedDerivativesInVariableAnnuityMember
us-gaap:MeasurementInputCounterpartyCreditRiskMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2018-12-31
0000898174
srt:MaximumMember
rga:FundsWithheldAtInterestEmbeddedDerivativesMember
us-gaap:MeasurementInputWithdrawalRateMember
us-gaap:IncomeApproachValuationTechniqueMember
2019-06-30
0000898174
srt:MinimumMember
us-gaap:CorporateDebtSecuritiesMember
us-gaap:MarketApproachValuationTechniqueMember
2018-12-31
0000898174
srt:WeightedAverageMember
rga:EmbeddedDerivativesInVariableAnnuityMember
us-gaap:MeasurementInputWithdrawalRateMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2019-06-30
0000898174
srt:MinimumMember
us-gaap:CorporateDebtSecuritiesMember
us-gaap:MarketApproachValuationTechniqueMember
2019-06-30
0000898174
srt:WeightedAverageMember
rga:LongevitySwapMember
us-gaap:MeasurementInputMortalityRateMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2018-12-31
0000898174
srt:WeightedAverageMember
us-gaap:USGovernmentAgenciesDebtSecuritiesMember
us-gaap:MarketApproachValuationTechniqueMember
2018-12-31
0000898174
srt:WeightedAverageMember
us-gaap:ForeignCorporateDebtSecuritiesMember
us-gaap:MarketApproachValuationTechniqueMember
2019-06-30
0000898174
srt:WeightedAverageMember
us-gaap:ForeignCorporateDebtSecuritiesMember
us-gaap:MarketApproachValuationTechniqueMember
2018-12-31
0000898174
srt:MaximumMember
rga:LongevitySwapMember
rga:MeasurementInputMortalityImprovementMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2018-12-31
0000898174
srt:WeightedAverageMember
us-gaap:AssetBackedSecuritiesMember
us-gaap:MarketApproachValuationTechniqueMember
2018-12-31
0000898174
srt:MinimumMember
us-gaap:AssetBackedSecuritiesMember
us-gaap:MarketApproachValuationTechniqueMember
2018-12-31
0000898174
srt:MaximumMember
rga:LongevitySwapMember
us-gaap:MeasurementInputMortalityRateMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2018-12-31
0000898174
srt:MaximumMember
us-gaap:EquitySecuritiesMember
us-gaap:MeasurementInputEbitdaMultipleMember
us-gaap:MarketApproachValuationTechniqueMember
2019-06-30
0000898174
srt:MaximumMember
us-gaap:CorporateDebtSecuritiesMember
us-gaap:MeasurementInputEbitdaMultipleMember
us-gaap:MarketApproachValuationTechniqueMember
2018-12-31
0000898174
srt:MinimumMember
rga:FundsWithheldAtInterestEmbeddedDerivativesMember
rga:MeasurementInputCreditingRateMember
us-gaap:IncomeApproachValuationTechniqueMember
2018-12-31
0000898174
srt:MaximumMember
rga:MortalitySwapMember
us-gaap:MeasurementInputMortalityRateMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2018-12-31
0000898174
srt:WeightedAverageMember
rga:FundsWithheldAtInterestEmbeddedDerivativesMember
us-gaap:MeasurementInputWithdrawalRateMember
us-gaap:IncomeApproachValuationTechniqueMember
2018-12-31
0000898174
srt:MinimumMember
us-gaap:CorporateDebtSecuritiesMember
us-gaap:MeasurementInputEbitdaMultipleMember
us-gaap:MarketApproachValuationTechniqueMember
2018-12-31
0000898174
srt:WeightedAverageMember
rga:EmbeddedDerivativesInVariableAnnuityMember
us-gaap:MeasurementInputLapseRateMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2018-12-31
0000898174
srt:MinimumMember
rga:EmbeddedDerivativesInIndexedAnnuityMember
us-gaap:MeasurementInputWithdrawalRateMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2019-06-30
0000898174
srt:MaximumMember
rga:FundsWithheldAtInterestEmbeddedDerivativesMember
us-gaap:MeasurementInputCounterpartyCreditRiskMember
us-gaap:IncomeApproachValuationTechniqueMember
2018-12-31
0000898174
srt:MaximumMember
us-gaap:CorporateDebtSecuritiesMember
us-gaap:MeasurementInputEbitdaMultipleMember
us-gaap:MarketApproachValuationTechniqueMember
2019-06-30
0000898174
srt:WeightedAverageMember
us-gaap:USGovernmentAgenciesDebtSecuritiesMember
us-gaap:MarketApproachValuationTechniqueMember
2019-06-30
0000898174
srt:MaximumMember
rga:EmbeddedDerivativesInIndexedAnnuityMember
us-gaap:MeasurementInputLapseRateMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2019-06-30
0000898174
srt:MaximumMember
rga:EmbeddedDerivativesInIndexedAnnuityMember
us-gaap:MeasurementInputLapseRateMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2018-12-31
0000898174
srt:MinimumMember
rga:EmbeddedDerivativesInVariableAnnuityMember
us-gaap:MeasurementInputMortalityRateMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2018-12-31
0000898174
srt:MinimumMember
rga:EmbeddedDerivativesInIndexedAnnuityMember
us-gaap:MeasurementInputMortalityRateMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2019-06-30
0000898174
srt:MinimumMember
rga:LongevitySwapMember
rga:MeasurementInputMortalityImprovementMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2019-06-30
0000898174
srt:WeightedAverageMember
rga:FundsWithheldAtInterestEmbeddedDerivativesMember
us-gaap:MeasurementInputLapseRateMember
us-gaap:IncomeApproachValuationTechniqueMember
2019-06-30
0000898174
srt:MinimumMember
rga:EmbeddedDerivativesInIndexedAnnuityMember
us-gaap:MeasurementInputMortalityRateMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2018-12-31
0000898174
srt:MaximumMember
us-gaap:USGovernmentAgenciesDebtSecuritiesMember
us-gaap:MarketApproachValuationTechniqueMember
2018-12-31
0000898174
srt:MaximumMember
rga:FundsWithheldAtInterestEmbeddedDerivativesMember
us-gaap:MeasurementInputWithdrawalRateMember
us-gaap:IncomeApproachValuationTechniqueMember
2018-12-31
0000898174
srt:MaximumMember
us-gaap:ForeignCorporateDebtSecuritiesMember
us-gaap:MarketApproachValuationTechniqueMember
2018-12-31
0000898174
srt:WeightedAverageMember
rga:EmbeddedDerivativesInVariableAnnuityMember
us-gaap:MeasurementInputMortalityRateMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2019-06-30
0000898174
srt:MaximumMember
us-gaap:AssetBackedSecuritiesMember
us-gaap:MarketApproachValuationTechniqueMember
2019-06-30
0000898174
srt:WeightedAverageMember
us-gaap:CorporateDebtSecuritiesMember
us-gaap:MeasurementInputEbitdaMultipleMember
us-gaap:MarketApproachValuationTechniqueMember
2018-12-31
0000898174
srt:WeightedAverageMember
rga:EmbeddedDerivativesInIndexedAnnuityMember
us-gaap:MeasurementInputMortalityRateMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2019-06-30
0000898174
srt:MaximumMember
rga:MortalitySwapMember
us-gaap:MeasurementInputMortalityRateMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2019-06-30
0000898174
srt:WeightedAverageMember
rga:FundsWithheldAtInterestEmbeddedDerivativesMember
rga:MeasurementInputCreditingRateMember
us-gaap:IncomeApproachValuationTechniqueMember
2018-12-31
0000898174
srt:WeightedAverageMember
rga:FundsWithheldAtInterestEmbeddedDerivativesMember
us-gaap:MeasurementInputLapseRateMember
us-gaap:IncomeApproachValuationTechniqueMember
2018-12-31
0000898174
srt:MinimumMember
rga:FundsWithheldAtInterestEmbeddedDerivativesMember
us-gaap:MeasurementInputLapseRateMember
us-gaap:IncomeApproachValuationTechniqueMember
2018-12-31
0000898174
srt:MinimumMember
us-gaap:EquitySecuritiesMember
us-gaap:MarketApproachValuationTechniqueMember
2018-12-31
0000898174
srt:MinimumMember
rga:EmbeddedDerivativesInIndexedAnnuityMember
us-gaap:MeasurementInputLapseRateMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2018-12-31
0000898174
srt:WeightedAverageMember
us-gaap:CorporateDebtSecuritiesMember
us-gaap:MeasurementInputEbitdaMultipleMember
us-gaap:MarketApproachValuationTechniqueMember
2019-06-30
0000898174
srt:WeightedAverageMember
rga:FundsWithheldAtInterestEmbeddedDerivativesMember
us-gaap:MeasurementInputMortalityRateMember
us-gaap:IncomeApproachValuationTechniqueMember
2019-06-30
0000898174
srt:MinimumMember
rga:EmbeddedDerivativesInIndexedAnnuityMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2019-06-30
0000898174
srt:MinimumMember
rga:EmbeddedDerivativesInVariableAnnuityMember
us-gaap:MeasurementInputLongTermRevenueGrowthRateMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2018-12-31
0000898174
srt:WeightedAverageMember
rga:EmbeddedDerivativesInVariableAnnuityMember
us-gaap:MeasurementInputCounterpartyCreditRiskMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2019-06-30
0000898174
srt:MaximumMember
rga:EmbeddedDerivativesInIndexedAnnuityMember
us-gaap:MeasurementInputMortalityRateMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2019-06-30
0000898174
srt:AsiaPacificMember
2018-04-01
2018-06-30
0000898174
us-gaap:LifeInsuranceSegmentMember
country:CA
2019-04-01
2019-06-30
0000898174
us-gaap:LifeInsuranceSegmentMember
srt:AmericasMember
2019-04-01
2019-06-30
0000898174
us-gaap:NontraditionalLongDurationContractsMember
country:CA
2018-04-01
2018-06-30
0000898174
us-gaap:LifeInsuranceSegmentMember
srt:AsiaPacificMember
2019-01-01
2019-06-30
0000898174
us-gaap:LifeInsuranceSegmentMember
srt:AmericasMember
2018-04-01
2018-06-30
0000898174
us-gaap:NontraditionalLongDurationContractsMember
srt:AmericasMember
2019-04-01
2019-06-30
0000898174
us-gaap:LifeInsuranceSegmentMember
country:CA
2018-04-01
2018-06-30
0000898174
us-gaap:LifeInsuranceSegmentMember
srt:AsiaPacificMember
2019-04-01
2019-06-30
0000898174
us-gaap:NontraditionalLongDurationContractsMember
us-gaap:EMEAMember
2019-01-01
2019-06-30
0000898174
srt:AmericasMember
2018-01-01
2018-06-30
0000898174
country:CA
2019-01-01
2019-06-30
0000898174
us-gaap:CorporateAndOtherMember
2018-04-01
2018-06-30
0000898174
us-gaap:NontraditionalLongDurationContractsMember
us-gaap:EMEAMember
2019-04-01
2019-06-30
0000898174
us-gaap:LifeInsuranceSegmentMember
us-gaap:EMEAMember
2019-01-01
2019-06-30
0000898174
us-gaap:NontraditionalLongDurationContractsMember
country:CA
2019-04-01
2019-06-30
0000898174
us-gaap:LifeInsuranceSegmentMember
us-gaap:EMEAMember
2019-04-01
2019-06-30
0000898174
srt:AmericasMember
2019-01-01
2019-06-30
0000898174
srt:AmericasMember
2018-04-01
2018-06-30
0000898174
us-gaap:NontraditionalLongDurationContractsMember
srt:AmericasMember
2018-04-01
2018-06-30
0000898174
us-gaap:NontraditionalLongDurationContractsMember
us-gaap:EMEAMember
2018-04-01
2018-06-30
0000898174
us-gaap:NontraditionalLongDurationContractsMember
srt:AmericasMember
2018-01-01
2018-06-30
0000898174
srt:AmericasMember
2019-04-01
2019-06-30
0000898174
us-gaap:LifeInsuranceSegmentMember
country:CA
2019-01-01
2019-06-30
0000898174
us-gaap:LifeInsuranceSegmentMember
srt:AmericasMember
2018-01-01
2018-06-30
0000898174
srt:AsiaPacificMember
2019-01-01
2019-06-30
0000898174
us-gaap:NontraditionalLongDurationContractsMember
us-gaap:EMEAMember
2018-01-01
2018-06-30
0000898174
us-gaap:NontraditionalLongDurationContractsMember
srt:AsiaPacificMember
2019-04-01
2019-06-30
0000898174
us-gaap:EMEAMember
2018-01-01
2018-06-30
0000898174
us-gaap:EMEAMember
2019-04-01
2019-06-30
0000898174
us-gaap:LifeInsuranceSegmentMember
srt:AsiaPacificMember
2018-01-01
2018-06-30
0000898174
us-gaap:CorporateAndOtherMember
2019-01-01
2019-06-30
0000898174
us-gaap:LifeInsuranceSegmentMember
country:CA
2018-01-01
2018-06-30
0000898174
us-gaap:NontraditionalLongDurationContractsMember
srt:AmericasMember
2019-01-01
2019-06-30
0000898174
us-gaap:NontraditionalLongDurationContractsMember
country:CA
2019-01-01
2019-06-30
0000898174
us-gaap:NontraditionalLongDurationContractsMember
srt:AsiaPacificMember
2018-01-01
2018-06-30
0000898174
us-gaap:EMEAMember
2019-01-01
2019-06-30
0000898174
us-gaap:NontraditionalLongDurationContractsMember
country:CA
2018-01-01
2018-06-30
0000898174
country:CA
2018-01-01
2018-06-30
0000898174
us-gaap:EMEAMember
2018-04-01
2018-06-30
0000898174
us-gaap:CorporateAndOtherMember
2018-01-01
2018-06-30
0000898174
us-gaap:LifeInsuranceSegmentMember
us-gaap:EMEAMember
2018-01-01
2018-06-30
0000898174
srt:AsiaPacificMember
2019-04-01
2019-06-30
0000898174
us-gaap:NontraditionalLongDurationContractsMember
srt:AsiaPacificMember
2018-04-01
2018-06-30
0000898174
us-gaap:LifeInsuranceSegmentMember
srt:AmericasMember
2019-01-01
2019-06-30
0000898174
country:CA
2019-04-01
2019-06-30
0000898174
us-gaap:LifeInsuranceSegmentMember
srt:AsiaPacificMember
2018-04-01
2018-06-30
0000898174
us-gaap:LifeInsuranceSegmentMember
us-gaap:EMEAMember
2018-04-01
2018-06-30
0000898174
srt:AsiaPacificMember
2018-01-01
2018-06-30
0000898174
country:CA
2018-04-01
2018-06-30
0000898174
us-gaap:CorporateAndOtherMember
2019-04-01
2019-06-30
0000898174
us-gaap:NontraditionalLongDurationContractsMember
srt:AsiaPacificMember
2019-01-01
2019-06-30
0000898174
srt:AmericasMember
2019-06-30
0000898174
country:CA
2018-12-31
0000898174
us-gaap:CorporateAndOtherMember
2018-12-31
0000898174
us-gaap:NontraditionalLongDurationContractsMember
country:CA
2019-06-30
0000898174
us-gaap:NontraditionalLongDurationContractsMember
us-gaap:EMEAMember
2019-06-30
0000898174
us-gaap:LifeInsuranceSegmentMember
country:CA
2019-06-30
0000898174
us-gaap:NontraditionalLongDurationContractsMember
country:CA
2018-12-31
0000898174
us-gaap:LifeInsuranceSegmentMember
country:CA
2018-12-31
0000898174
srt:AsiaPacificMember
2018-12-31
0000898174
us-gaap:LifeInsuranceSegmentMember
srt:AmericasMember
2019-06-30
0000898174
us-gaap:EMEAMember
2019-06-30
0000898174
srt:AmericasMember
2018-12-31
0000898174
us-gaap:LifeInsuranceSegmentMember
us-gaap:EMEAMember
2019-06-30
0000898174
us-gaap:NontraditionalLongDurationContractsMember
srt:AmericasMember
2019-06-30
0000898174
us-gaap:NontraditionalLongDurationContractsMember
srt:AsiaPacificMember
2019-06-30
0000898174
us-gaap:LifeInsuranceSegmentMember
us-gaap:EMEAMember
2018-12-31
0000898174
us-gaap:CorporateAndOtherMember
2019-06-30
0000898174
us-gaap:LifeInsuranceSegmentMember
srt:AsiaPacificMember
2018-12-31
0000898174
us-gaap:EMEAMember
2018-12-31
0000898174
us-gaap:NontraditionalLongDurationContractsMember
srt:AmericasMember
2018-12-31
0000898174
us-gaap:NontraditionalLongDurationContractsMember
srt:AsiaPacificMember
2018-12-31
0000898174
us-gaap:LifeInsuranceSegmentMember
srt:AmericasMember
2018-12-31
0000898174
us-gaap:NontraditionalLongDurationContractsMember
us-gaap:EMEAMember
2018-12-31
0000898174
us-gaap:LifeInsuranceSegmentMember
srt:AsiaPacificMember
2019-06-30
0000898174
country:CA
2019-06-30
0000898174
srt:AsiaPacificMember
2019-06-30
0000898174
rga:EquityReleaseMortgagesMember
2019-06-30
0000898174
us-gaap:LimitedPartnerMember
2018-12-31
0000898174
us-gaap:BankLoanObligationsMember
2019-06-30
0000898174
us-gaap:LimitedPartnerMember
2019-06-30
0000898174
us-gaap:CommercialLoanMember
2018-12-31
0000898174
us-gaap:CommercialLoanMember
2019-06-30
0000898174
us-gaap:BankLoanObligationsMember
2018-12-31
0000898174
rga:EquityReleaseMortgagesMember
2018-12-31
0000898174
rga:CommitmentPeriodTwoThousandThirtyEightMember
2019-06-30
0000898174
rga:CommitmentPeriodTwoThousandThirtyFiveMember
2019-06-30
0000898174
rga:CommitmentPeriodTwoThousandThirtyFourMember
2019-06-30
0000898174
rga:CommitmentPeriodTwoThousandThirtySixMember
2019-06-30
0000898174
rga:CommitmentPeriodTwoThousandThirtySevenMember
2019-06-30
0000898174
rga:CommitmentPeriodTwoThousandThirtyNineMember
2019-06-30
0000898174
rga:CommitmentPeriodTwoThousandTwentyThreeMember
2019-06-30
0000898174
rga:GuaranteeOfBorrowedSecuritiesMember
2018-12-31
0000898174
rga:GuaranteeOfBorrowedSecuritiesMember
2019-06-30
0000898174
rga:InsuranceTreatyGuaranteeNetOfAssetsHeldInTrustMember
2019-06-30
0000898174
us-gaap:ProductFinancingArrangementMember
2018-12-31
0000898174
rga:InsuranceTreatyGuaranteeNetOfAssetsHeldInTrustMember
2018-12-31
0000898174
us-gaap:ProductFinancingArrangementMember
2019-06-30
0000898174
rga:GuaranteeOfLeaseObligationsMember
2018-12-31
0000898174
rga:InsuranceTreatyGuaranteeMember
2018-12-31
0000898174
rga:GuaranteeOfLeaseObligationsMember
2019-06-30
0000898174
rga:InsuranceTreatyGuaranteeMember
2019-06-30
0000898174
us-gaap:PensionPlansDefinedBenefitMember
2019-01-01
2019-06-30
0000898174
us-gaap:PensionPlansDefinedBenefitMember
2018-01-01
2018-06-30
0000898174
us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember
2018-01-01
2018-06-30
0000898174
us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember
2019-01-01
2019-06-30
0000898174
us-gaap:PensionPlansDefinedBenefitMember
2018-04-01
2018-06-30
0000898174
us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember
2018-04-01
2018-06-30
0000898174
us-gaap:PensionPlansDefinedBenefitMember
2019-04-01
2019-06-30
0000898174
us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember
2019-04-01
2019-06-30
0000898174
srt:AMBestAMinusRatingMember
2019-01-01
2019-06-30
0000898174
srt:AMBestAPlusPlusRatingMember
rga:ReinsurerDMember
2018-12-31
0000898174
srt:AMBestAPlusPlusRatingMember
rga:ReinsurerDMember
2019-01-01
2019-06-30
0000898174
srt:AMBestAPlusRatingMember
rga:ReinsurerEMember
2018-12-31
0000898174
rga:OtherReinsurersMember
2018-01-01
2018-12-31
0000898174
srt:AMBestAPlusRatingMember
rga:ReinsurerBMember
2019-01-01
2019-06-30
0000898174
srt:AMBestARatingMember
rga:ReinsurerCMember
2018-01-01
2018-12-31
0000898174
srt:AMBestAPlusRatingMember
rga:ReinsurerBMember
2018-01-01
2018-12-31
0000898174
srt:AMBestAPlusRatingMember
rga:ReinsurerAMember
2019-01-01
2019-06-30
0000898174
srt:AMBestAPlusPlusRatingMember
rga:ReinsurerDMember
2019-06-30
0000898174
srt:AMBestAPlusRatingMember
rga:ReinsurerEMember
2019-06-30
0000898174
rga:OtherReinsurersMember
2018-12-31
0000898174
srt:AMBestAPlusRatingMember
rga:ReinsurerAMember
2018-12-31
0000898174
srt:AMBestAPlusPlusRatingMember
rga:ReinsurerDMember
2018-01-01
2018-12-31
0000898174
rga:OtherReinsurersMember
2019-06-30
0000898174
srt:AMBestAPlusRatingMember
rga:ReinsurerBMember
2018-12-31
0000898174
srt:AMBestARatingMember
rga:ReinsurerCMember
2019-06-30
0000898174
srt:AMBestAPlusRatingMember
rga:ReinsurerBMember
2019-06-30
0000898174
rga:OtherReinsurersMember
2019-01-01
2019-06-30
0000898174
srt:AMBestAPlusRatingMember
rga:ReinsurerEMember
2019-01-01
2019-06-30
0000898174
srt:AMBestAPlusRatingMember
rga:ReinsurerAMember
2018-01-01
2018-12-31
0000898174
srt:AMBestARatingMember
rga:ReinsurerCMember
2019-01-01
2019-06-30
0000898174
srt:AMBestARatingMember
rga:ReinsurerCMember
2018-12-31
0000898174
srt:AMBestAPlusRatingMember
rga:ReinsurerEMember
2018-01-01
2018-12-31
0000898174
srt:AMBestAPlusRatingMember
rga:ReinsurerAMember
2019-06-30
0000898174
srt:AMBestAMinusRatingMember
2018-01-01
2018-12-31
0000898174
rga:SeniorNotesDue2019Member
2019-06-30
0000898174
us-gaap:SeniorNotesMember
2019-06-30
0000898174
us-gaap:SeniorNotesMember
2019-01-01
2019-06-30
xbrli:shares
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:pure
Table of Contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
10-Q
☒
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended
June 30, 2019
OR
☐
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Commission File Number
1-11848
REINSURANCE GROUP OF AMERICA, INCORPORATED
(Exact name of Registrant as specified in its charter)
Missouri
43-1627032
(State or other jurisdiction
(IRS employer
of incorporation or organization)
identification number)
16600 Swingley Ridge Road
Chesterfield
,
Missouri
63017
(Address of principal executive offices)
(
636
)
736-7000
(Registrant’s telephone number, including area code)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes
x
No
o
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).
Yes
☒
No
o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer
x
Accelerated filer
o
Non-accelerated filer
o
Smaller reporting company
☐
Emerging growth company
☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes
☐
No
☒
Table of Contents
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, par value $0.01
RGA
New York Stock Exchange
6.20% Fixed-To-Floating Rate Subordinated Debentures due 2042
RZA
New York Stock Exchange
5.75% Fixed-To-Floating Rate Subordinated Debentures due 2056
RZB
New York Stock Exchange
As of
July 31, 2019
,
62,761,461
shares of the registrant’s common stock were outstanding.
Table of Contents
REINSURANCE GROUP OF AMERICA, INCORPORATED AND SUBSIDIARIES
TABLE OF CONTENTS
Item
Page
PART I – FINANCIAL INFORMATION
1
Financial Statements
Condensed Consolidated Balance Sheets (Unaudited)
June 30, 2019 and December 31, 2018
3
Condensed Consolidated Statements of Income (Unaudited)
Three and six months ended June 30, 2019 and 2018
4
Condensed Consolidated Statements of Comprehensive Income (Unaudited)
Three and six months ended June 30, 2019 and 2018
5
Condensed Consolidated Statements of Stockholders’ Equity (Unaudited)
Three and six months ended June 30, 2019 and 2018
6
Condensed Consolidated Statements of Cash Flows (Unaudited)
Six months ended June 30, 2019 and 2018
7
Notes to Condensed Consolidated Financial Statements (Unaudited):
8
1. Business and Basis of Presentation
8
2. Earnings Per Share
8
3. Equity
9
4. Investments
11
5. Derivative Instruments
20
6. Fair Value of Assets and Liabilities
26
7. Segment Information
36
8. Commitments, Contingencies and Guarantees
38
9. Income Tax
40
10. Employee Benefit Plans
41
11. Reinsurance
41
12. Policy Claims and Benefits
42
13. Financing Activities
42
14. New Accounting Standards
43
2
Management’s Discussion and Analysis of
Financial Condition and Results of Operations
45
3
Quantitative and Qualitative Disclosures About Market Risk
73
4
Controls and Procedures
73
PART II – OTHER INFORMATION
1
Legal Proceedings
73
1A
Risk Factors
73
2
Unregistered Sales of Equity Securities and Use of Proceeds
74
6
Exhibits
74
Index to Exhibits
75
Signatures
76
2
Table of Contents
PART I - FINANCIAL INFORMATION
ITEM 1. Financial Statements
REINSURANCE GROUP OF AMERICA, INCORPORATED AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited)
June 30,
2019
December 31,
2018
(Dollars in thousands, except share data)
Assets
Fixed maturity securities available-for-sale, at fair value (amortized cost $42,457,618 and $38,882,168)
$
46,189,305
$
39,992,346
Equity securities, at fair value (cost $166,159 and $107,721)
146,755
82,197
Mortgage loans on real estate (net of allowances of $11,692 and $11,286)
5,405,422
4,966,298
Policy loans
1,319,722
1,344,980
Funds withheld at interest
5,696,217
5,761,471
Short-term investments
158,788
142,598
Other invested assets
2,121,406
1,915,297
Total investments
61,037,615
54,205,187
Cash and cash equivalents
2,287,526
1,889,733
Accrued investment income
470,074
427,893
Premiums receivable and other reinsurance balances
2,944,820
3,017,868
Reinsurance ceded receivables
851,380
757,572
Deferred policy acquisition costs
3,440,339
3,397,770
Other assets
1,012,062
839,222
Total assets
$
72,043,816
$
64,535,245
Liabilities and Stockholders’ Equity
Future policy benefits
$
26,995,770
$
25,285,400
Interest-sensitive contract liabilities
19,748,683
18,004,526
Other policy claims and benefits
6,136,374
5,642,755
Other reinsurance balances
512,924
487,177
Deferred income taxes
2,443,429
1,798,800
Other liabilities
1,480,914
1,396,200
Long-term debt
3,381,411
2,787,873
Collateral finance and securitization notes
635,300
681,961
Total liabilities
61,334,805
56,084,692
Commitments and contingent liabilities (See Note 8)
Stockholders’ Equity:
Preferred stock - par value $.01 per share, 10,000,000 shares authorized, no shares issued or outstanding
—
—
Common stock - par value $.01 per share, 140,000,000 shares authorized, 79,137,758 shares issued at June 30, 2019 and December 31, 2018
791
791
Additional paid-in capital
1,920,144
1,898,652
Retained earnings
7,549,737
7,284,949
Treasury stock, at cost - 16,379,267 and 16,323,390 shares
(
1,403,774
)
(
1,370,602
)
Accumulated other comprehensive income
2,642,113
636,763
Total stockholders’ equity
10,709,011
8,450,553
Total liabilities and stockholders’ equity
$
72,043,816
$
64,535,245
See accompanying notes to condensed consolidated financial statements (unaudited).
3
Table of Contents
REINSURANCE GROUP OF AMERICA, INCORPORATED AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(Unaudited)
Three months ended June 30,
Six months ended June 30,
2019
2018
2019
2018
Revenues:
(Dollars in thousands, except per share data)
Net premiums
$
2,763,786
$
2,594,460
$
5,501,599
$
5,177,011
Investment income, net of related expenses
584,078
528,061
1,163,955
1,044,390
Investment related gains (losses), net:
Other-than-temporary impairments on fixed maturity securities
—
(
3,350
)
(
9,453
)
(
3,350
)
Other investment related gains (losses), net
12,472
(
7,222
)
29,713
(
7,692
)
Total investment related gains (losses), net
12,472
(
10,572
)
20,260
(
11,042
)
Other revenues
107,072
83,959
201,625
159,256
Total revenues
3,467,408
3,195,908
6,887,439
6,369,615
Benefits and Expenses:
Claims and other policy benefits
2,515,211
2,279,593
5,023,535
4,641,694
Interest credited
157,842
109,327
291,031
189,776
Policy acquisition costs and other insurance expenses
260,345
320,276
572,226
677,178
Other operating expenses
223,499
194,959
424,982
386,233
Interest expense
43,283
37,025
83,456
74,479
Collateral finance and securitization expense
7,151
7,440
15,568
15,042
Total benefits and expenses
3,207,331
2,948,620
6,410,798
5,984,402
Income before income taxes
260,077
247,288
476,641
385,213
Provision for income taxes
57,379
42,914
104,436
80,609
Net income
$
202,698
$
204,374
$
372,205
$
304,604
Earnings per share:
Basic earnings per share
$
3.23
$
3.19
$
5.93
$
4.74
Diluted earnings per share
$
3.18
$
3.13
$
5.83
$
4.65
See accompanying notes to condensed consolidated financial statements (unaudited).
4
Table of Contents
REINSURANCE GROUP OF AMERICA, INCORPORATED AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(Unaudited)
Three months ended June 30,
Six months ended June 30,
2019
2018
2019
2018
Comprehensive income (loss)
(Dollars in thousands)
Net income
$
202,698
$
204,374
$
372,205
$
304,604
Other comprehensive income (loss), net of tax:
Foreign currency translation adjustments
24,603
(
54,677
)
45,989
(
55,837
)
Net unrealized investment gains (losses)
851,523
(
368,719
)
1,959,734
(
1,002,323
)
Defined benefit pension and postretirement plan adjustments
22
(
29
)
(
373
)
(
500
)
Total other comprehensive income (loss), net of tax
876,148
(
423,425
)
2,005,350
(
1,058,660
)
Total comprehensive income (loss)
$
1,078,846
$
(
219,051
)
$
2,377,555
$
(
754,056
)
See accompanying notes to condensed consolidated financial statements (unaudited).
5
Table of Contents
REINSURANCE GROUP OF AMERICA, INCORPORATED AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
(in thousands except per share amounts)
(Unaudited)
Three months ended June 30, 2019 and 2018
Common
Stock
Additional Paid In Capital
Retained
Earnings
Treasury
Stock
Accumulated Other Comprehensive Income
Total
Balance, March 31, 2019
$
791
$
1,906,291
$
7,412,081
$
(
1,415,020
)
$
1,765,965
$
9,670,108
Net income
202,698
202,698
Total other comprehensive income (loss)
876,148
876,148
Dividends to stockholders, $0.60 per share
(
37,640
)
(
37,640
)
Purchase of treasury stock
(
18,692
)
(
18,692
)
Reissuance of treasury stock
13,853
(
27,402
)
29,938
16,389
Balance, June 30, 2019
$
791
$
1,920,144
$
7,549,737
$
(
1,403,774
)
$
2,642,113
$
10,709,011
Balance, March 31, 2018
$
791
$
1,880,352
$
6,797,545
$
(
1,098,823
)
$
1,428,396
$
9,008,261
Net income
204,374
204,374
Total other comprehensive income (loss)
(
423,425
)
(
423,425
)
Dividends to stockholders, $0.50 per share
(
32,129
)
(
32,129
)
Purchase of treasury stock
(
162,453
)
(
162,453
)
Reissuance of treasury stock
6,984
(
17,620
)
17,710
7,074
Balance, June 30, 2018
$
791
$
1,887,336
$
6,952,170
$
(
1,243,566
)
$
1,004,971
$
8,601,702
Six months ended June 30, 2019 and 2018
Common
Stock
Additional Paid In Capital
Retained
Earnings
Treasury
Stock
Accumulated Other Comprehensive Income
Total
Balance, December 31, 2018
$
791
$
1,898,652
$
7,284,949
$
(
1,370,602
)
$
636,763
$
8,450,553
Adoption of new accounting standards
(
87
)
(
87
)
Net income
372,205
372,205
Total other comprehensive income (loss)
2,005,350
2,005,350
Dividends to stockholders, $1.20 per share
(
75,347
)
(
75,347
)
Purchase of treasury stock
(
67,744
)
(
67,744
)
Reissuance of treasury stock
21,492
(
31,983
)
34,572
24,081
Balance, June 30, 2019
$
791
$
1,920,144
$
7,549,737
$
(
1,403,774
)
$
2,642,113
$
10,709,011
Balance, December 31, 2017
$
791
$
1,870,906
$
6,736,265
$
(
1,102,058
)
$
2,063,631
$
9,569,535
Adoption of new accounting standards
(
2,020
)
(
2,020
)
Net income
304,604
304,604
Total other comprehensive income (loss)
(
1,058,660
)
(
1,058,660
)
Dividends to stockholders, $1.00 per share
(
64,370
)
(
64,370
)
Purchase of treasury stock
(
165,069
)
(
165,069
)
Reissuance of treasury stock
16,430
(
22,309
)
23,561
17,682
Balance, June 30, 2018
$
791
$
1,887,336
$
6,952,170
$
(
1,243,566
)
$
1,004,971
$
8,601,702
See accompanying notes to condensed consolidated financial statements (unaudited).
6
Table of Contents
REINSURANCE GROUP OF AMERICA, INCORPORATED AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
Six months ended June 30,
2019
2018
(Dollars in thousands)
Cash Flows from Operating Activities:
Net income
$
372,205
$
304,604
Adjustments to reconcile net income to net cash provided by operating activities:
Change in operating assets and liabilities:
Accrued investment income
(
12,200
)
1,834
Premiums receivable and other reinsurance balances
84,599
(
345,253
)
Deferred policy acquisition costs
(
114,895
)
20,528
Reinsurance ceded receivable balances
(
109,011
)
18,245
Future policy benefits, other policy claims and benefits, and other reinsurance balances
736,251
598,015
Deferred income taxes
92,442
48,117
Other assets and other liabilities, net
(
122,629
)
(
98,807
)
Amortization of net investment premiums, discounts and other
(
33,742
)
(
25,713
)
Depreciation and amortization expense
22,163
21,554
Investment related (gains) losses, net
(
20,260
)
11,042
Other, net
75,408
29,422
Net cash provided by operating activities
970,331
583,588
Cash Flows from Investing Activities:
Sales of fixed maturity securities available-for-sale
5,096,692
3,836,575
Maturities of fixed maturity securities available-for-sale
438,749
328,097
Sales of equity securities
36
29,099
Principal payments and sales of mortgage loans on real estate
166,483
213,691
Principal payments on policy loans
43,849
24,793
Purchases of fixed maturity securities available-for-sale
(
5,689,268
)
(
3,880,733
)
Purchases of equity securities
(
56,732
)
(
11,930
)
Cash invested in mortgage loans on real estate
(
598,309
)
(
376,470
)
Cash invested in policy loans
(
4,940
)
(
6,421
)
Cash invested in funds withheld at interest
(
54,030
)
(
42,761
)
Purchase of businesses, net of cash acquired of $27,374 and $4,938
3,561
(
29,315
)
Purchases of property and equipment
(
17,467
)
(
14,573
)
Change in short-term investments
67,177
(
9,843
)
Change in other invested assets
(
160,204
)
(
160,824
)
Net cash used in investing activities
(
764,403
)
(
100,615
)
Cash Flows from Financing Activities:
Dividends to stockholders
(
75,347
)
(
64,370
)
Repayment of collateral finance and securitization notes
(
52,644
)
(
53,102
)
Proceeds from long-term debt issuance
598,524
—
Debt issuance costs
(
4,750
)
—
Principal payments of long-term debt
(
1,387
)
(
1,331
)
Purchases of treasury stock
(
67,744
)
(
165,069
)
Exercise of stock options, net
2,590
1,252
Change in cash collateral for derivative positions and other arrangements
(
80,214
)
17,578
Deposits on universal life and other investment type policies and contracts
256,373
225,876
Withdrawals on universal life and other investment type policies and contracts
(
390,295
)
(
329,899
)
Net cash provided by (used in) financing activities
185,106
(
369,065
)
Effect of exchange rate changes on cash
6,759
(
19,753
)
Change in cash and cash equivalents
397,793
94,155
Cash and cash equivalents, beginning of period
1,889,733
1,303,524
Cash and cash equivalents, end of period
$
2,287,526
$
1,397,679
Supplemental disclosures of cash flow information:
Interest paid
$
85,829
$
84,670
Income taxes paid, net of refunds
$
22,632
$
59,397
Non-cash investing activities:
Transfer of invested assets
$
3,420,531
$
604,374
Right-of-use assets acquired through operating losses
$
1,105
$
—
Purchase of businesses:
Assets acquired, excluding cash acquired
$
8,303
$
65,948
Liabilities assumed
(
11,864
)
(
36,633
)
Net cash (received) paid on purchase
$
(
3,561
)
$
29,315
See accompanying notes to condensed consolidated financial statements (unaudited).
7
Table of Contents
REINSURANCE GROUP OF AMERICA, INCORPORATED AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements
(Unaudited)
1.
Business and Basis of Presentation
Business
Reinsurance Group of America, Incorporated (“RGA”) is an insurance holding company that was formed on December 31, 1992. RGA and its subsidiaries (collectively, the “Company”) is engaged in providing traditional reinsurance, which includes individual and group life and health, disability, and critical illness reinsurance. The Company also provides financial solutions, which includes longevity reinsurance, financial reinsurance, stable value products and asset-intensive products, primarily annuities.
Basis of Presentation
The unaudited condensed consolidated financial statements of the Company have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X of the Securities and Exchange Commission (“SEC”). Accordingly, these condensed consolidated financial statements do not include all of the information and footnotes required by GAAP for complete financial statements and should be read in conjunction with the Company’s 2018 Annual Report on Form 10-K filed with the SEC on February 27, 2019 (the “2018 Annual Report”).
In the opinion of management, all adjustments, including normal recurring adjustments necessary for a fair presentation have been included. Interim results are not necessarily indicative of the results that may be expected for the year ending December 31, 2019.
Consolidation
These unaudited condensed consolidated financial statements include the accounts of RGA and its subsidiaries and all intercompany accounts and transactions have been eliminated. Entities in which the Company has significant influence over the operating and financing decisions but are not required to be consolidated are reported under the equity method of accounting.
2.
Earnings Per Share
The following table sets forth the computation of basic and diluted earnings per share on net income (in thousands, except per share information):
Three months ended June 30,
Six months ended June 30,
2019
2018
2019
2018
Earnings:
Net income (numerator for basic and diluted calculations)
$
202,698
$
204,374
$
372,205
$
304,604
Shares:
Weighted average outstanding shares (denominator for basic calculation)
62,678
64,071
62,719
64,278
Equivalent shares from outstanding stock options
1,020
1,179
1,100
1,277
Denominator for diluted calculation
63,698
65,250
63,819
65,555
Earnings per share:
Basic
$
3.23
$
3.19
$
5.93
$
4.74
Diluted
$
3.18
$
3.13
$
5.83
$
4.65
The calculation of common equivalent shares does not include the impact of options having a strike or conversion price that exceeds the average stock price for the earnings period, as the result would be antidilutive. The calculation of common equivalent shares also excludes the impact of outstanding performance contingent shares, as the conditions necessary for their issuance have not been satisfied as of the end of the reporting period.
The following table presents approximate amounts of stock options and performance contingent shares excluded from the calculation of common equivalent shares (in thousands):
Three months ended June 30,
Six months ended June 30,
2019
2018
2019
2018
Excluded from common equivalent shares:
Stock options
250
225
420
295
Performance contingent shares
242
229
171
217
8
Table of Contents
3.
Equity
Common Stock
The changes in the number of common stock issued, held in treasury and outstanding are as follows for the periods indicated:
Issued
Held In Treasury
Outstanding
Balance, December 31, 2018
79,137,758
16,323,390
62,814,368
Common stock acquired
—
344,237
(
344,237
)
Stock-based compensation
(1)
—
(
288,360
)
288,360
Balance, June 30, 2019
79,137,758
16,379,267
62,758,491
Issued
Held In Treasury
Outstanding
Balance, December 31, 2017
79,137,758
14,685,663
64,452,095
Common stock acquired
—
991,477
(
991,477
)
Stock-based compensation
(1)
—
(
211,868
)
211,868
Balance, June 30, 2018
79,137,758
15,465,272
63,672,486
(1)
Represents net shares issued from treasury pursuant to the Company’s equity-based compensation programs.
Common Stock Held in Treasury
Common stock held in treasury is accounted for at average cost. Gains resulting from the reissuance of common stock held in treasury are credited to additional paid-in capital. Losses resulting from the reissuance of common stock held in treasury are charged first to additional paid-in capital to the extent the Company has previously recorded gains on treasury share transactions, then to retained earnings.
In January 2019, RGA’s board of directors authorized a repurchase program for up to
$
400.0
million
of RGA’s outstanding common stock. The authorization was effective immediately and does not have an expiration date. Repurchases would be made in accordance with applicable securities laws and would be made through market transactions, block trades, privately negotiated transactions or other means or a combination of these methods, with the timing and number of shares repurchased dependent on a variety of factors, including share price, corporate and regulatory requirements and market and business conditions. Repurchases may be commenced or suspended from time to time without prior notice. In connection with this new authorization, the board of directors terminated the stock repurchase authority granted in 2017. During the first
six
months of 2019, RGA repurchased
0.3
million
shares of common stock under this program for
$
50.0
million
. During the first
six
months of 2018, RGA repurchased
1.0
million
shares of common stock under the 2017 repurchase program for
$
150.0
million
.
Accumulated Other Comprehensive Income (Loss)
The balance of and changes in each component of accumulated other comprehensive income (loss) (“AOCI”) for the
six
months ended
June 30, 2019
and
2018
are as follows (dollars in thousands):
Accumulated
Currency
Translation
Adjustments
Unrealized
Appreciation
(Depreciation)
of Investments
(1)
Pension and
Postretirement
Benefits
Total
Balance, December 31, 2018
$
(
168,698
)
$
856,159
$
(
50,698
)
$
636,763
Other comprehensive income (loss) before reclassifications
43,534
2,617,211
(
3,369
)
2,657,376
Amounts reclassified to (from) AOCI
—
(
98,502
)
2,893
(
95,609
)
Deferred income tax benefit (expense)
2,455
(
558,975
)
103
(
556,417
)
Balance, June 30, 2019
$
(
122,709
)
$
2,815,893
$
(
51,071
)
$
2,642,113
Accumulated
Currency
Translation
Adjustments
Unrealized
Appreciation
(Depreciation)
of Investments
(1)
Pension and
Postretirement
Benefits
Total
Balance, December 31, 2017
$
(
86,350
)
$
2,200,661
$
(
50,680
)
$
2,063,631
Other comprehensive income (loss) before reclassifications
(
44,227
)
(
1,327,195
)
(
2,986
)
(
1,374,408
)
Amounts reclassified to (from) AOCI
—
53,646
2,366
56,012
Deferred income tax benefit (expense)
(
11,610
)
271,226
120
259,736
Balance, June 30, 2018
$
(
142,187
)
$
1,198,338
$
(
51,180
)
$
1,004,971
(1)
Includes cash flow hedges of
$(
14,862
)
and
$
8,788
as of
June 30, 2019
and
December 31, 2018
, respectively, and
$
22,656
and
$
2,619
as of
June 30, 2018
and
December 31, 2017
, respectively. See Note 5 - “Derivative Instruments” for additional information on cash flow hedges.
9
Table of Contents
The following table presents the amounts of AOCI reclassifications for the
three and six months ended June 30, 2019
and
2018
(dollars in thousands):
Amount Reclassified from AOCI
Three months ended June 30,
Six months ended June 30,
Details about AOCI Components
2019
2018
2019
2018
Affected Line Item in
Statements of Income
Net unrealized investment gains (losses):
Net unrealized gains (losses) on available-for-sale securities
$
20,249
$
(
24,642
)
$
19,976
$
(
39,098
)
Investment related gains (losses), net
Cash flow hedges - Interest rate
383
29
852
(
342
)
(1)
Cash flow hedges - Currency/Interest rate
(
6
)
76
19
221
(1)
Deferred policy acquisition costs attributed to unrealized gains and losses
63,182
(
7,835
)
77,655
(
14,427
)
(2)
Total
83,808
(
32,372
)
98,502
(
53,646
)
Provision for income taxes
(
17,273
)
6,945
(
20,279
)
11,623
Net unrealized gains (losses), net of tax
$
66,535
$
(
25,427
)
$
78,223
$
(
42,023
)
Amortization of defined benefit plan items:
Prior service cost (credit)
$
268
$
247
$
537
$
493
(3)
Actuarial gains/(losses)
(
1,875
)
(
1,267
)
(
3,430
)
(
2,859
)
(3)
Total
(
1,607
)
(
1,020
)
(
2,893
)
(
2,366
)
Provision for income taxes
338
214
608
497
Amortization of defined benefit plans, net of tax
$
(
1,269
)
$
(
806
)
$
(
2,285
)
$
(
1,869
)
Total reclassifications for the period
$
65,266
$
(
26,233
)
$
75,938
$
(
43,892
)
(1)
See Note 5 - “Derivative Instruments” for additional information on cash flow hedges.
(2)
This AOCI component is included in the computation of the deferred policy acquisition cost. See Note 8 – “Deferred Policy Acquisition Costs” of the 2018 Annual Report for additional details.
(3)
This AOCI component is included in the computation of the net periodic pension cost. See Note 10 – “Employee Benefit Plans” for additional deta
ils.
Equity Based Compensation
Equity compensation expense was
$
21.5
million
and
$
16.6
million
in the first six months of
2019
and
2018
, respectively. In the first quarter of 2019, the Company granted
0.2
million
stock appreciation rights at
$
145.25
weighted average exercise price per share and
0.1
million
performance contingent units to employees. Additionally, non-employee directors were granted a total of
8,472
shares of common stock. As of
June 30, 2019
,
1.5
million
share options at a weighted average strike price per share of
$
75.03
were vested and exercisable, with a remaining weighted average exercise period of
4.3
years. As of
June 30, 2019
, the total compensation cost of non-vested awards not yet recognized in the condensed consolidated financial statements was
$
28.2
million
. It is estimated that these costs will vest over a weighted average period of
1.0
years.
10
Table of Contents
4.
Investments
Fixed Maturity Securities Available-for-Sale
The Company holds various types of fixed maturity securities available-for-sale and classifies them as corporate securities (“Corporate”), Canadian and Canadian provincial government securities (“Canadian government”), residential mortgage-backed securities (“RMBS”), asset-backed securities (“ABS”), commercial mortgage-backed securities (“CMBS”), U.S. government and agencies (“U.S. government”), state and political subdivisions, and other foreign government, supranational and foreign government-sponsored enterprises (“Other foreign government”).
The following tables provide information relating to investments in fixed maturity securities by sector as of June 30, 2019 and
December 31, 2018
(dollars in thousands):
June 30, 2019:
Amortized Cost
Unrealized Gains
Unrealized Losses
Estimated Fair Value
% of Total
Other-than-
temporary Impairments in AOCI
Available-for-sale:
Corporate
$
26,055,078
$
1,651,141
$
70,788
$
27,635,431
59.8
%
$
—
Canadian government
2,960,943
1,613,153
133
4,573,963
9.9
—
RMBS
2,214,963
64,629
3,077
2,276,515
4.9
—
ABS
2,482,012
25,714
13,062
2,494,664
5.4
275
CMBS
1,687,024
60,775
514
1,747,285
3.8
—
U.S. government
1,738,348
40,202
370
1,778,180
3.8
—
State and political subdivisions
1,221,461
83,621
1,508
1,303,574
2.9
—
Other foreign government
4,097,789
288,833
6,929
4,379,693
9.5
—
Total fixed maturity securities
$
42,457,618
$
3,828,068
$
96,381
$
46,189,305
100.0
%
$
275
December 31, 2018:
Amortized Cost
Unrealized Gains
Unrealized Losses
Estimated Fair Value
% of Total
Other-than-
temporary Impairments in AOCI
Available-for-sale:
Corporate
$
24,006,407
$
530,804
$
555,092
$
23,982,119
59.9
%
$
—
Canadian government
2,768,466
1,126,227
2,308
3,892,385
9.7
—
RMBS
1,872,236
22,267
25,282
1,869,221
4.7
—
ABS
2,171,254
10,779
32,829
2,149,204
5.4
275
CMBS
1,428,115
9,153
18,234
1,419,034
3.5
—
U.S. government
2,233,537
10,204
57,867
2,185,874
5.5
—
State and political subdivisions
721,290
39,914
9,010
752,194
1.9
—
Other foreign government
3,680,863
109,320
47,868
3,742,315
9.4
—
Total fixed maturity securities
$
38,882,168
$
1,858,668
$
748,490
$
39,992,346
100.0
%
$
275
The Company enters into various collateral arrangements with counterparties that require both the pledging and acceptance of fixed maturity securities as collateral. Pledged fixed maturity securities are included in fixed maturity securities, available-for-sale in the condensed consolidated balance sheets. Fixed maturity securities received as collateral are held in separate custodial accounts and are not recorded on the Company’s condensed consolidated balance sheets. Subject to certain constraints, the Company is permitted by contract to sell or repledge collateral it receives; however, as of June 30, 2019 and
December 31, 2018
, none of the collateral received had been sold or repledged. The Company also holds assets in trust to satisfy collateral requirements under derivative transactions and certain third-party reinsurance treaties.
The following table includes fixed maturity securities pledged and received as collateral and assets in trust held to satisfy collateral requirements under derivative transactions and certain third-party reinsurance treaties as of
June 30, 2019
and
December 31, 2018
(dollars in thousands):
June 30, 2019
December 31, 2018
Amortized
Cost
Estimated
Fair Value
Amortized
Cost
Estimated
Fair Value
Fixed maturity securities pledged as collateral
$
85,651
$
89,295
$
80,891
$
83,950
Fixed maturity securities received as collateral
n/a
687,071
n/a
616,584
Assets in trust held to satisfy collateral requirements
23,697,506
25,212,508
20,072,735
20,366,170
11
Table of Contents
The Company monitors its concentrations of financial instruments on an ongoing basis and mitigates credit risk by maintaining a diversified investment portfolio that limits exposure to any one issuer.
The Company’s exposure to concentrations of credit risk from single issuers greater than
10
%
of the Company’s stockholders’ equity included securities of the U.S. government and its agencies as well as the securities disclosed below as of
June 30, 2019
and
December 31, 2018
(dollars in thousands).
June 30, 2019
December 31, 2018
Amortized
Cost
Estimated
Fair Value
Amortized
Cost
Estimated
Fair Value
Fixed maturity securities guaranteed or issued by:
Canadian province of Quebec
$
1,168,749
$
2,115,321
$
1,091,018
$
1,757,087
Canadian province of Ontario
978,025
1,361,749
913,642
1,187,526
The amortized cost and estimated fair value of fixed maturity securities classified as available-for-sale at
June 30, 2019
are shown by contractual maturity in the table below (dollars in thousands). Actual maturities can differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties. Asset and mortgage-backed securities are shown separately in the table below, as they are not due at a single maturity date.
Amortized Cost
Estimated Fair Value
Available-for-sale:
Due in one year or less
$
1,305,265
$
1,314,533
Due after one year through five years
8,823,728
9,130,980
Due after five years through ten years
9,519,138
10,171,840
Due after ten years
16,425,488
19,053,488
Asset and mortgage-backed securities
6,383,999
6,518,464
Total
$
42,457,618
$
46,189,305
Corporate Fixed Maturity Securities
The tables below show the major industry types of the Company’s corporate fixed maturity holdings as of
June 30, 2019
and
December 31, 2018
(dollars in thousands):
June 30, 2019:
Estimated
Amortized Cost
Fair Value
% of Total
Finance
$
9,865,739
$
10,385,443
37.6
%
Industrial
13,063,121
13,878,056
50.2
Utility
3,126,218
3,371,932
12.2
Total
$
26,055,078
$
27,635,431
100.0
%
December 31, 2018:
Estimated
Amortized Cost
Fair Value
% of Total
Finance
$
8,793,742
$
8,730,568
36.3
%
Industrial
12,336,857
12,342,111
51.6
Utility
2,875,808
2,909,440
12.1
Total
$
24,006,407
$
23,982,119
100.0
%
Other-Than-Temporary Impairments - Fixed Maturity Securities
As discussed in Note 2 – “Significant Accounting Policies and Pronouncements” of the 2018 Annual Report, a portion of certain other-than-temporary impairment (“OTTI”) losses on fixed maturity securities is recognized in AOCI. For these securities, the net amount recognized in the condensed consolidated statements of income (“credit loss impairments”) represents the difference between the amortized cost of the security and the net present value of its projected future cash flows discounted at the effective interest rate implicit in the debt security prior to impairment. Any remaining difference between the fair value and amortized cost is recognized in AOCI. The amount of pre-tax credit loss impairments on fixed maturity securities held by the Company, for which a portion of the OTTI loss was recognized in AOCI, was
$
3.7
million
as of
June 30, 2019
and 2018. There were no changes in these amounts from their respective prior-year ending balances
.
12
Table of Contents
Unrealized Losses for Fixed Maturity Securities Available-for-Sale
The following table presents the total gross unrealized losses for the
921
and
3,109
fixed maturity securities as of
June 30, 2019
and December 31, 2018, respectively, where the estimated fair value had declined and remained below amortized cost by the indicated amount (dollars in thousands):
June 30, 2019
December 31, 2018
Gross
Unrealized
Losses
% of Total
Gross
Unrealized
Losses
% of Total
Less than 20%
$
73,351
76.1
%
$
721,015
96.3
%
20% or more for less than six months
21,995
22.8
21,336
2.9
20% or more for six months or greater
1,035
1.1
6,139
0.8
Total
$
96,381
100.0
%
$
748,490
100.0
%
The Company’s determination of whether a decline in value is other-than-temporary includes an analysis of the underlying credit and the extent and duration of a decline in value. The Company’s credit analysis of an investment includes determining whether the issuer is current on its contractual payments, evaluating whether it is probable that the Company will be able to collect all amounts due according to the contractual terms of the security and analyzing the overall ability of the Company to recover the amortized cost of the investment.
The following tables present the estimated fair values and gross unrealized losses, including other-than-temporary impairment losses reported in AOCI, for
921
and
3,109
fixed maturity securities that have estimated fair values below amortized cost as of
June 30, 2019
and December 31, 2018, respectively (dollars in thousands). These investments are presented by class and grade of security, as well as the length of time the related fair value has remained below amortized cost.
Less than 12 months
12 months or greater
Total
Gross
Gross
Gross
June 30, 2019:
Estimated
Unrealized
Estimated
Unrealized
Estimated
Unrealized
Fair Value
Losses
Fair Value
Losses
Fair Value
Losses
Investment grade securities:
Corporate
$
780,802
$
8,757
$
1,276,130
$
28,924
$
2,056,932
$
37,681
Canadian government
2,535
2
17,555
131
20,090
133
RMBS
57,572
489
240,046
2,577
297,618
3,066
ABS
753,026
5,383
399,818
7,679
1,152,844
13,062
CMBS
79,372
240
37,442
274
116,814
514
U.S. government
257,328
36
76,098
334
333,426
370
State and political subdivisions
42,876
11
13,856
1,497
56,732
1,508
Other foreign government
90,066
2,565
110,341
2,697
200,407
5,262
Total investment grade securities
2,063,577
17,483
2,171,286
44,113
4,234,863
61,596
Below investment grade securities:
Corporate
216,611
22,148
139,318
10,959
355,929
33,107
RMBS
—
—
976
11
976
11
Other foreign government
6,337
77
18,664
1,590
25,001
1,667
Total below investment grade securities
222,948
22,225
158,958
12,560
381,906
34,785
Total fixed maturity securities
$
2,286,525
$
39,708
$
2,330,244
$
56,673
$
4,616,769
$
96,381
13
Table of Contents
Less than 12 months
12 months or greater
Total
Gross
Gross
Gross
December 31, 2018:
Estimated
Unrealized
Estimated
Unrealized
Estimated
Unrealized
Fair Value
Losses
Fair Value
Losses
Fair Value
Losses
Investment grade securities:
Corporate
$
8,505,371
$
302,604
$
3,611,266
$
195,082
$
12,116,637
$
497,686
Canadian government
25,169
419
131,806
1,612
156,975
2,031
RMBS
269,558
2,488
836,741
22,760
1,106,299
25,248
ABS
1,102,677
24,271
381,609
8,523
1,484,286
32,794
CMBS
384,259
4,304
414,719
13,930
798,978
18,234
U.S. government
8,616
80
1,086,694
57,787
1,095,310
57,867
State and political subdivisions
103,504
1,538
157,330
7,472
260,834
9,010
Other foreign government
789,859
24,509
472,934
17,446
1,262,793
41,955
Total investment grade securities
11,189,013
360,213
7,093,099
324,612
18,282,112
684,825
Below investment grade securities:
Corporate
755,679
42,760
122,559
14,646
878,238
57,406
Canadian government
443
34
1,770
243
2,213
277
RMBS
—
—
1,026
34
1,026
34
ABS
—
—
1,063
35
1,063
35
Other foreign government
128,725
5,574
7,479
339
136,204
5,913
Total below investment grade securities
884,847
48,368
133,897
15,297
1,018,744
63,665
Total fixed maturity securities
$
12,073,860
$
408,581
$
7,226,996
$
339,909
$
19,300,856
$
748,490
The Company has no intention to sell, nor does it expect to be required to sell, the securities outlined in the table above, as of the dates indicated. However, unforeseen facts and circumstances may cause the Company to sell fixed maturity securities in the ordinary course of managing its portfolio to meet certain diversification, credit quality and liquidity guidelines. Changes in unrealized losses are primarily driven by changes in interest rates.
Investment Income, Net of Related Expenses
Major categories of investment income, net of related expenses, consist of the following (dollars in thousands):
Three months ended June 30,
Six months ended June 30,
2019
2018
2019
2018
Fixed maturity securities available-for-sale
$
427,841
$
373,624
$
842,928
$
742,827
Equity securities
645
709
1,891
2,391
Mortgage loans on real estate
60,509
50,460
120,071
100,659
Policy loans
14,394
14,775
28,503
29,555
Funds withheld at interest
65,972
86,417
127,706
161,862
Short-term investments and cash and cash equivalents
7,465
2,964
14,365
6,209
Other invested assets
31,910
20,785
74,146
44,613
Investment income
608,736
549,734
1,209,610
1,088,116
Investment expense
(
24,658
)
(
21,673
)
(
45,655
)
(
43,726
)
Investment income, net of related expenses
$
584,078
$
528,061
$
1,163,955
$
1,044,390
14
Table of Contents
Investment Related Gains (Losses), Net
Investment related gains (losses), net, consist of the following (dollars in thousands):
Three months ended June 30,
Six months ended June 30,
2019
2018
2019
2018
Fixed maturity securities available-for-sale:
Other-than-temporary impairment losses
$
—
$
(
3,350
)
$
(
9,453
)
$
(
3,350
)
Gain on investment activity
20,384
21,140
48,429
32,106
Loss on investment activity
(
6,870
)
(
35,934
)
(
25,593
)
(
56,314
)
Equity securities:
Gain on investment activity
—
469
74
497
Loss on investment activity
—
—
(
1
)
(
950
)
Change in unrealized gains (losses) recognized in earnings
2,673
(
6,966
)
6,417
(
11,103
)
Other impairment losses and change in mortgage loan provision
(
5,609
)
(
1,357
)
(
7,468
)
(
1,669
)
Derivatives and other, net
1,894
15,426
7,855
29,741
Total investment related gains (losses), net
$
12,472
$
(
10,572
)
$
20,260
$
(
11,042
)
There were no fixed maturity impairments for the three months ended
June 30, 2019
. The fixed maturity impairments for the six months ended June 30, 2019 were primarily related to a U.S. utility company. The fixed maturity impairments for the three and six months ended June 30, 2018 were primarily related to high-yield corporate securities. The other impairment losses and change in mortgage loan provision for the three months ended June 30, 2019 includes impairments on limited partnerships. The other impairment losses and change in mortgage loan provision for the
six
months ended June 30, 2019 includes impairments on real estate joint ventures and limited partnerships. The other impairment losses and change in mortgage loan provision for the three months and
six
months ended June 30, 2018 includes impairments on real estate joint ventures. The fluctuations in investment related gains (losses) for derivatives and other for the three and six months ended
June 30, 2019
, compared to the same periods in
2018
, are primarily due to changes in the fair value of embedded derivatives and interest rate swaps.
During the three months ended
June 30, 2019
and
2018
, the Company sold fixed maturity securities with fair values of
$
466.1
million
and
$
1,174.4
million
at losses of
$
6.9
million
and
$
35.9
million
, respectively. During the
six
months ended
June 30, 2019
and
2018
, the Company sold fixed maturity securities with fair values of
$
1,712.7
million
and
$
2,438.0
million
at losses of
$
25.6
million
and
$
56.3
million
, respectively. The Company did not sell any equity securities at losses during the three months ended
June 30, 2019
and
2018
. During the
six
months ended
June 30, 2019
, the Company sold equity securities for immaterial losses. During the six months ended June 30,
2018
, the Company sold equity securities with fair values
$
28.4
million
at losses of
$
1.0
million
. The Company generally does not buy and sell securities on a short-term basis.
15
Table of Contents
Securities Borrowing, Lending and Other
The following table includes the amount of borrowed securities, securities lent and securities collateral received as part of the securities lending program and repurchased/reverse repurchased securities pledged and received as of
June 30, 2019
and
December 31, 2018
(dollars in thousands).
June 30, 2019
December 31, 2018
Amortized
Cost
Estimated
Fair Value
Amortized
Cost
Estimated
Fair Value
Borrowed securities
$
343,093
$
376,665
$
335,781
$
366,663
Securities lending:
Securities loaned
97,596
103,009
101,981
102,618
Securities received
n/a
107,000
n/a
112,000
Repurchase program/reverse repurchase program:
Securities pledged
576,381
596,412
554,806
554,589
Securities received
n/a
578,112
n/a
530,932
The Company also held cash collateral for repurchase/reverse repurchase programs of
$
28.6
million
at both
June 30, 2019
and
December 31, 2018
. No cash or securities have been pledged by the Company for its securities borrowing program as of
June 30, 2019
and
December 31, 2018
.
The following tables present information on the Company’s securities lending and repurchase transactions as of
June 30, 2019
and
December 31, 2018
(dollars in thousands). Collateral associated with certain borrowed securities is not included within the table, as the collateral pledged to each counterparty is the right to reinsurance treaty cash flows.
June 30, 2019
Remaining Contractual Maturity of the Agreements
Overnight and Continuous
Up to 30 Days
30-90 Days
Greater than 90 Days
Total
Securities lending transactions:
Corporate
$
—
$
—
$
—
$
103,009
$
103,009
Total
—
—
—
103,009
103,009
Repurchase transactions:
Corporate
—
—
—
289,659
289,659
U.S. government
—
—
—
209,581
209,581
Foreign government
—
—
—
97,172
97,172
Other
—
—
—
—
—
Total
—
—
—
596,412
596,412
Total borrowings
$
—
$
—
$
—
$
699,421
$
699,421
Gross amount of recognized liabilities for securities lending and repurchase transactions in preceding table
$
713,727
Amounts related to agreements not included in offsetting disclosure
$
14,306
16
Table of Contents
December 31, 2018
Remaining Contractual Maturity of the Agreements
Overnight and Continuous
Up to 30 Days
30-90 Days
Greater than 90 Days
Total
Securities lending transactions:
Corporate
$
—
$
—
$
—
$
102,618
$
102,618
Total
$
—
$
—
$
—
$
102,618
$
102,618
Repurchase transactions:
Corporate
$
—
$
—
$
—
$
254,151
$
254,151
U.S. government
—
—
—
221,572
221,572
Foreign government
—
—
—
78,866
78,866
Total
—
—
—
554,589
554,589
Total borrowings
$
—
$
—
$
—
$
657,207
$
657,207
Gross amount of recognized liabilities for securities lending and repurchase transactions in preceding table
$
671,492
Amounts related to agreements not included in offsetting disclosure
$
14,285
The Company has elected to offset amounts recognized as receivables and payables resulting from the repurchase/reverse repurchase programs. After the effect of offsetting, the net amount presented on the condensed consolidated balance sheets was a liability of
$
0.5
million
and
$
0.4
million
as of
June 30, 2019
and
December 31, 2018
, respectively. As of
June 30, 2019
and
December 31, 2018
, the Company recognized payables resulting from cash received as collateral associated with a repurchase agreement as discussed above. Amounts owed to and due from the counterparties may be settled in cash or offset, in accordance with the agreements.
Mortgage Loans on Real Estate
Mortgage loans represented approximately
8.9
%
and
9.1
%
of the Company’s total investments as of
June 30, 2019
and
December 31, 2018
. As of
June 30, 2019
, mortgage loans were geographically dispersed throughout the U.S. with the largest concentrations in California (
16.8
%
), Texas (
13.4
%
) and Washington (
7.1
%
) and include loans secured by properties in Canada (
2.9
%
) and United Kingdom (
0.5
%
). The recorded investment in mortgage loans on real estate presented below is gross of unamortized deferred loan origination fees and expenses, and valuation allowances.
The distribution of mortgage loans by property type is as follows as of
June 30, 2019
and
December 31, 2018
(dollars in thousands):
June 30, 2019
December 31, 2018
Property type:
Carrying Value
% of Total
Carrying Value
% of Total
Office building
$
1,718,595
31.7
%
$
1,725,748
34.6
%
Retail
1,526,267
28.1
1,432,394
28.7
Industrial
1,112,460
20.5
961,924
19.3
Apartment
730,452
13.5
571,291
11.5
Other commercial
336,371
6.2
291,997
5.9
Recorded investment
5,424,145
100.0
%
4,983,354
100.0
%
Unamortized balance of loan origination fees and expenses
(
7,031
)
(
5,770
)
Valuation allowances
(
11,692
)
(
11,286
)
Total mortgage loans on real estate
$
5,405,422
$
4,966,298
The maturities of mortgage loans as of
June 30, 2019
and
December 31, 2018
are as follows (dollars in thousands):
June 30, 2019
December 31, 2018
Recorded
Investment
% of Total
Recorded
Investment
% of Total
Due within five years
$
1,624,003
29.9
%
$
1,425,598
28.6
%
Due after five years through ten years
2,921,184
53.9
2,686,264
53.9
Due after ten years
878,958
16.2
871,492
17.5
Total
$
5,424,145
100.0
%
$
4,983,354
100.0
%
17
Table of Contents
The following tables set forth certain key credit quality indicators of the Company’s recorded investment in mortgage loans as of
June 30, 2019
and
December 31, 2018
(dollars in thousands):
Recorded Investment
Debt Service Ratios
Construction Loans
>1.20x
1.00x - 1.20x
<1.00x
Total
% of Total
June 30, 2019:
Loan-to-Value Ratio
0% - 59.99%
$
2,570,786
$
99,194
$
64,707
$
—
$
2,734,687
50.4
%
60% - 69.99%
1,786,531
108,392
41,680
39,432
1,976,035
36.4
70% - 79.99%
447,382
39,170
22,766
—
509,318
9.4
Greater than 80%
106,070
49,306
48,729
—
204,105
3.8
Total
$
4,910,769
$
296,062
$
177,882
$
39,432
$
5,424,145
100.0
%
Recorded Investment
Debt Service Ratios
Construction
Loans
>1.20x
1.00x - 1.20x
<1.00x
Total
% of Total
December 31, 2018:
Loan-to-Value Ratio
0% - 59.99%
$
2,410,556
$
61,246
$
38,177
$
13,691
$
2,523,670
50.6
%
60% - 69.99%
1,618,374
73,908
38,120
18,929
1,749,331
35.1
70% - 79.99%
414,269
48,438
54,440
—
517,147
10.4
Greater than 80%
117,978
49,668
25,560
—
193,206
3.9
Total
$
4,561,177
$
233,260
$
156,297
$
32,620
$
4,983,354
100.0
%
The age analysis of the Company’s past due recorded investments in mortgage loans as of
June 30, 2019
and
December 31, 2018
is as follows (dollars in thousands):
June 30, 2019
December 31, 2018
31-60 days past due
$
11,715
$
—
Total past due
11,715
—
Current
5,412,430
4,983,354
Total
$
5,424,145
$
4,983,354
The following table presents the recorded investment in mortgage loans, by method of measuring impairment, and the related valuation allowances as of
June 30, 2019
and
December 31, 2018
(dollars in thousands):
June 30, 2019
December 31, 2018
Mortgage loans:
Individually measured for impairment
$
17,014
$
30,635
Collectively measured for impairment
5,407,131
4,952,719
Recorded investment
$
5,424,145
$
4,983,354
Valuation allowances:
Individually measured for impairment
$
—
$
—
Collectively measured for impairment
11,692
11,286
Total valuation allowances
$
11,692
$
11,286
18
Table of Contents
Information regarding the Company’s loan valuation allowances for mortgage loans for the three and
six
months ended
June 30, 2019
and
2018
is as follows (dollars in thousands):
Three months ended June 30,
Six months ended June 30,
2019
2018
2019
2018
Balance, beginning of period
$
11,218
$
8,864
$
11,286
$
9,384
Provision (release)
470
845
397
329
Translation adjustment
4
(
3
)
9
(
7
)
Balance, end of period
$
11,692
$
9,706
$
11,692
$
9,706
Information regarding the portion of the Company’s mortgage loans that were impaired as of
June 30, 2019
and
December 31, 2018
is as follows (dollars in thousands):
Unpaid
Principal
Balance
Recorded
Investment
Related
Allowance
Carrying
Value
June 30, 2019:
Impaired mortgage loans with no valuation allowance recorded
$
17,017
$
17,014
$
—
$
17,014
Impaired mortgage loans with valuation allowance recorded
—
—
—
—
Total impaired mortgage loans
$
17,017
$
17,014
$
—
$
17,014
December 31, 2018:
Impaired mortgage loans with no valuation allowance recorded
$
30,660
$
30,635
$
—
$
30,635
Impaired mortgage loans with valuation allowance recorded
—
—
—
—
Total impaired mortgage loans
$
30,660
$
30,635
$
—
$
30,635
The Company’s average investment balance of impaired mortgage loans and the related interest income are reflected in the table below for the periods indicated (dollars in thousands):
Three months ended June 30,
2019
2018
Average
Recorded
Investment
(1)
Interest
Income
Average
Recorded
Investment
(1)
Interest
Income
Impaired mortgage loans with no valuation allowance recorded
$
17,047
$
171
$
27,038
$
247
Impaired mortgage loans with valuation allowance recorded
—
—
—
—
Total impaired mortgage loans
$
17,047
$
171
$
27,038
$
247
Six months ended June 30,
2019
2018
Average
Recorded
Investment
(1)
Interest
Income
Average
Recorded
Investment
(1)
Interest
Income
Impaired mortgage loans with no valuation allowance recorded
$
21,576
$
499
$
19,978
$
304
Impaired mortgage loans with valuation allowance recorded
—
—
—
—
Total impaired mortgage loans
$
21,576
$
499
$
19,978
$
304
(1)
Average recorded investment represents the average loan balances as of the beginning of period and all subsequent quarterly end of period balances.
The Company did not acquire any impaired mortgage loans during the
six
months ended
June 30, 2019
and
2018
. The Company had no mortgage loans that were on a nonaccrual status at
June 30, 2019
and
December 31, 2018
.
Policy Loans
Policy loans comprised approximately
2.2
%
and
2.5
%
of the Company’s total investments as of
June 30, 2019
and
December 31, 2018
, respectively, the majority of which are associated with one client. These policy loans present no credit risk because the amount of the loan cannot exceed the obligation due to the ceding company upon the death of the insured or surrender of the underlying policy. The provisions of the treaties in force and the underlying policies determine the policy loan interest rates. The Company earns a spread between the interest rate earned on policy loans and the interest rate credited to corresponding liabilities.
19
Table of Contents
Funds Withheld at Interest
Funds withheld at interest comprised approximately
9.3
%
and
10.6
%
of the Company’s total investments as of
June 30, 2019
and
December 31, 2018
, respectively. Of the
$
5.7
billion
funds withheld at interest balance, net of embedded derivatives, as of
June 30, 2019
,
$
3.6
billion
of the balance is associated with one client. For reinsurance agreements written on a modified coinsurance basis and certain agreements written on a coinsurance funds withheld basis, assets equal to the net statutory reserves are withheld and legally owned and managed by the ceding company and are reflected as funds withheld at interest on the Company’s condensed consolidated balance sheets. In the event of a ceding company’s insolvency, the Company would need to assert a claim on the assets supporting its reserve liabilities. However, the risk of loss to the Company is mitigated by its ability to offset amounts it owes the ceding company for claims or allowances against amounts owed to the Company from the ceding company.
Other Invested Assets
Other invested assets represented approximately
3.5
%
of the Company’s total investments as of
June 30, 2019
and
December 31, 2018
.
Carrying values of these assets as of
June 30, 2019
and
December 31, 2018
were as follows (dollars in thousands):
June 30, 2019
December 31, 2018
Limited partnership interests and real estate joint ventures
$
1,008,571
$
965,094
Equity release mortgages
641,611
475,905
Derivatives
122,484
180,699
FVO contractholder-directed unit-linked investments
255,174
197,770
Other
93,566
95,829
Total other invested assets
$
2,121,406
$
1,915,297
5.
Derivative Instruments
Accounting for Derivative Instruments and Hedging Activities
See Note 2 – “Significant Accounting Policies and Pronouncements” of the Company’s 2018 Annual Report for a detailed discussion of the accounting treatment for derivative instruments, including embedded derivatives. See Note 6 – “Fair Value of Assets and Liabilities” for additional disclosures related to the fair value hierarchy for derivative instruments, including embedded derivatives.
Types of Derivatives Used by the Company
Commonly used derivative instruments include, but are not necessarily limited to: credit default swaps, financial futures, equity options, foreign currency swaps, foreign currency forwards, interest rate swaps, synthetic guaranteed investment contracts (“GICs”), consumer price index (“CPI”) swaps, longevity swaps, mortality swaps and embedded derivatives.
For detailed information on these derivative instruments and the related strategies, see Note 5 – “Derivative Instruments” of the Company’s 2018 Annual Report.
20
Table of Contents
Summary of Derivative Positions
Derivatives, except for embedded derivatives and longevity and mortality swaps, are carried on the Company’s condensed consolidated balance sheets in other invested assets or other liabilities, at fair value. Longevity and mortality swaps are included on the condensed consolidated balance sheets in other assets or other liabilities, at fair value. Embedded derivative assets and liabilities on modified coinsurance (“modco”) or funds withheld arrangements are included on the condensed consolidated balance sheets with the host contract in funds withheld at interest, at fair value. Embedded derivative liabilities on indexed annuity and variable annuity products are included on the condensed consolidated balance sheets with the host contract in interest-sensitive contract liabilities, at fair value.
The following table presents the notional amounts and gross fair value of derivative instruments prior to taking into account the netting effects of master netting agreements as of
June 30, 2019
and
December 31, 2018
(dollars in thousands):
June 30, 2019
December 31, 2018
Primary Underlying Risk
Notional
Carrying Value/Fair Value
Notional
Carrying Value/Fair Value
Amount
Assets
Liabilities
Amount
Assets
Liabilities
Derivatives not designated as hedging instruments:
Interest rate swaps
Interest rate
$
922,478
$
71,535
$
3,447
$
1,040,588
$
47,652
$
961
Financial futures
Equity
389,353
—
—
325,620
—
—
Foreign currency swaps
Foreign currency
149,698
—
12,194
149,698
504
4,659
Foreign currency forwards
Foreign currency
—
—
—
25,000
—
234
Consumer price index swaps
CPI
438,587
189
25,481
385,580
—
11,384
Credit default swaps
Credit
1,331,300
6,190
134
1,338,300
6,003
1,166
Equity options
Equity
371,869
14,644
—
439,158
42,836
—
Longevity swaps
Longevity
909,840
51,755
—
917,360
47,789
—
Mortality swaps
Mortality
25,000
—
853
25,000
—
369
Synthetic guaranteed investment contracts
Interest rate
13,526,503
—
—
13,397,729
—
—
Embedded derivatives in:
Modified coinsurance or funds withheld arrangements
—
112,767
—
—
109,597
—
Indexed annuity products
—
—
740,683
—
—
776,940
Variable annuity products
—
—
167,808
—
—
167,925
Total non-hedging derivatives
18,064,628
257,080
950,600
18,044,033
254,381
963,638
Derivatives designated as hedging instruments:
Interest rate swaps
Foreign currency/Interest rate
535,000
825
27,560
435,000
—
27,257
Foreign currency swaps
Foreign currency
408,910
28,400
2,425
494,461
51,311
—
Foreign currency forwards
Foreign currency
987,606
27,532
653
911,197
50,974
—
Total hedging derivatives
1,931,516
56,757
30,638
1,840,658
102,285
27,257
Total derivatives
$
19,996,144
$
313,837
$
981,238
$
19,884,691
$
356,666
$
990,895
21
Table of Contents
Fair Value Hedges
The Company designates and reports certain foreign currency swaps to hedge the foreign currency fair value exposure of foreign currency denominated assets as fair value hedges when they meet the requirements of the general accounting principles for
Derivatives and Hedging
.
The gain or loss on the hedged item attributable to a change in foreign currency and the offsetting gain or loss on the related foreign currency swaps as of
June 30, 2019
and 2018, were (dollars in thousands):
Type of Fair Value Hedge
Hedged Item
Gains (Losses) Recognized for Derivatives
Gains (Losses) Recognized for Hedged Items
Investment Related Gains (Losses)
For the three months ended June 30, 2019:
Foreign currency swaps
Foreign-denominated fixed maturity securities
$
(
3,718
)
$
1,118
For the three months ended June 30, 2018:
Foreign currency swaps
Foreign-denominated fixed maturity securities
$
(
1,134
)
$
4,942
For the six months ended June 30, 2019:
Foreign currency swaps
Foreign-denominated fixed maturity securities
$
(
4,426
)
$
415
For the six months ended June 30, 2018:
Foreign currency swaps
Foreign-denominated fixed maturity securities
$
(
3,025
)
$
6,833
Cash Flow Hedges
Certain derivative instruments are designated as cash flow hedges when they meet the requirements of the general accounting principles for
Derivatives and Hedging
. The Company designates and accounts for the following as cash flow hedges: (i) certain interest rate swaps, in which the cash flows of assets and liabilities are variable based on a benchmark rate; and (ii) certain interest rate swaps, in which the cash flows of assets are denominated in different currencies, commonly referred to as cross-currency swaps.
The following table presents the components of AOCI, before income tax, and the condensed consolidated income statement classification where the gain or loss is recognized related to cash flow hedges for the
three and six months ended June 30, 2019 and 2018
(dollars in thousands):
Three months ended June 30,
2019
2018
Balance beginning of period
$
(
1,902
)
$
20,662
Gains (losses) deferred in other comprehensive income (loss)
(
12,583
)
2,099
Amounts reclassified to investment income
6
(
76
)
Amounts reclassified to interest expense
(
383
)
(
29
)
Balance end of period
$
(
14,862
)
$
22,656
Six months ended June 30,
2019
2018
Balance beginning of period
$
8,788
$
2,619
Gains (losses) deferred in other comprehensive income (loss)
(
22,779
)
19,916
Amounts reclassified to investment income
(
19
)
(
221
)
Amounts reclassified to interest expense
(
852
)
342
Balance end of period
$
(
14,862
)
$
22,656
As of
June 30, 2019
, the before-tax deferred net gains (losses) on derivative instruments recorded in AOCI that are expected to be reclassified to earnings during the next twelve months are approximately
$
0.1
million
and
$(
0.3
) million
in investment income and interest expense, respectively.
22
Table of Contents
The following table presents the effect of derivatives in cash flow hedging relationships on the condensed consolidated statements of income and the condensed consolidated statements of comprehensive income for the
three and six months ended June 30, 2019 and 2018
(dollars in thousands):
Derivative Type
Gain (Loss) Deferred in AOCI
Gain (Loss) Reclassified into Income from AOCI
Investment Income
Interest Expense
For the three months ended June 30, 2019:
Interest rate
$
(
9,869
)
$
—
$
383
Currency/Interest rate
(
2,714
)
(
6
)
—
Total
$
(
12,583
)
$
(
6
)
$
383
For the three months ended June 30, 2018:
Interest rate
$
4,742
$
—
$
29
Currency/Interest rate
(
2,643
)
76
—
Total
$
2,099
$
76
$
29
For the six months ended June 30, 2019:
Interest rate
$
(
21,970
)
$
—
$
852
Currency/Interest rate
(
809
)
19
—
Total
$
(
22,779
)
$
19
$
852
For the six months ended June 30, 2018:
Interest rate
$
19,727
$
—
$
(
342
)
Currency/Interest rate
189
221
—
Total
$
19,916
$
221
$
(
342
)
Hedges of Net Investments in Foreign Operations
The Company uses foreign currency swaps and foreign currency forwards to hedge a portion of its net investment in certain foreign operations against adverse movements in exchange rates.
The following table illustrates the Company’s net investments in foreign operations (“NIFO”) hedges for the
three and six months ended June 30, 2019 and 2018
(dollars in thousands):
Derivative Gains (Losses) Deferred in AOCI
For the three months ended June 30,
For the six months ended June 30,
Type of NIFO Hedge
(1)
2019
2018
2019
2018
Foreign currency swaps
$
(
2,486
)
$
8,197
$
(
9,493
)
$
17,002
Foreign currency forwards
(
5,984
)
11,063
(
24,095
)
23,299
Total
$
(
8,470
)
$
19,260
$
(
33,588
)
$
40,301
(1)
There were no sales or substantial liquidations of net investments in foreign operations that would have required the reclassification of gains or losses from accumulated other comprehensive income (loss) into investment income during the periods presented.
The cumulative foreign currency translation gain recorded in AOCI related to these hedges was
$
167.4
million
and
$
201.0
million
at
June 30, 2019
and
December 31, 2018
, respectively. If a hedged foreign operation was sold or substantially liquidated, the amounts in AOCI would be reclassified to the condensed consolidated statements of income. A pro rata portion would be reclassified upon partial sale of a hedged foreign operation.
Non-qualifying Derivatives and Derivatives for Purposes Other Than Hedging
The Company uses various other derivative instruments for risk management purposes that either do not qualify or have not been qualified for hedge accounting treatment. The gain or loss related to the change in fair value for these derivative instruments is recognized in investment related gains (losses), net in the condensed consolidated statements of income, except where otherwise noted.
23
Table of Contents
A summary of the effect of non-hedging derivatives, including embedded derivatives, on the Company’s condensed consolidated statements of income for the
three and six months ended June 30, 2019 and 2018
is as follows (dollars in thousands):
Gain (Loss) for the three months ended
June 30,
Type of Non-hedging Derivative
Income Statement Location of Gain (Loss)
2019
2018
Interest rate swaps
Investment related gains (losses), net
$
33,404
$
(
8,600
)
Financial futures
Investment related gains (losses), net
(
7,685
)
(
897
)
Foreign currency swaps
Investment related gains (losses), net
(
6,380
)
—
Foreign currency forwards
Investment related gains (losses), net
(
258
)
(
262
)
CPI swaps
Investment related gains (losses), net
(
6,812
)
1,041
Credit default swaps
Investment related gains (losses), net
5,078
1,084
Equity options
Investment related gains (losses), net
(
4,828
)
(
8,007
)
Longevity swaps
Other revenues
2,184
2,289
Mortality swaps
Other revenues
(
1,342
)
(
799
)
Subtotal
13,361
(
14,151
)
Embedded derivatives in:
Modified coinsurance or funds withheld arrangements
Investment related gains (losses), net
5,262
8,805
Indexed annuity products
Interest credited
(
8,459
)
6,519
Variable annuity products
Investment related gains (losses), net
(
18,044
)
15,324
Total non-hedging derivatives
$
(
7,880
)
$
16,497
Gain (Loss) for the six months ended
June 30,
Type of Non-hedging Derivative
Income Statement Location of Gain (Loss)
2019
2018
Interest rate swaps
Investment related gains (losses), net
$
57,378
$
(
35,171
)
Financial futures
Investment related gains (losses), net
(
29,963
)
(
768
)
Foreign currency swaps
Investment related gains (losses), net
(
5,657
)
—
Foreign currency forwards
Investment related gains (losses), net
234
61
CPI swaps
Investment related gains (losses), net
(
15,663
)
3,227
Credit default swaps
Investment related gains (losses), net
19,578
682
Equity options
Investment related gains (losses), net
(
27,512
)
(
5,414
)
Longevity swaps
Other revenues
4,327
4,557
Mortality swaps
Other revenues
(
484
)
(
799
)
Subtotal
2,238
(
33,625
)
Embedded derivatives in:
Modified coinsurance or funds withheld arrangements
Investment related gains (losses), net
3,170
22,416
Indexed annuity products
Interest credited
(
5,389
)
31,870
Variable annuity products
Investment related gains (losses), net
117
30,109
Total non-hedging derivatives
$
136
$
50,770
24
Table of Contents
Credit Derivatives
The following table presents the estimated fair value, maximum amount of future payments and weighted average years to maturity of credit default swaps sold by the Company at
June 30, 2019
and
December 31, 2018
(dollars in thousands):
June 30, 2019
December 31, 2018
Rating Agency Designation of Referenced Credit Obligations
(1)
Estimated Fair
Value of Credit
Default Swaps
Maximum
Amount of Future
Payments under
Credit Default
Swaps
(2)
Weighted
Average
Years to
Maturity
(3)
Estimated Fair
Value of Credit
Default Swaps
Maximum
Amount of Future
Payments under
Credit Default
Swaps
(2)
Weighted
Average
Years to
Maturity
(3)
AAA/AA+/AA/AA-/A+/A/A-
Single name credit default swaps
$
2,015
$
147,000
2.1
$
1,953
$
152,000
2.2
Subtotal
2,015
147,000
2.1
1,953
152,000
2.2
BBB+/BBB/BBB-
Single name credit default swaps
3,762
321,700
2.0
2,930
353,700
2.2
Credit default swaps referencing indices
288
852,600
4.8
(
76
)
817,600
6.4
Subtotal
4,050
1,174,300
4.1
2,854
1,171,300
5.1
BB+/BB/BB-
Single name credit default swaps
(
9
)
10,000
0.3
30
15,000
0.7
Subtotal
(
9
)
10,000
0.3
30
15,000
0.7
Total
$
6,056
$
1,331,300
3.8
$
4,837
$
1,338,300
4.7
(1)
The rating agency designations are based on ratings from Standard and Poor’s (“S&P”).
(2)
Assumes the value of the referenced credit obligations is zero.
(3)
The weighted average years to maturity of the credit default swaps is calculated based on weighted average notional amounts.
Netting Arrangements and Credit Risk
Certain of the Company’s derivatives are subject to enforceable master netting arrangements and reported as a net asset or liability in the condensed consolidated balance sheets. The Company nets all derivatives that are subject to such arrangements.
The Company has elected to include all derivatives, except embedded derivatives, in the tables below, irrespective of whether they are subject to an enforceable master netting arrangement or a similar agreement. See Note 4 – “Investments” for information regarding the Company’s securities borrowing, lending, repurchase and repurchase/reverse repurchase programs.
The following table provides information relating to the Company’s derivative instruments as of
June 30, 2019
and
December 31, 2018
(dollars in thousands):
Gross Amounts Not
Offset in the Balance Sheet
Gross Amounts
Recognized
Gross Amounts
Offset in the
Balance Sheet
Net Amounts
Presented in the
Balance Sheet
Financial Instruments
(1)
Cash Collateral
Pledged/
Received
Net Amount
June 30, 2019:
Derivative assets
$
201,070
$
(
26,831
)
$
174,239
$
—
$
(
189,265
)
$
(
15,026
)
Derivative liabilities
72,747
(
26,831
)
45,916
(
72,803
)
(
56,310
)
(
83,197
)
December 31, 2018:
Derivative assets
$
247,069
$
(
18,581
)
$
228,488
$
—
$
(
235,611
)
$
(
7,123
)
Derivative liabilities
46,030
(
18,581
)
27,449
(
71,376
)
(
24,080
)
(
68,007
)
(1)
Includes initial margin posted to a central clearing partner.
The Company may be exposed to credit-related losses in the event of non-performance by counterparties to derivative financial instruments with a positive fair value. Generally, the credit exposure of the Company’s derivative contracts is limited to the fair value at the reporting date plus or minus any collateral posted or held by the Company. The Company had no credit exposure related to its derivative contracts, as of
June 30, 2019
and
December 31, 2018
, as the net amount of collateral pledged to the Company from counterparties exceeded the fair value of the derivative contracts.
Derivatives may be exchange-traded or they may be privately negotiated contracts, which are referred to as over-the-counter (“OTC”) derivatives. Certain of the Company’s OTC derivatives are cleared and settled through central clearing counterparties (“OTC cleared”) and others are bilateral contracts between two counterparties. The Company manages its credit risk related to OTC derivatives by entering into transactions with creditworthy counterparties, maintaining collateral arrangements and through the use of master netting agreements that provide for a single net payment to be made by one counterparty to another at each due date and upon termination. The Company is only exposed to the default of the central clearing counterparties for OTC cleared derivatives, and these transactions require initial and daily variation margin collateral postings. Exchange-traded derivatives are
25
Table of Contents
settled on a daily basis, thereby reducing the credit risk exposure in the event of non-performance by counterparties to such financial instruments.
6.
Fair Value of Assets and Liabilities
Fair Value Measurement
General accounting principles for
Fair Value Measurements and Disclosures
define fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. These principles also establish a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value and describes three levels of inputs that may be used to measure fair value:
Level 1 - Unadjusted quoted prices in active markets for identical assets or liabilities. The Company’s Level 1 assets and liabilities are traded in active exchange markets.
Level 2 - Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or market standard valuation techniques and assumptions that use significant inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
Level 3 - Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the related assets or liabilities. Prices are determined using valuation methodologies such as discounted cash flow models and other similar techniques that require management’s judgment or estimation in developing inputs that are consistent with what other market participants would use when pricing similar assets and liabilities. Additionally, the Company’s embedded derivatives, all of which are associated with reinsurance treaties and longevity and mortality swaps, are classified in Level 3 since their values include significant unobservable inputs.
For a discussion of the Company’s valuation methodologies for assets and liabilities measured at fair value and the fair value hierarchy, see Note 6 in the Notes to Consolidated Financial Statements included in the Company’s 2018 Annual Report.
26
Table of Contents
Assets and Liabilities by Hierarchy Level
Assets and liabilities measured at fair value on a recurring basis as of June 30, 2019 and
December 31, 2018
are summarized below (dollars in thousands):
June 30, 2019:
Fair Value Measurements Using:
Total
Level 1
Level 2
Level 3
Assets:
Fixed maturity securities – available-for-sale:
Corporate
$
27,635,431
$
—
$
25,991,067
$
1,644,364
Canadian government
4,573,963
—
3,902,936
671,027
RMBS
2,276,515
—
2,260,483
16,032
ABS
2,494,664
—
2,384,342
110,322
CMBS
1,747,285
—
1,747,266
19
U.S. government
1,778,180
1,651,425
109,349
17,406
State and political subdivisions
1,303,574
—
1,293,719
9,855
Other foreign government
4,379,693
—
4,364,007
15,686
Total fixed maturity securities – available-for-sale
46,189,305
1,651,425
42,053,169
2,484,711
Equity securities
146,755
101,948
—
44,807
Funds withheld at interest – embedded derivatives
112,767
—
—
112,767
Cash equivalents
755,129
737,286
17,843
—
Short-term investments
126,468
17,963
80,118
28,387
Other invested assets:
Derivatives:
Interest rate swaps
61,298
—
61,298
—
Foreign currency forwards
27,532
—
27,532
—
Credit default swaps
(
6,696
)
—
(
6,696
)
—
Equity options
14,375
—
14,375
—
Foreign currency swaps
25,975
—
25,975
—
FVO contractholder-directed unit-linked investments
255,174
205,805
49,369
—
Total other invested assets
377,658
205,805
171,853
—
Other assets - longevity swaps
51,755
—
—
51,755
Total
$
47,759,837
$
2,714,427
$
42,322,983
$
2,722,427
Liabilities:
Interest sensitive contract liabilities – embedded derivatives
$
908,491
$
—
$
—
$
908,491
Other liabilities:
Derivatives:
Interest rate swaps
19,945
—
19,945
—
Foreign currency swaps - non-hedged
12,194
—
12,194
—
Foreign currency forwards
653
—
653
—
CPI swaps
25,292
—
25,292
—
Credit default swaps
(
12,752
)
—
(
12,752
)
—
Equity options
(
269
)
—
(
269
)
—
Mortality swaps
853
—
—
853
Total
$
954,407
$
—
$
45,063
$
909,344
27
Table of Contents
December 31, 2018:
Fair Value Measurements Using:
Total
Level 1
Level 2
Level 3
Assets:
Fixed maturity securities – available-for-sale:
Corporate
$
23,982,119
$
—
$
22,651,194
$
1,330,925
Canadian government
3,892,385
—
3,364,261
528,124
RMBS
1,869,221
—
1,862,366
6,855
ABS
2,149,204
—
2,053,632
95,572
CMBS
1,419,034
—
1,419,012
22
U.S. government
2,185,874
2,067,529
100,320
18,025
State and political subdivisions
752,194
—
741,992
10,202
Other foreign government
3,742,315
—
3,737,309
5,006
Total fixed maturity securities – available-for-sale
39,992,346
2,067,529
35,930,086
1,994,731
Equity securities
82,197
48,737
—
33,460
Funds withheld at interest – embedded derivatives
109,597
—
—
109,597
Cash equivalents
485,167
473,509
11,658
—
Short-term investments
105,991
4,989
98,774
2,228
Other invested assets:
Derivatives:
Interest rate swaps
37,976
—
37,976
—
Foreign currency forwards
50,740
—
50,740
—
Credit default swaps
4,466
—
4,466
—
Equity options
36,206
—
36,206
—
Foreign currency swaps
51,311
—
51,311
—
FVO contractholder-directed unit-linked investments
197,770
196,781
989
—
Total other invested assets
378,469
196,781
181,688
—
Other assets - longevity swaps
47,789
—
—
47,789
Total
$
41,201,556
$
2,791,545
$
36,222,206
$
2,187,805
Liabilities:
Interest sensitive contract liabilities – embedded derivatives
$
944,865
$
—
$
—
$
944,865
Other liabilities:
Derivatives:
Interest rate swaps
18,542
—
18,542
—
Foreign currency swaps - non-hedged
4,155
—
4,155
—
CPI swaps
11,384
—
11,384
—
Credit default swaps
(
371
)
—
(
371
)
—
Equity options
(
6,630
)
—
(
6,630
)
—
Mortality swaps
369
—
—
369
Total
$
972,314
$
—
$
27,080
$
945,234
28
Table of Contents
Transfers between Levels 1 and 2
Transfers between Levels 1 and 2 are made to reflect changes in observability of inputs and market activity. The Company recognizes transfers of assets and liabilities into and out of levels within the fair value hierarchy at the beginning of the quarter in which the actual event or change in circumstances that caused the transfer occurs. There were no transfers between Level 1 and Level 2 during the six months ended
June 30, 2019
or 2018.
Quantitative Information Regarding Internally - Priced Assets and Liabilities
The following table presents quantitative information about significant unobservable inputs used in Level 3 fair value measurements that are developed internally by the Company as of
June 30, 2019
and
December 31, 2018
(dollars in thousands):
Estimated Fair Value
Valuation Technique
Unobservable Inputs
Range (Weighted Average)
June 30, 2019
December 31, 2018
June 30, 2019
December 31, 2018
Assets:
Corporate
$
808,416
$
642,647
Market comparable securities
Liquidity premium
0-5% (1%)
0-5% (1%)
EBITDA Multiple
5.9x
5.9x-7.5x (6.5x)
ABS
97,055
77,842
Market comparable securities
Liquidity premium
0-4% (1%)
0-1% (1%)
U.S. government
17,406
18,025
Market comparable securities
Liquidity premium
0-1% (1%)
0-1% (1%)
Other foreign government
15,686
5,006
Market comparable securities
Liquidity premium
1
%
1
%
Equity securities
31,617
25,007
Market comparable securities
Liquidity premium
4
%
4
%
EBITDA Multiple
6.9x-12.3x (8.2x)
6.9x-12.3x (7.9x)
Funds withheld at interest- embedded derivatives
112,767
109,597
Total return swap
Mortality
0-100% (2%)
0-100% (2%)
Lapse
0-35% (12%)
0-35% (10%)
Withdrawal
0-5% (3%)
0-5% (3%)
CVA
0-5% (1%)
0-5% (1%)
Crediting rate
2-4% (2%)
2-4% (2%)
Longevity swaps
51,755
47,789
Discounted cash flow
Mortality
0-100% (2%)
0-100% (2%)
Mortality improvement
(10%)-10% (3%)
(10%)-10% (3%)
Liabilities:
Interest sensitive contract liabilities- embedded derivatives- indexed annuities
740,683
776,940
Discounted cash flow
Mortality
0-100% (2%)
0-100% (2%)
Lapse
0-35% (12%)
0-35% (10%)
Withdrawal
0-5% (3%)
0-5% (3%)
Option budget projection
2-4% (2%)
2-4% (2%)
Interest sensitive contract liabilities- embedded derivatives- variable annuities
167,808
167,925
Discounted cash flow
Mortality
0-100% (1%)
0-100% (1%)
Lapse
0-25% (5%)
0-25% (5%)
Withdrawal
0-7% (5%)
0-7% (5%)
CVA
0-5% (1%)
0-5% (1%)
Long-term volatility
0-27% (13%)
0-27% (13%)
Mortality swaps
853
369
Discounted cash flow
Mortality
0-100% (1%)
0-100% (1%)
29
Table of Contents
Changes in Level 3 Assets and Liabilities
Assets and liabilities transferred into Level 3 are due to a lack of observable market transactions and price information. Transfers out of Level 3 are primarily the result of the Company obtaining observable pricing information or a third party pricing quotation that appropriately reflects the fair value of those assets and liabilities. In 2018, the Company transferred equity securities with a fair value of approximately
$
38.9
million
into Level 3 as a result of the adoption of the new accounting guidance for the recognition and measurement of equity securities (see “New Accounting Pronouncements - Financial Instruments - Recognition and Measurement” in Note 2 - “Significant Accounting Policies and Pronouncements” in the Notes to Consolidated Financial Statements included in the Company’s 2018 Annual Report).
For further information on the Company’s valuation processes, see Note 6 in the Notes to Consolidated Financial Statements included in the Company’s 2018 Annual Report.
The reconciliations for all assets and liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) are as follows (dollars in thousands):
For the three months ended June 30, 2019:
Fixed maturity securities - available-for-sale
Corporate
Canadian government
RMBS
ABS
Fair value, beginning of period
$
1,530,755
$
607,791
$
6,522
$
113,787
Total gains/losses (realized/unrealized)
Included in earnings, net:
Investment income, net of related expenses
27
3,569
(
21
)
5
Investment related gains (losses), net
15
—
—
110
Included in other comprehensive income
16,728
59,667
70
1,048
Purchases
(1)
176,431
—
3,018
8,425
Sales
(1)
(
13,925
)
—
—
—
Settlements
(1)
(
80,213
)
—
(
1,239
)
(
13,053
)
Transfers into Level 3
16,041
—
7,682
—
Transfers out of Level 3
(
1,495
)
—
—
—
Fair value, end of period
$
1,644,364
$
671,027
$
16,032
$
110,322
Unrealized gains and losses recorded in earnings for the period relating to those Level 3 assets and liabilities that were still held at the end of the period
Included in earnings, net:
Investment income, net of related expenses
$
70
$
3,569
$
(
21
)
$
4
For the three months ended June 30, 2019 (continued):
Fixed maturity securities available-for-sale
CMBS
U.S. government
State
and political
subdivisions
Other foreign government
Equity securities
Fair value, beginning of period
$
21
$
17,209
$
10,162
$
5,066
$
40,422
Total gains/losses (realized/unrealized)
Included in earnings, net:
Investment income, net of related expenses
—
(
86
)
5
—
—
Investment related gains (losses), net
—
—
—
—
1,785
Included in other comprehensive income
—
322
39
620
—
Purchases
(1)
—
102
—
10,000
2,600
Settlements
(1)
(
2
)
(
141
)
(
351
)
—
—
Fair value, end of period
$
19
$
17,406
$
9,855
$
15,686
$
44,807
Unrealized gains and losses recorded in earnings for the period relating to those Level 3 assets and liabilities that were still held at the end of the period
Included in earnings, net:
Investment income, net of related expenses
$
—
$
(
86
)
$
5
$
—
$
—
Investment related gains (losses), net
—
—
—
—
1,785
30
Table of Contents
For the three months ended June 30, 2019 (continued):
Funds withheld
at interest-
embedded
derivatives
Cash equivalents
Short-term Investments
Other assets - longevity swaps
Interest sensitive contract liabilities embedded derivatives
Other liabilities - mortality swaps
Fair value, beginning of period
$
107,506
$
19
$
29,202
$
48,869
$
(
903,935
)
$
489
Total gains/losses (realized/unrealized)
Included in earnings, net:
Investment income, net of related expenses
—
—
56
—
—
—
Investment related gains (losses), net
5,261
—
17
—
(
18,044
)
—
Claims & other policy benefits
—
—
—
—
—
—
Interest credited
—
—
—
—
(
8,459
)
—
Policy acquisition costs and other insurance expenses
—
—
—
—
—
—
Included in other comprehensive income
—
—
(
67
)
702
—
—
Other revenues
—
—
—
2,184
2,585
(
1,342
)
Purchases
(1)
—
—
1,265
—
—
—
Sales
(1)
—
—
(
1,517
)
—
—
—
Settlements
(1)
—
—
(
547
)
—
19,362
—
Transfers out of Level 3
—
(
19
)
(
22
)
—
—
—
Fair value, end of period
$
112,767
$
—
$
28,387
$
51,755
$
(
908,491
)
$
(
853
)
Unrealized gains and losses recorded in earnings for the period relating to those Level 3 assets and liabilities that were still held at the end of the period
Included in earnings, net:
Investment income, net of related expenses
$
—
$
—
$
56
$
—
$
—
$
—
Investment related gains (losses), net
5,261
—
—
—
(
19,842
)
—
Other revenues
—
—
—
2,184
—
(
1,342
)
Interest credited
—
—
—
—
(
27,820
)
—
For the six months ended June 30, 2019:
Fixed maturity securities - available-for-sale
Corporate
Canadian government
RMBS
ABS
Fair value, beginning of period
$
1,330,925
$
528,124
$
6,855
$
95,572
Total gains/losses (realized/unrealized)
Included in earnings, net:
Investment income, net of related expenses
160
7,062
(
19
)
22
Investment related gains (losses), net
15
—
—
110
Included in other comprehensive income
36,132
135,841
71
2,023
Purchases
(1)
390,872
—
3,018
39,747
Sales
(1)
(
24,637
)
—
—
—
Settlements
(1)
(
103,649
)
—
(
1,575
)
(
27,152
)
Transfers into Level 3
16,041
—
7,682
—
Transfers out of Level 3
(
1,495
)
—
—
—
Fair value, end of period
$
1,644,364
$
671,027
$
16,032
$
110,322
Unrealized gains and losses recorded in earnings for the period relating to those Level 3 assets and liabilities that were still held at the end of the period
Included in earnings, net:
Investment income, net of related expenses
$
236
$
7,062
$
(
19
)
$
21
31
Table of Contents
For the six months ended June 30, 2019 (continued):
Fixed maturity securities available-for-sale
CMBS
U.S. government
State
and political
subdivisions
Other foreign government
Equity securities
Fair value, beginning of period
$
22
$
18,025
$
10,202
$
5,006
$
33,460
Total gains/losses (realized/unrealized)
Included in earnings, net:
Investment income, net of related expenses
—
(
175
)
10
—
—
Investment related gains (losses), net
—
—
—
—
5,547
Included in other comprehensive income
—
589
32
680
—
Purchases
(1)
—
186
—
10,000
5,800
Settlements
(1)
(
3
)
(
1,219
)
(
389
)
—
—
Fair value, end of period
$
19
$
17,406
$
9,855
$
15,686
$
44,807
Unrealized gains and losses recorded in earnings for the period relating to those Level 3 assets and liabilities that were still held at the end of the period
Included in earnings, net:
Investment income, net of related expenses
$
—
$
(
175
)
$
10
$
—
$
—
Investment related gains (losses), net
—
—
—
—
5,547
For the six months ended June 30, 2019 (continued):
Funds withheld
at interest-
embedded
derivatives
Cash equivalents
Short-term Investments
Other assets - longevity swaps
Interest sensitive contract liabilities embedded derivatives
Other liabilities - mortality swaps
Fair value, beginning of period
$
109,597
$
—
$
2,228
$
47,789
$
(
944,865
)
$
(
369
)
Total gains/losses (realized/unrealized)
Included in earnings, net:
Investment income, net of related expenses
—
—
88
—
—
—
Investment related gains (losses), net
3,170
—
17
—
117
—
Interest credited
—
—
—
—
(
5,389
)
—
Included in other comprehensive income
—
—
132
(
361
)
—
—
Other revenues
—
—
—
4,327
—
(
484
)
Purchases
(1)
—
19
28,008
—
3,983
—
Sales
(1)
—
—
(
1,517
)
—
—
—
Settlements
(1)
—
—
(
547
)
—
37,663
—
Transfers out of Level 3
—
(
19
)
(
22
)
—
—
—
Fair value, end of period
$
112,767
$
—
$
28,387
$
51,755
$
(
908,491
)
$
(
853
)
Unrealized gains and losses recorded in earnings for the period relating to those Level 3 assets and liabilities that were still held at the end of the period
Included in earnings, net:
Investment income, net of related expenses
$
—
$
—
$
88
$
—
$
—
$
—
Investment related gains (losses), net
3,170
—
—
—
(
3,076
)
—
Other revenues
—
—
—
4,327
—
(
484
)
Interest credited
—
—
—
—
(
43,052
)
—
32
Table of Contents
For the three months ended June 30, 2018:
Fixed maturity securities - available-for-sale
Corporate
Canadian government
RMBS
ABS
Fair value, beginning of period
$
1,299,264
$
572,747
$
120,614
$
130,706
Total gains/losses (realized/unrealized)
Included in earnings, net:
Investment income, net of related expenses
(
305
)
3,468
(
43
)
76
Investment related gains (losses), net
(
3,141
)
—
312
1,282
Included in other comprehensive income
2,178
(
3,517
)
(
671
)
(
1,544
)
Purchases
(1)
155,498
—
24,412
—
Sales
(1)
(
11,089
)
—
(
4,961
)
—
Settlements
(1)
(
68,328
)
—
(
1,572
)
(
19,544
)
Transfers into Level 3
—
—
3,031
4,968
Transfers out of Level 3
(
6,923
)
—
(
86,283
)
(
45,258
)
Fair value, end of period
$
1,367,154
$
572,698
$
54,839
$
70,686
Unrealized gains and losses recorded in earnings for the period relating to those Level 3 assets and liabilities that were still held at the end of the period
Included in earnings, net:
Investment income, net of related expenses
$
(
304
)
$
3,468
$
(
13
)
$
68
Investment related gains (losses), net
(
3,141
)
—
—
—
For the three months ended June 30, 2018 (continued):
Fixed maturity securities available-for-sale
CMBS
U.S. government
State
and political
subdivisions
Other foreign government
Fair value, beginning of period
$
1,884
$
21,053
$
41,876
$
5,004
Total gains/losses (realized/unrealized)
Included in earnings, net:
Investment income, net of related expenses
—
(
107
)
(
10
)
—
Included in other comprehensive income
(
16
)
(
173
)
(
110
)
40
Purchases
(1)
—
118
—
—
Settlements
(1)
(
2
)
(
156
)
(
86
)
—
Transfers out of Level 3
1
—
(
25,165
)
—
Fair value, end of period
$
1,867
$
20,735
$
16,505
$
5,044
Unrealized gains and losses recorded in earnings for the period relating to those Level 3 assets and liabilities that were still held at the end of the period
Included in earnings, net:
Investment income, net of related expenses
$
—
$
(
108
)
$
(
11
)
$
—
For the three months ended June 30, 2018 (continued):
Equity securities
Funds withheld
at interest-
embedded
derivatives
Short-term Investments
Other assets - longevity swaps
Interest sensitive contract liabilities embedded derivatives
Other liabilities - mortality swaps
Fair value, beginning of period
$
36,152
$
135,805
$
3,217
$
44,011
$
(
964,794
)
$
(
1,683
)
Total gains/losses (realized/unrealized)
Included in earnings, net:
Investment related gains (losses), net
(
4,922
)
8,805
—
—
15,324
—
Interest credited
—
—
—
—
6,519
—
Included in other comprehensive income
—
—
(
21
)
(
2,329
)
—
—
Other revenues
—
—
—
2,289
—
(
799
)
Purchases
(1)
12,248
—
335
—
(
4,205
)
—
Sales
(1)
(
541
)
—
—
—
—
—
Settlements
(1)
—
—
(
314
)
—
18,359
1,700
Fair value, end of period
$
42,937
$
144,610
$
3,217
$
43,971
$
(
928,797
)
$
(
782
)
Unrealized gains and losses recorded in earnings for the period relating to those Level 3 assets and liabilities that were still held at the end of the period
Included in earnings, net:
Investment related gains (losses), net
$
(
5,000
)
$
8,805
$
—
$
—
$
13,474
$
—
Other revenues
—
—
—
2,289
—
(
799
)
Interest credited
—
—
—
—
(
11,839
)
—
33
Table of Contents
For the six months ended June 30, 2018:
Fixed maturity securities - available-for-sale
Corporate
Canadian government
RMBS
ABS
Fair value, beginning of period
$
1,337,272
$
593,942
$
107,882
$
123,474
Total gains/losses (realized/unrealized)
Included in earnings, net:
Investment income, net of related expenses
(
666
)
6,912
(
135
)
182
Investment related gains (losses), net
(
3,141
)
—
312
1,284
Included in other comprehensive income
(
30,674
)
(
28,156
)
(
1,781
)
(
691
)
Purchases
(1)
255,668
—
45,328
11,000
Sales
(1)
(
17,269
)
—
(
4,961
)
—
Settlements
(1)
(
143,474
)
—
(
4,535
)
(
22,283
)
Transfers into Level 3
7,166
—
3,031
4,968
Transfers out of Level 3
(
37,728
)
—
(
90,302
)
(
47,248
)
Fair value, end of period
$
1,367,154
$
572,698
$
54,839
$
70,686
Unrealized gains and losses recorded in earnings for the period relating to those Level 3 assets and liabilities that were still held at the end of the period
Included in earnings, net:
Investment income, net of related expenses
$
(
665
)
$
6,912
$
(
105
)
$
174
Investment related gains (losses), net
(
3,141
)
—
—
—
For the six months ended June 30, 2018 (continued):
Fixed maturity securities available-for-sale
CMBS
U.S. government
State
and political
subdivisions
Other foreign government
Fair value, beginning of period
$
3,234
$
22,511
$
41,203
$
5,092
Total gains/losses (realized/unrealized)
Included in earnings, net:
Investment income, net of related expenses
—
(
217
)
(
2
)
—
Included in other comprehensive income
(
63
)
(
513
)
590
(
48
)
Purchases
(1)
—
214
—
—
Settlements
(1)
(
3
)
(
1,260
)
(
121
)
—
Transfers out of Level 3
(
1,301
)
—
(
25,165
)
—
Fair value, end of period
$
1,867
$
20,735
$
16,505
$
5,044
Unrealized gains and losses recorded in earnings for the period relating to those Level 3 assets and liabilities that were still held at the end of the period
Included in earnings, net:
Investment income, net of related expenses
$
—
$
(
218
)
$
(
3
)
$
—
34
Table of Contents
For the six months ended June 30, 2018 (continued):
Equity securities
Funds withheld
at interest-
embedded
derivatives
Short-term Investments
Other assets - longevity swaps
Interest sensitive contract liabilities embedded derivatives
Other liabilities - mortality swaps
Fair value, beginning of period
$
—
$
122,194
$
3,096
$
40,659
$
(
1,014,228
)
$
(
1,683
)
Total gains/losses (realized/unrealized)
Included in earnings, net:
Investment related gains (losses), net
(
7,599
)
22,416
—
—
30,109
—
Interest credited
—
—
—
—
31,870
—
Included in other comprehensive income
—
—
(
46
)
(
1,245
)
—
—
Other revenues
—
—
—
4,557
—
(
799
)
Purchases
(1)
12,248
—
481
—
(
12,713
)
—
Sales
(1)
(
569
)
—
—
—
—
—
Settlements
(1)
(
48
)
—
(
314
)
—
36,165
1,700
Transfers into Level 3
38,905
—
—
—
—
—
Fair value, end of period
$
42,937
$
144,610
$
3,217
$
43,971
$
(
928,797
)
$
(
782
)
Unrealized gains and losses recorded in earnings for the period relating to those Level 3 assets and liabilities that were still held at the end of the period
Included in earnings, net:
Investment related gains (losses), net
$
(
7,705
)
$
22,416
$
—
$
—
$
26,375
$
—
Other revenues
—
—
—
4,557
—
(
799
)
Interest credited
—
—
—
—
(
4,295
)
—
(1)
The amount reported within purchases, sales and settlements is the purchase price (for purchases) and the sales/settlement proceeds (for sales and settlements) based upon the actual date purchased or sold/settled. Items purchased and sold/settled in the same period are excluded from the rollforward. The Company had no issuances during the period.
Nonrecurring Fair Value Measurements
The following table (dollars in thousands) presents information for assets measured at an estimated fair value on a nonrecurring basis during the 2019 periods presented and still held at the reporting date (for example, when there is evidence of impairment). The estimated fair values for these assets were determined using significant unobservable inputs (Level 3). The Company did not have any adjustments to financial instruments measured at fair value on a non-recurring basis that were still held as of June 30, 2018.
Carrying Value After Measurement
Investment Related Gains (Losses), Net
Three months ended June 30,
Six months ended June 30,
At June 30, 2019
2019
2019
Limited partnership interests
(1)
$
5,694
$
(
5,049
)
$
(
5,049
)
(1)
The impaired limited partnership interests presented above were accounted for using the cost method. Impairments on these cost method investments were recognized at estimated fair value determined using the net asset values of the Company’s ownership interest as provided in the financial statements of the investees. The market for these investments has limited activity and price transparency.
Fair Value of Financial Instruments
The Company is required by general accounting principles for
Fair Value Measurements and Disclosures
to disclose the fair value of certain financial instruments including those that are not carried at fair value.
The following table presents the carrying amounts and estimated fair values of the Company’s financial instruments, which were not measured at fair value on a recurring basis, as of
June 30, 2019
and
December 31, 2018
(dollars in thousands). For additional information regarding the methods and significant assumptions used by the Company to estimate these fair values, see Note 6 in the Notes to Consolidated Financial Statements included in the Company’s 2018 Annual Report. This table excludes any payables or receivables for collateral under repurchase agreements and other transactions. The estimated fair value of the excluded amount approximates carrying value as they equal the amount of cash collateral received/paid.
35
Table of Contents
June 30, 2019:
Carrying Value
(1)
Estimated
Fair Value
Fair Value Measurement Using:
Level 1
Level 2
Level 3
NAV
Assets:
Mortgage loans on real estate
$
5,405,422
$
5,598,551
$
—
$
—
$
5,598,551
$
—
Policy loans
1,319,722
1,319,722
—
1,319,722
—
—
Funds withheld at interest
5,576,162
5,882,101
—
—
5,882,101
—
Cash and cash equivalents
1,532,397
1,532,397
1,532,397
—
—
—
Short-term investments
32,320
32,320
32,320
—
—
—
Other invested assets
1,122,777
1,151,725
5,317
83,680
661,289
401,439
Accrued investment income
470,074
470,074
—
470,074
—
—
Liabilities:
Interest-sensitive contract liabilities
$
16,367,006
$
17,283,769
$
—
$
—
$
17,283,769
$
—
Long-term debt
3,381,411
3,508,853
—
—
3,508,853
—
Collateral finance and securitization notes
635,300
584,310
—
—
584,310
—
December 31, 2018:
Carrying Value
(1)
Estimated
Fair Value
Fair Value Measurement Using:
Level 1
Level 2
Level 3
NAV
Assets:
Mortgage loans on real estate
$
4,966,298
$
4,917,416
$
—
$
—
$
4,917,416
$
—
Policy loans
1,344,980
1,344,980
—
1,344,980
—
—
Funds withheld at interest
5,655,055
5,802,518
—
—
5,802,518
—
Cash and cash equivalents
1,404,566
1,404,566
1,404,566
—
—
—
Short-term investments
36,607
36,607
36,607
—
—
—
Other invested assets
945,731
941,449
4,640
83,203
477,214
376,392
Accrued investment income
427,893
427,893
—
427,893
—
—
Liabilities:
Interest-sensitive contract liabilities
$
14,547,436
$
14,611,011
$
—
$
—
$
14,611,011
$
—
Long-term debt
2,787,873
2,752,047
—
—
2,752,047
—
Collateral finance and securitization notes
681,961
626,731
—
—
626,731
—
(1)
Carrying values presented herein may differ from those in the Company’s condensed consolidated balance sheets because certain items within the respective financial statement captions may be measured at fair value on a recurring basis.
7.
Segment Information
The accounting policies of the segments are the same as those described in the Significant Accounting Policies and Pronouncements in Note 2 of the consolidated financial statements accompanying the 2018 Annual Report. The Company measures segment performance primarily based on profit or loss from operations before income taxes. There are no intersegment reinsurance transactions and the Company does not have any material long-lived assets.
The Company allocates capital to its segments based on an internally developed economic capital model, the purpose of which is to measure the risk in the business and to provide a basis upon which capital is deployed. The economic capital model considers the unique and specific nature of the risks inherent in the Company’s businesses. As a result of the economic capital allocation process, a portion of investment income is attributed to the segments based on the level of allocated capital. In addition, the segments are charged for excess capital utilized above the allocated economic capital basis. This charge is included in policy acquisition costs and other insurance expenses.
36
Table of Contents
The Company has geographic-based and business-based operational segments. Geographic-based operations are further segmented into traditional and financial solutions businesses.
Information related to revenues, income (loss) before income taxes and total assets of the Company for each reportable segment are summarized below (dollars in thousands).
Three months ended June 30,
Six months ended June 30,
Revenues:
2019
2018
2019
2018
U.S. and Latin America:
Traditional
$
1,584,676
$
1,564,147
$
3,125,342
$
3,053,841
Financial Solutions
301,257
229,948
555,917
443,300
Total
1,885,933
1,794,095
3,681,259
3,497,141
Canada:
Traditional
318,142
312,199
630,475
614,518
Financial Solutions
23,929
12,089
47,503
24,866
Total
342,071
324,288
677,978
639,384
Europe, Middle East and Africa:
Traditional
369,499
372,538
753,505
766,320
Financial Solutions
113,986
100,675
223,407
188,818
Total
483,485
473,213
976,912
955,138
Asia Pacific:
Traditional
633,417
570,520
1,306,589
1,185,059
Financial Solutions
59,558
17,992
114,086
37,838
Total
692,975
588,512
1,420,675
1,222,897
Corporate and Other
62,944
15,800
130,615
55,055
Total
$
3,467,408
$
3,195,908
$
6,887,439
$
6,369,615
Three months ended June 30,
Six months ended June 30,
Income (loss) before income taxes:
2019
2018
2019
2018
U.S. and Latin America:
Traditional
$
55,175
$
71,978
$
66,829
$
74,870
Financial Solutions
92,018
82,388
175,295
149,809
Total
147,193
154,366
242,124
224,679
Canada:
Traditional
46,259
21,805
96,538
45,512
Financial Solutions
3,813
3,544
5,161
6,735
Total
50,072
25,349
101,699
52,247
Europe, Middle East and Africa:
Traditional
16,121
6,468
31,545
21,889
Financial Solutions
51,801
65,369
90,191
104,533
Total
67,922
71,837
121,736
126,422
Asia Pacific:
Traditional
34,775
58,862
71,399
81,749
Financial Solutions
1,918
4,138
8,001
8,159
Total
36,693
63,000
79,400
89,908
Corporate and Other
(
41,803
)
(
67,264
)
(
68,318
)
(
108,043
)
Total
$
260,077
$
247,288
$
476,641
$
385,213
37
Table of Contents
Assets:
June 30, 2019
December 31, 2018
U.S. and Latin America:
Traditional
$
19,142,106
$
19,235,781
Financial Solutions
22,698,262
19,870,388
Total
41,840,368
39,106,169
Canada:
Traditional
4,198,875
4,200,792
Financial Solutions
133,642
154,000
Total
4,332,517
4,354,792
Europe, Middle East and Africa:
Traditional
3,755,356
3,643,174
Financial Solutions
5,916,625
4,737,529
Total
9,671,981
8,380,703
Asia Pacific:
Traditional
6,339,047
5,680,978
Financial Solutions
1,618,609
1,180,745
Total
7,957,656
6,861,723
Corporate and Other
8,241,294
5,831,858
Total
$
72,043,816
$
64,535,245
8.
Commitments, Contingencies and Guarantees
Commitments
Funding of Investments
The Company’s commitments to fund investments as of
June 30, 2019
and
December 31, 2018
are presented in the following table (dollars in thousands):
June 30, 2019
December 31, 2018
Limited partnership interests and joint ventures
$
625,286
$
523,903
Commercial mortgage loans
146,553
22,605
Bank loans and private placements
90,052
137,076
Equity release mortgages
53,252
264,858
The Company anticipates that the majority of its current commitments will be invested over the next five years; however, these commitments could become due any time at the request of the counterparties. Bank loans and private placements are included in fixed maturity securities available-for-sale.
Contingencies
Litigation
The Company is subject to litigation in the normal course of its business. The Company currently has no material litigation. A legal reserve is established when the Company is notified of an arbitration demand or litigation or is notified that an arbitration demand or litigation is imminent, it is probable that the Company will incur a loss as a result and the amount of the probable loss is reasonably capable of being estimated.
Other Contingencies
The Company indemnifies its directors and officers as provided in its charters and by-laws. Since this indemnity generally is not subject to limitation with respect to duration or amount, the Company does not believe that it is possible to determine the maximum potential amount due under this indemnity in the future.
38
Table of Contents
Guarantees
Statutory Reserve Support
RGA, through wholly-owned subsidiaries, has committed to provide statutory reserve support to third parties, in exchange for a fee, by funding loans if certain defined events occur. Such statutory reserves are required under the U.S. Valuation of Life Policies Model Regulation (commonly referred to as Regulation XXX for term life insurance policies and Regulation A-XXX for universal life secondary guarantees). The third parties have recourse to RGA should the subsidiary fail to provide the required funding, however, as of
June 30, 2019
, the Company does not believe that it will be required to provide any funding under these commitments as the occurrence of the defined events is considered remote.
The following table presents the maximum potential obligation for these commitments as of
June 30, 2019
(dollars in millions):
Commitment Period:
Maximum Potential Obligation
2023
$
500.0
2034
2,000.0
2035
1,314.2
2036
2,658.0
2037
5,750.0
2038
1,800.0
2039
1,750.0
Other Guarantees
RGA has issued guarantees to third parties on behalf of its subsidiaries for the payment of amounts due under certain securities borrowing and repurchase arrangements, financing arrangements and office lease obligations, whereby, if a subsidiary fails to meet an obligation, RGA or one of its other subsidiaries will make a payment to fulfill the obligation. Additionally, in limited circumstances, treaty guarantees are granted to ceding companies in order to provide them additional security, particularly in cases where RGA’s subsidiary is relatively new, unrated, or not of a significant size, relative to the ceding company. Liabilities supported by the treaty guarantees, before consideration of any legally offsetting amounts due from the guaranteed party are reflected on the Company’s condensed consolidated balance sheets in future policy benefits. Potential guaranteed amounts of future payments will vary depending on production levels and underwriting results. Guarantees related to securities borrowing and repurchase arrangements provide additional security to third parties should a subsidiary fail to provide securities when due.
RGA’s guarantees issued as of
June 30, 2019
and
December 31, 2018
are reflected in the following table (dollars in thousands):
June 30, 2019
December 31, 2018
Treaty guarantees
$
1,500,220
$
1,392,352
Treaty guarantees, net of assets in trust
1,402,737
1,291,445
Securities borrowing and repurchase arrangements
274,555
269,980
Financing arrangements
50,666
61,273
Lease obligations
156
392
39
Table of Contents
9.
Income Tax
The provision for income tax expense differed from the amounts computed by applying the U.S. federal income tax statutory rate of 21.0% to pre-tax income as a result of the following for the
three and six months ended June 30, 2019 and 2018
, respectively (dollars in thousands):
Three months ended June 30,
Six months ended June 30,
2019
2018
2019
2018
Tax provision at U.S. statutory rate
$
54,616
$
51,931
$
100,095
$
80,895
Increase (decrease) in income taxes resulting from:
U.S. Tax Reform provisional adjustments
—
(
4,314
)
—
(
3,539
)
Foreign tax rate differing from U.S. tax rate
627
(
330
)
1,292
1,103
Differences in tax bases in foreign jurisdictions
(
5,997
)
(
1,132
)
(
21,076
)
(
6,892
)
Deferred tax valuation allowance
4,662
3,079
23,207
10,501
Amounts related to tax audit contingencies
2,404
(
2,036
)
2,964
(
1,201
)
Corporate rate changes
94
145
(
1,737
)
417
Subpart F
301
(
348
)
466
310
Foreign tax credits
(
415
)
113
(
107
)
(
459
)
Global intangible low-taxed income, net of credit
—
(
119
)
—
4,291
Equity compensation excess benefit
(
3,694
)
(
3,135
)
(
5,155
)
(
4,250
)
Return to provision adjustments
3,376
(
503
)
3,596
(
139
)
Other, net
1,405
(
437
)
891
(
428
)
Total provision for income taxes
$
57,379
$
42,914
$
104,436
$
80,609
Effective tax rate
22.1
%
17.4
%
21.9
%
20.9
%
The effective tax rates for the second quarter and first six months of 2019 were higher than the U.S. Statutory rate of 21.0% primarily as a result of valuation allowances established on losses in foreign jurisdictions, accrual of uncertain tax positions, and return to provision adjustments. These expenses were partially offset by benefits from differences in bases in foreign jurisdictions and excess tax benefits related to equity compensation.
The effective tax rates for the second quarter and first six months of 2018 were lower than the U.S. Statutory rate of 21.0% primarily as a result of U.S. Tax Reform related adjustments, the effective settlement of an uncertain tax position, benefits from differences in bases in foreign jurisdictions and excess tax benefits related to equity compensation. These benefits were partially offset by valuation allowances established on losses in foreign jurisdictions.
40
Table of Contents
10.
Employee Benefit Plans
The components of net periodic benefit costs, included in other operating expenses on the condensed consolidated statements of income, for the
three and six months ended June 30, 2019 and 2018
were as follows (dollars in thousands):
Pension Benefits
Other Benefits
Three months ended June 30,
Three months ended June 30,
2019
2018
2019
2018
Service cost
$
3,169
$
3,570
$
757
$
636
Interest cost
1,931
1,357
579
529
Expected return on plan assets
(
1,692
)
(
2,213
)
—
—
Amortization of prior service cost (credit)
61
82
(
329
)
(
329
)
Amortization of prior actuarial losses
1,231
769
644
498
Net periodic benefit cost
$
4,700
$
3,565
$
1,651
$
1,334
Pension Benefits
Other Benefits
Six months ended June 30,
Six months ended June 30,
2019
2018
2019
2018
Service cost
$
6,307
$
6,224
$
1,514
$
1,272
Interest cost
3,317
2,687
1,159
1,059
Expected return on plan assets
(
3,576
)
(
3,767
)
—
—
Amortization of prior service cost (credit)
121
165
(
658
)
(
658
)
Amortization of prior actuarial losses
2,142
1,863
1,288
996
Net periodic benefit cost
$
8,311
$
7,172
$
3,303
$
2,669
11.
Reinsurance
Retrocession reinsurance treaties do not relieve the Company from its obligations to direct writing companies. Failure of retrocessionaires to honor their obligations could result in losses to the Company. Consequently, allowances would be established for amounts deemed uncollectible. At
June 30, 2019
and
December 31, 2018
, no allowances were deemed necessary. The Company regularly evaluates the financial condition of the insurance companies from which it assumes and to which it cedes reinsurance.
Retrocessions are arranged through the Company’s retrocession pools for amounts in excess of the Company’s retention limit. As of
June 30, 2019
and
December 31, 2018
, all rated retrocession pool participants followed by the A.M. Best Company were rated
“A- (excellent)”
or better. The Company verifies retrocession pool participants’ ratings on a quarterly basis. For a majority of the retrocessionaires that were not rated, security in the form of letters of credit or trust assets has been posted. In addition, the Company performs annual financial reviews of its retrocessionaires to evaluate financial stability and performance.
The following table presents information for the Company’s reinsurance ceded receivable assets, including the respective amount and A.M. Best rating for each reinsurer representing in excess of five percent of the total as of
June 30, 2019
or
December 31, 2018
(dollars in thousands):
June 30, 2019
December 31, 2018
Reinsurer
A.M. Best Rating
Amount
% of Total
Amount
% of Total
Reinsurer A
A+
$
347,916
40.9
%
$
303,036
40.0
%
Reinsurer B
A+
201,983
23.7
193,324
25.5
Reinsurer C
A
74,214
8.7
69,885
9.2
Reinsurer D
A++
59,796
7.0
36,600
4.8
Reinsurer E
A+
40,253
4.7
40,004
5.3
Other reinsurers
127,218
15.0
114,723
15.2
Total
$
851,380
100.0
%
$
757,572
100.0
%
Included in the total reinsurance ceded receivables balance were
$
211.6
million
and
$
242.8
million
of claims recoverable, of which
$
5.7
million
and
$
17.4
million
were in excess of 90 days past due, as of
June 30, 2019
and
December 31, 2018
, respectively.
41
Table of Contents
12.
Policy Claims and Benefits
The liability for unpaid claims is reported in future policy benefits and other policy-related balances within the Company’s consolidated balance sheet. Activity associated with unpaid claims is summarized below (dollars in thousands):
Six months ended June 30,
2019
2018
Balance at beginning of year
$
6,584,668
$
5,896,469
Less: reinsurance recoverable
(
432,582
)
(
455,547
)
Net balance at beginning of year
6,152,086
5,440,922
Incurred:
Current year
5,457,193
5,046,146
Prior years
58,249
66,022
Total incurred
5,515,442
5,112,168
Payments:
Current year
(
1,063,092
)
(
1,097,105
)
Prior years
(
3,978,853
)
(
3,518,791
)
Total payments
(
5,041,945
)
(
4,615,896
)
Other changes:
Interest accretion
13,185
12,299
Foreign exchange adjustments
2,663
(
117,352
)
Total other changes
15,848
(
105,053
)
Net balance at end the period
6,641,431
5,832,141
Plus: reinsurance recoverable
524,808
439,568
Balance at end of the period
$
7,166,239
$
6,271,709
Incurred claims related to prior years reflected in the table above, resulted in part from developed claims for prior years being different than were anticipated when the liabilities for unpaid claims were originally estimated. These trends have been considered in establishing the current year liability for unpaid claims.
13.
Financing Activities
On
May 15, 2019
, RGA issued
3.9
%
Senior Notes due
May 15, 2029
with a face amount of
$
600.0
million
. The net proceeds were approximately
$
593.8
million
and will be used in part to repay upon maturity the Company’s
$
400.0
million
6.45
%
Senior Notes that mature in November 2019. The remainder will be used for general corporate purposes. Capitalized issue costs were approximately
$
4.8
million
.
42
Table of Contents
14.
New Accounting Standards
Changes to the general accounting principles are established by the Financial Accounting Standards Board (“FASB”) in the form of accounting standards updates to the FASB Accounting Standards Codification™. Accounting standards updates not listed below were assessed and determined to be either not applicable or are expected to have minimal impact on the Company’s condensed consolidated financial statements.
Description
Date of Adoption
Effect on the financial statements or other significant matters
Standards adopted:
Financial Instruments - Recognition and Measurement
This guidance requires equity investments that are not accounted for under the equity method of accounting to be measured at fair value with changes recognized in net income and also updates certain presentation and disclosure requirements.
January 1, 2018
This guidance required a cumulative-effect adjustment for certain items upon adoption. The adoption of the new guidance was not material to the Company's financial position.
Compensation - Retirement Benefits - Defined Benefit Plans - General
This guidance is part of the FASB’s disclosure framework project and eliminates certain disclosure requirements for defined benefit pension and other postretirement plans. Early adoption is permitted.
December 31, 2018
This guidance was applied retrospectively to all periods presented in the year of adoption. The adoption of the new guidance was not material to the Company’s financial position.
Leases
This new standard, based on the principle that entities should recognize assets and liabilities arising from leases, does not significantly change the lessees’ recognition, measurement and presentation of expenses and cash flows from the previous accounting standard. Leases are classified as finance or operating. The new standard’s primary change is the requirement for entities to recognize a lease liability for payments and a right of use asset representing the right to use the leased asset during the term of operating lease arrangements. Lessees are permitted to make an accounting policy election to not recognize the asset and liability for leases with a term of twelve months or less. Lessors’ accounting is largely unchanged from the previous accounting standard. In addition, the new standard expands the disclosure requirements of lease arrangements. Early adoption is permitted.
January 1, 2019
This guidance was adopted by applying the optional transition method. The adoption of the standard did not have a material impact on the Company’s results of operations or financial position. The adoption of the updated guidance resulted in the Company recognizing a right-to-use asset and lease liability of $55.2 million included in other assets and other liabilities, respectively, in the condensed consolidated balance sheets.
Derivatives and Hedging
This updated guidance improves the financial reporting of hedging relationships to better portray the economic results of an entity’s risk management activities in its financial statements and make certain targeted improvements to simplify the application of the hedge accounting in current GAAP related to the assessment of hedge effectiveness. Early adoption is permitted.
January 1, 2019
This guidance was adopted by applying a modified retrospective approach to existing hedging relationships as of the date of adoption. The adoption of the new standard did not have a material impact on the Company’s results of operations or financial position. Upon adoption of the guidance, the Company recorded an immaterial adjustment to retained earnings as of the beginning of the first reporting period in which the guidance was effective and modified some disclosures.
43
Table of Contents
Description
Anticipated Date of Adoption
Effect on the financial statements or other significant matters
Standards not yet adopted:
Financial Services - Insurance
This guidance significantly changes how insurers account for long-duration insurance contracts. The new guidance also significantly expands the disclosure requirements of long-duration insurance contracts. On July 17, 2019, the FASB tentatively agreed to defer the original effective date by one year. If finalized, the new guidance will be effective for annual and interim reporting periods beginning January 1, 2022. Below are the most significant areas of change:
January 1, 2022
See each significant area of change below for the method of adoption and impact to the Company’s results of operations and financial position.
Cash flow assumptions for measuring liability for future policy benefits
The new guidance requires insurers to review, and if necessary, update the cash flow assumptions used to measure liabilities for future policy benefits periodically. The change in the liability estimate as a result of updating cash flow assumptions will be recognized in net income.
Cash flow assumptions for measuring liability for future policy benefits
The Company will likely adopt this guidance on a modified retrospective basis as of the earliest period presented in the year of adoption. The Company is currently evaluating the impact of this amendment on its results of operations and financial position but anticipates the updated guidance will likely have a material impact.
Discount rate assumption for measuring liability for future policy benefits
The new guidance requires insurers to update the discount rate assumption used to measure liabilities for future policy benefits at each reporting period, and the discount rate utilized must be based on an upper-medium grade fixed income instrument yield. The change in the liability estimate as a result of updating the discount rate assumption will be recognized in other comprehensive income.
Discount rate assumption for measuring liability for future policy benefits
The Company will likely adopt this guidance on a modified retrospective basis as of the earliest period presented in the year of adoption. The Company is currently evaluating the impact of this amendment on its results of operations and financial position but anticipates the updated guidance will likely have a material impact.
Market risk benefits
The new guidance created a new category of benefit features called market risk benefits that will be measured at fair value with changes in fair value attributable to a change in the instrument-specific credit risk recognized in other comprehensive income.
Market risk benefits
The Company will adopt this guidance on a retrospective basis as of the earliest period presented in the year of adoption. The Company is currently evaluating the impact of this amendment on its results of operations and financial position but anticipates the updated guidance will likely have a material impact.
Amortization of deferred acquisition costs (“DAC”) and other balances
The new guidance requires DAC and other balances to be amortized on a constant level basis over the expected term of the related contracts.
Amortization of deferred acquisition costs (“DAC”) and other balances
The Company will likely adopt this guidance on a modified retrospective basis as of the earliest period presented in the year of adoption. The Company is currently evaluating the impact of this amendment on its results of operations and financial position but anticipates the updated guidance will likely have a material impact.
Financial Instruments - Credit Losses
This guidance adds to U.S. GAAP an impairment model, known as current expected credit loss (“CECL”) model that is based on expected losses rather than incurred losses. For traditional and other receivables, held-to-maturity debt securities, loans and other instruments entities will be required to use the new forward-looking “expected loss” model that generally will result in earlier recognition of allowance for losses. For available-for-sale debt securities with unrealized losses, entities will measure credit losses similar to what they do today, except the losses will be recognized as allowances rather than reduction to the amortized cost of the securities. Early adoption is permitted.
January 1, 2020
For asset classes within the scope of the CECL model, this guidance will be adopted through a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is effective (that is, a modified-retrospective approach). For available-for-sale debt securities, this guidance will be applied prospectively. The Company is in the process of finalizing its CECL models, and it anticipates an immaterial adjustment to retained earnings upon adoption of this new standard. The magnitude of the adjustment will depend upon the nature and characteristics of the Company’s loan portfolio at the adoption date, as well as macroeconomic conditions and forecasts at that date.
Fair Value Measurement
This guidance is part of the FASB’s disclosure framework project and eliminates certain disclosure requirements for fair value measurement, requires entities to disclose new information and modifies existing disclosure requirements. Early adoption is permitted.
January 1, 2020
Certain disclosure changes in this guidance will be applied prospectively in the year of adoption. The remaining changes in this guidance will be applied retrospectively to all periods presented in the year of adoption. The Company does not expect the adoption of this guidance to have a material impact on its financial position.
44
Table of Contents
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Cautionary Note Regarding Forward-Looking Statements
This report contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 including, among others, statements relating to projections of the future operations, strategies, earnings, revenues, income or loss, ratios, financial performance and growth potential of the Company. Forward-looking statements often contain words and phrases such as “intend,” “expect,” “project,” “estimate,” “predict,” “anticipate,” “should,” “believe” and other similar expressions. Forward-looking statements are based on management’s current expectations and beliefs concerning future developments and their potential effects on the Company. Forward-looking statements are not a guarantee of future performance and are subject to risks and uncertainties, some of which cannot be predicted or quantified. Future events and actual results, performance, and achievements could differ materially from those set forth in, contemplated by or underlying the forward-looking statements.
Numerous important factors could cause actual results and events to differ materially from those expressed or implied by forward-looking statements including, without limitation: (1) adverse changes in mortality, morbidity, lapsation or claims experience, (2) inadequate risk analysis and underwriting, (3) adverse capital and credit market conditions and their impact on the Company’s liquidity, access to capital and cost of capital, (4) changes in the Company’s financial strength and credit ratings and the effect of such changes on the Company’s future results of operations and financial condition, (5) the availability and cost of collateral necessary for regulatory reserves and capital, (6) requirements to post collateral or make payments due to declines in market value of assets subject to the Company’s collateral arrangements, (7) action by regulators who have authority over the Company’s reinsurance operations in the jurisdictions in which it operates, (8) the effect of the Company parent’s status as an insurance holding company and regulatory restrictions on its ability to pay principal of and interest on its debt obligations, (9) general economic conditions or a prolonged economic downturn affecting the demand for insurance and reinsurance in the Company’s current and planned markets, (10) the impairment of other financial institutions and its effect on the Company’s business, (11) fluctuations in U.S. or foreign currency exchange rates, interest rates, or securities and real estate markets, (12) market or economic conditions that adversely affect the value of the Company’s investment securities or result in the impairment of all or a portion of the value of certain of the Company’s investment securities, that in turn could affect regulatory capital, (13) market or economic conditions that adversely affect the Company’s ability to make timely sales of investment securities, (14) risks inherent in the Company’s risk management and investment strategy, including changes in investment portfolio yields due to interest rate or credit quality changes, (15) the fact that the determination of allowances and impairments taken on the Company’s investments is highly subjective, (16) the stability of and actions by governments and economies in the markets in which the Company operates, including ongoing uncertainties regarding the amount of U.S. sovereign debt and the credit ratings thereof, (17) the Company’s dependence on third parties, including those insurance companies and reinsurers to which the Company cedes some reinsurance, third-party investment managers and others, (18) financial performance of the Company’s clients, (19) the threat of natural disasters, catastrophes, terrorist attacks, epidemics or pandemics anywhere in the world where the Company or its clients do business, (20) competitive factors and competitors’ responses to the Company’s initiatives, (21) development and introduction of new products and distribution opportunities, (22) execution of the Company’s entry into new markets, (23) integration of acquired blocks of business and entities, (24) interruption or failure of the Company’s telecommunication, information technology or other operational systems, or the Company’s failure to maintain adequate security to protect the confidentiality or privacy of personal or sensitive data stored on such systems, (25) adverse litigation or arbitration results, (26) the adequacy of reserves, resources and accurate information relating to settlements, awards and terminated and discontinued lines of business, (27) changes in laws, regulations, and accounting standards applicable to the Company or its business, (28) the effects of the Tax Cuts and Jobs Act of 2017 may be different than expected and (29) other risks and uncertainties described in this document and in the Company’s other filings with the Securities and Exchange Commission (“SEC”).
Forward-looking statements should be evaluated together with the many risks and uncertainties that affect the Company’s business, including those mentioned in this document and described in the periodic reports the Company files with the SEC. These forward-looking statements speak only as of the date on which they are made. The Company does not undertake any obligation to update these forward-looking statements, even though the Company’s situation may change in the future. For a discussion of these risks and uncertainties that could cause actual results to differ materially from those contained in the forward-looking statements, you are advised to see Item 1A - “Risk Factors” in the 2018 Annual Report.
Overview
The Company is among the leading global providers of life reinsurance and financial solutions, with $3.4 trillion of life reinsurance in force and assets of
$72.0 billion
as of June 30, 2019. Traditional reinsurance includes individual and group life and health, disability, and critical illness reinsurance. Financial solutions includes longevity reinsurance, asset-intensive reinsurance, financial reinsurance and stable value products. The Company derives revenues primarily from renewal premiums from existing reinsurance treaties, new business premiums from existing or new reinsurance treaties, fee income from financial solutions business and income earned on invested assets.
45
Table of Contents
Historically, the Company’s primary business has been traditional life reinsurance, which involves reinsuring life insurance policies that are often in force for the remaining lifetime of the underlying individuals insured, with premiums earned typically over a period of 10 to 30 years. Each year, however, a portion of the business under existing treaties terminates due to, among other things, lapses or voluntary surrenders of underlying policies, deaths of insureds, and the exercise of recapture options by ceding companies. The Company has expanded its financial solutions business, including significant asset-intensive and longevity risk transactions, which allow its clients to take advantage of growth opportunities and manage their capital, longevity and investment risk.
The Company’s long-term profitability largely depends on the volume and amount of death- and health-related claims incurred and the ability to adequately price the risks it assumes. While death claims are reasonably predictable over a period of many years, claims become less predictable over shorter periods and are subject to significant fluctuation from quarter to quarter and year to year. For longevity business, the Company’s profitability depends on the lifespan of the underlying contract holders and the investment performance for certain contracts. Additionally, the Company generates profits on investment spreads associated with the reinsurance of investment type contracts and generates fees from financial reinsurance transactions, which are typically shorter duration than its traditional life reinsurance business. The Company believes its sources of liquidity are sufficient to cover potential claims payments on both a short-term and long-term basis.
As is customary in the reinsurance business, clients continually update, refine, and revise reinsurance information provided to the Company. Such revised information is used by the Company in preparation of its condensed consolidated financial statements and the financial effects resulting from the incorporation of revised data are reflected in the current period.
Segment Presentation
The Company has geographic-based and business-based operational segments. Geographic-based operations are further segmented into traditional and financial solutions businesses. The Company allocates capital to its segments based on an internally developed economic capital model, the purpose of which is to measure the risk in the business and to provide a consistent basis upon which capital is deployed. The economic capital model considers the unique and specific nature of the risks inherent in RGA’s businesses.
As a result of the economic capital allocation process, a portion of investment income is credited to the segments based on the level of allocated capital. In addition, the segments are charged for excess capital utilized above the allocated economic capital basis. This charge is included in policy acquisition costs and other insurance expenses. Segment investment performance varies with the composition of investments and the relative allocation of capital to the operating segments.
Segment revenue levels can be significantly influenced by currency fluctuations, large transactions, mix of business and reporting practices of ceding companies, and therefore may fluctuate from period to period. Although reasonably predictable over a period of years, segment claims experience can be volatile over shorter periods. See “Results of Operations by Segment” below for further information about the Company’s segments.
46
Table of Contents
Consolidated Results of Operations
The following table summarizes net income for the periods presented.
Three months ended June 30,
Six months ended June 30,
2019
2018
2019
2018
Revenues:
(Dollars in thousands, except per share data)
Net premiums
$
2,763,786
$
2,594,460
$
5,501,599
$
5,177,011
Investment income, net of related expenses
584,078
528,061
1,163,955
1,044,390
Investment related gains (losses), net:
Other-than-temporary impairments on fixed maturity securities
—
(3,350
)
(9,453
)
(3,350
)
Other investment related gains (losses), net
12,472
(7,222
)
29,713
(7,692
)
Investment related gains (losses), net
12,472
(10,572
)
20,260
(11,042
)
Other revenues
107,072
83,959
201,625
159,256
Total revenues
3,467,408
3,195,908
6,887,439
6,369,615
Benefits and Expenses:
Claims and other policy benefits
2,515,211
2,279,593
5,023,535
4,641,694
Interest credited
157,842
109,327
291,031
189,776
Policy acquisition costs and other insurance expenses
260,345
320,276
572,226
677,178
Other operating expenses
223,499
194,959
424,982
386,233
Interest expense
43,283
37,025
83,456
74,479
Collateral finance and securitization expense
7,151
7,440
15,568
15,042
Total benefits and expenses
3,207,331
2,948,620
6,410,798
5,984,402
Income before income taxes
260,077
247,288
476,641
385,213
Provision for income taxes
57,379
42,914
104,436
80,609
Net income
$
202,698
$
204,374
$
372,205
$
304,604
Earnings per share:
Basic earnings per share
$
3.23
$
3.19
$
5.93
$
4.74
Diluted earnings per share
$
3.18
$
3.13
$
5.83
$
4.65
Consolidated income before income taxes increased $12.8 million, or 5.2%, and $91.4 million, or 23.7%, for the three and six months ended June 30, 2019, respectively, as compared to the same periods in 2018. The increase in income for the second quarter of 2019 was primarily due to improved claims experience in the Canada Traditional segment and favorable experience in the various Financial Solutions segments and was partially offset by unfavorable results in the U.S. and Latin America and Asia Pacific Traditional segments. In addition, the increase in income for the first six months of 2019 reflects favorable changes in investment related gain (losses) resulting from changes in the fair value of embedded derivatives on modco or funds withheld treaties within the U.S. segment due to changes in interest rates and credit spreads. The effect of the change in fair value of these embedded derivatives on income is discussed below. Foreign currency fluctuations relative to the prior year decreased income before income taxes by $4.7 million in the second quarter and decreased income by $13.9 million in the first six months of 2019, as compared to the same periods in 2018.
47
Table of Contents
The Company recognizes in consolidated income, any changes in the fair value of embedded derivatives on modco or funds withheld treaties, equity-indexed annuity treaties (“EIAs”) and variable annuities with guaranteed minimum benefit riders. The Company utilizes freestanding derivatives to minimize the income statement volatility due to changes in the fair value of embedded derivatives associated with guaranteed minimum benefit riders. The following table presents the effect of embedded derivatives and related freestanding derivatives on income before income taxes for the periods indicated (dollars in thousands):
Three months ended June 30,
Six months ended June 30,
2019
2018
2019
2018
Modco/Funds withheld:
Unrealized gains (losses)
$
5,262
$
8,805
$
3,170
$
22,416
Deferred acquisition costs/retrocession
(5,560
)
405
(8,417
)
(2,668
)
Net effect
(298
)
9,210
(5,247
)
19,748
EIAs:
Unrealized gains (losses)
(18,539
)
(565
)
(20,057
)
27,998
Deferred acquisition costs/retrocession
9,635
(418
)
10,511
(15,711
)
Net effect
(8,904
)
(983
)
(9,546
)
12,287
Guaranteed minimum benefit riders:
Unrealized gains (losses)
(18,044
)
15,324
117
30,109
Deferred acquisition costs/retrocession
(6,074
)
3,864
(22,850
)
6,195
Net effect
(24,118
)
19,188
(22,733
)
36,304
Related freestanding derivatives
27,490
(18,805
)
24,913
(41,304
)
Net effect after related freestanding derivatives
3,372
383
2,180
(5,000
)
Total net effect of embedded derivatives
(33,320
)
27,415
(37,526
)
68,339
Related freestanding derivatives
27,490
(18,805
)
24,913
(41,304
)
Total net effect after freestanding derivatives
$
(5,830
)
$
8,610
$
(12,613
)
$
27,035
Consolidated net premiums increased $169.3 million, or 6.5%, and $324.6 million, or 6.3%, for the three and six months ended June 30, 2019, as compared to the same periods in 2018, primarily due to growth in life reinsurance in force. Foreign currency fluctuations decreased net premiums by $60.0 million and $138.8 million in the second quarter and the first six months of 2019, as compared to the same periods in 2018. Consolidated assumed life insurance in force increased to $3,377.2 billion as of June 30, 2019 from $3,340.6 billion as of June 30, 2018 due to new business production and in force transactions. The Company added new business production, measured by face amount of insurance in force, of $70.4 billion and $99.7 billion during the second quarter of 2019 and 2018, respectively, and $149.7 billion and $196.4 billion during the first six months of 2019 and 2018, respectively.
Consolidated investment income, net of related expenses, increased $56.0 million, or 10.6%, and $119.6 million, or 11.4%, for the three and six months ended June 30, 2019, as compared to the same periods in 2018. The increases are primarily attributable to an increase in the average invested asset base and higher variable investment income. Investment income is affected by changes in the fair value of the Company’s funds withheld at interest assets associated with the reinsurance of certain EIA products. The re-measurement of these funds withheld assets decreased investment income by $3.7 million in the second quarter and decreased investment income by $10.1 million in the first six months of 2019, respectively, as compared to the same periods in 2018. The effect on investment income of the EIA's market value changes is substantially offset by a corresponding change in interest credited to policyholder account balances resulting in an insignificant effect on net income.
Average invested assets at amortized cost, excluding spread related business, for the six months ended June 30, 2019 were $28.1 billion, a 4.9% increase over June 30, 2018. The average yield earned on investments, excluding spread related business, was 4.38% and 4.32% for the second quarter of 2019 and 2018, respectively, and 4.43% and 4.39% for the six months ended June 30, 2019 and 2018, respectively. The average yield will vary from quarter to quarter and year to year depending on a number of variables, including the prevailing interest rate and credit spread environment, prepayment fees, make-whole premiums and changes in the mix of the underlying investments and cash balances, and the timing of dividends and distributions on certain investments. A continued low interest rate environment is expected to put downward pressure on this yield in future reporting periods.
Total investment related gains (losses), net were $12.5 million and $(10.6) million for the second quarter of 2019 and 2018, respectively, and $20.3 million and $(11.0) million for the first six months of 2019 and 2018, respectively. A portion of the increase in investment related gains (losses) was offset by changes in the value of embedded derivatives related to reinsurance treaties written on a modco or funds withheld basis, reflecting the impact of changes in interest rates and credit spreads on the calculation
48
Table of Contents
of fair value. Changes in the fair value of these embedded derivatives increased investment related gains by $5.3 million and $8.8 million for the second quarter of 2019 and 2018, respectively, and $3.2 million and $22.4 million for the first six months of 2019 and 2018, respectively. In addition, impairments on fixed maturity securities decreased by $3.4 million in the second quarter and increased by $6.1 million in the first six months of 2019, respectively, as compared to the same periods in 2018. See Note 4 - “Investments” and Note 5 - “Derivative Instruments” in the Notes to Condensed Consolidated Financial Statements for additional information on the impairment losses and derivatives.
The effective tax rate on a consolidated basis was 22.1% and 17.4% for the second quarter 2019 and 2018, respectively, and 21.9% and 20.9% for the first six months of 2019 and 2018, respectively. See Note 9 - “Income Tax” in the Notes to Condensed Consolidated Financial Statements for additional information on the Company’s consolidated effective tax rates.
Critical Accounting Policies
The preparation of financial statements in conformity with GAAP requires the application of accounting policies that often involve a significant degree of judgment. Management, on an ongoing basis, reviews estimates and assumptions used in the preparation of financial statements. If management determines that modifications in assumptions and estimates are appropriate given current facts and circumstances, results of operations and financial position as reported in the condensed consolidated financial statements could change significantly.
Management believes the critical accounting policies relating to the following areas are most dependent on the application of estimates and assumptions:
Premiums receivable;
Deferred acquisition costs;
Liabilities for future policy benefits and incurred but not reported claims;
Valuation of investments and other-than-temporary impairments to specific investments;
Valuation of embedded derivatives; and
Income taxes.
A discussion of each of the critical accounting policies may be found in the Company’s 2018 Annual Report under “Management’s Discussion and Analysis of Financial Condition and Results of Operations – Critical Accounting Policies.”
49
Table of Contents
Results of Operations by Segment
U.S. and Latin America Operations
The U.S. and Latin America operations include business generated by its offices in the U.S., Mexico and Brazil. The offices in Mexico and Brazil provide services to clients in other Latin American countries. U.S. and Latin America operations consist of two major segments: Traditional and Financial Solutions. The Traditional segment primarily specializes in the reinsurance of individual mortality-risk, health and long-term care and to a lesser extent, group reinsurance. The Financial Solutions segment consists of Asset-Intensive and Financial Reinsurance. Asset-Intensive within the Financial Solutions segment includes coinsurance of annuities and corporate-owned life insurance policies and to a lesser extent fee-based synthetic guaranteed investment contracts, which include investment-only, stable value contracts. Financial Reinsurance within the Financial Solutions segment primarily involves assisting ceding companies in meeting applicable regulatory requirements by enhancing the ceding companies’ financial strength and regulatory surplus position through relatively low risk reinsurance transactions. Due to the low-risk nature of financial reinsurance transactions, they typically do not qualify as reinsurance under GAAP, so only the related net fees are reflected in other revenues on the condensed consolidated statements of income.
For the three months ended June 30, 2019:
Financial Solutions
(dollars in thousands)
Asset-Intensive
Financial
Reinsurance
Total U.S. and Latin America
Traditional
Revenues:
Net premiums
$
1,410,503
$
8,220
$
—
$
1,418,723
Investment income, net of related expenses
173,310
203,894
1,029
378,233
Investment related gains (losses), net
(3,950
)
17,500
—
13,550
Other revenues
4,813
50,242
20,372
75,427
Total revenues
1,584,676
279,856
21,401
1,885,933
Benefits and expenses:
Claims and other policy benefits
1,292,852
48,663
—
1,341,515
Interest credited
19,517
123,786
—
143,303
Policy acquisition costs and other insurance expenses
179,947
25,657
(815
)
204,789
Other operating expenses
37,185
9,056
2,892
49,133
Total benefits and expenses
1,529,501
207,162
2,077
1,738,740
Income before income taxes
$
55,175
$
72,694
$
19,324
$
147,193
For the three months ended June 30, 2018:
Financial Solutions
(dollars in thousands)
Asset-Intensive
Financial
Reinsurance
Total U.S. and Latin America
Traditional
Revenues:
Net premiums
$
1,373,548
$
6,699
$
—
$
1,380,247
Investment income, net of related expenses
180,478
171,810
1,504
353,792
Investment related gains (losses), net
3,725
776
—
4,501
Other revenues
6,396
24,065
25,094
55,555
Total revenues
1,564,147
203,350
26,598
1,794,095
Benefits and expenses:
Claims and other policy benefits
1,255,007
22,590
—
1,277,597
Interest credited
20,992
74,810
—
95,802
Policy acquisition costs and other insurance expenses
182,064
37,939
2,609
222,612
Other operating expenses
34,106
7,171
2,441
43,718
Total benefits and expenses
1,492,169
142,510
5,050
1,639,729
Income before income taxes
$
71,978
$
60,840
$
21,548
$
154,366
50
Table of Contents
For the six months ended June 30, 2019:
Financial Solutions
(dollars in thousands)
Asset-Intensive
Financial
Reinsurance
Total U.S. and Latin America
Traditional
Revenues:
Net premiums
$
2,767,385
$
15,430
$
—
$
2,782,815
Investment income, net of related expenses
358,844
401,115
2,045
762,004
Investment related gains (losses), net
(10,422
)
18,546
—
8,124
Other revenues
9,535
72,916
45,865
128,316
Total revenues
3,125,342
508,007
47,910
3,681,259
Benefits and expenses:
Claims and other policy benefits
2,592,917
96,762
—
2,689,679
Interest credited
39,391
212,496
—
251,887
Policy acquisition costs and other insurance expenses
355,950
44,890
4,561
405,401
Other operating expenses
70,255
16,207
5,706
92,168
Total benefits and expenses
3,058,513
370,355
10,267
3,439,135
Income before income taxes
$
66,829
$
137,652
$
37,643
$
242,124
For the six months ended June 30, 2018:
Financial Solutions
(dollars in thousands)
Asset-Intensive
Financial
Reinsurance
Total U.S. and Latin America
Traditional
Revenues:
Net premiums
$
2,672,970
$
11,891
$
—
$
2,684,861
Investment income, net of related expenses
363,538
329,722
3,326
696,586
Investment related gains (losses), net
5,408
1,452
—
6,860
Other revenues
11,925
47,024
49,885
108,834
Total revenues
3,053,841
390,089
53,211
3,497,141
Benefits and expenses:
Claims and other policy benefits
2,509,968
38,535
—
2,548,503
Interest credited
41,272
129,022
—
170,294
Policy acquisition costs and other insurance expenses
359,704
99,974
6,609
466,287
Other operating expenses
68,027
14,456
4,895
87,378
Total benefits and expenses
2,978,971
281,987
11,504
3,272,462
Income before income taxes
$
74,870
$
108,102
$
41,707
$
224,679
Income before income taxes decreased by
$7.2 million
, or
4.6%
, and increased by
$17.4 million
, or
7.8%
, for the
three and six
months ended
June 30, 2019
, as compared to the same periods in
2018
. The decrease in income before income taxes for the second quarter was primarily due to changes in the value of the embedded derivatives associated with reinsurance treaties structured on a modco or funds withheld basis combined with lower investment income and higher expenses related to an increase in incentive based compensation. Offsetting this somewhat was contributions from new asset-intensive transactions executed since the second half of 2018 and favorable longevity experience. The increase in income before income taxes for the first six months was primarily due to the impact of higher investment related gains (losses) in the Asset-Intensive segment as well as contributions from new asset-intensive deals entered into since the second half of 2018. Additionally, the Traditional segment saw improved claims experience.
Traditional Reinsurance
Income before income taxes for the U.S. and Latin America Traditional segment decreased by
$16.8 million
, or
23.3%
, and
$8.0 million
, or
10.7%
, for the
three and six
months ended
June 30, 2019
, as compared to the same periods in
2018
. The decrease in the second quarter was primarily due to changes in the value of embedded derivatives associated with reinsurance treaties structured on a modco or funds withheld basis. Additionally, the segment reported lower investment income in part due to lower variable investment income. General expenses were also higher due to incentive-based compensation. Unfavorable individual mortality experience quarter over quarter was partially offset by improved claim experience in both the Group and Individual Health lines of business.
Net premiums increased
$37.0 million
, or
2.7%
, and
$94.4 million
, or
3.5%
, for the
three and six
months ended
June 30, 2019
, as compared to the same periods in
2018
. The increases in net premiums in the second quarter and first six months were due to organic growth as well as new sales. The segment added new individual life business production, measured by face amount of insurance in force of $24.7 billion and $29.3 billion for the
second
quarter and $53.5 billion and $52.6 billion for the first
six
months of
2019
and
2018
, respectively.
51
Table of Contents
Net investment income decreased
$7.2 million
, or
4.0%
, and
$4.7 million
, or
1.3%
, for the
three and six
months ended
June 30, 2019
, as compared to the same periods in
2018
. The decreases in the
second
quarter and first six months were primarily due to lower variable investment income partially offset by an increase in the asset base across all segments. Investment related gains (losses), net decreased
$7.7 million
and
$15.8 million
for the
three and six
months ended
June 30, 2019
, as compared to the same periods in
2018
.
Claims and other policy benefits as a percentage of net premiums (“loss ratios”) were
91.7%
and
91.4%
for the
second
quarter and
93.7%
and
93.9%
, for the
six
months ended
June 30, 2019
and
2018
, respectively. The increase in the loss ratio for the second quarter was primarily due to moderately unfavorable claims experience and impacts from client reporting adjustments in the mortality line of business. The decrease in the loss ratio for the first six months of 2019 compared to the same period in 2018 was primarily due to improved claim experience within the Group business offset somewhat by unfavorable claims experience in the mortality business.
Interest credited expense decreased
$1.5 million
, or
7.0%
, and
$1.9 million
, or
4.6%
, for the
three and six
months ended
June 30, 2019
, as compared to the same periods in
2018
. Interest credited in this segment relates to amounts credited on cash value products which also have a significant mortality component. Income before income taxes is affected by the spread between the investment income and the interest credited on the underlying products.
Policy acquisition costs and other insurance expenses as a percentage of net premiums were
12.8%
and
13.3%
for the
second
quarter and
12.9%
and
13.5%
for the
six
months ended
June 30, 2019
and
2018
, respectively. While these ratios are expected to remain in a predictable range, they may fluctuate from period to period due to varying allowance levels within coinsurance-type arrangements. In addition, the amortization pattern of previously capitalized amounts, which are subject to the form of the reinsurance agreement and the underlying insurance policies, may vary. Also, the mix of first year coinsurance business versus yearly renewable term business can cause the percentage to fluctuate from period to period
Other operating expenses increased
$3.1 million
, or
9.0%
, and
$2.2 million
, or
3.3%
, for the
three and six
months ended
June 30, 2019
, as compared to the same periods in
2018
. The increase in operating expenses, for both periods, is primarily related to expected expense levels needed to support the business as well as increased incentive-based compensation. Other operating expenses, as a percentage of net premiums were
2.6%
and
2.5%
for the
second
quarter and
2.5%
and
2.5%
first
six
months of
2019
and
2018
, respectively. The expense ratio tends to fluctuate only slightly from period to period due to the maturity and scale of this segment.
Financial Solutions - Asset-Intensive Reinsurance
Asset-Intensive reinsurance within the U.S. and Latin America Financial Solutions segment primarily involves assuming investment risk within underlying annuities and corporate-owned life insurance policies. Most of these agreements are coinsurance, coinsurance with funds withheld or modco. The Company recognizes profits or losses primarily from the spread between the investment income earned and the interest credited on the underlying deposit liabilities, income associated with longevity risk, and fees associated with variable annuity account values and guaranteed investment contracts.
Impact of certain derivatives:
Income from the asset-intensive business tends to be volatile due to changes in the fair value of certain derivatives, including embedded derivatives associated with reinsurance treaties structured on a modco or funds withheld basis, as well as embedded derivatives associated with the Company’s reinsurance of equity-indexed annuities and variable annuities with guaranteed minimum benefit riders. Fluctuations occur period to period primarily due to changing investment conditions including, but not limited to, interest rate movements (including risk-free rates and credit spreads), implied volatility, the Company’s own credit risk and equity market performance, all of which are factors in the calculations of fair value. Therefore, management believes it is helpful to distinguish between the effects of changes in these derivatives, net of related hedging activity, and the primary factors that drive profitability of the underlying treaties, namely investment income, fee income (included in other revenues), and interest credited. These fluctuations are considered unrealized by management and do not affect current cash flows, crediting rates or spread performance on the underlying treaties.
The following table summarizes the asset-intensive results and quantifies the impact of these embedded derivatives for the periods presented. Revenues before certain derivatives, benefits and expenses before certain derivatives, and income before income taxes and certain derivatives, should not be viewed as substitutes for GAAP revenues, GAAP benefits and expenses, and GAAP income before income taxes.
52
Table of Contents
(dollars in thousands)
Three months ended June 30,
Six months ended June 30,
2019
2018
2019
2018
Revenues:
Total revenues
$
279,856
$
203,350
$
508,007
$
390,089
Less:
Embedded derivatives – modco/funds withheld treaties
9,256
5,039
13,640
16,957
Guaranteed minimum benefit riders and related free standing derivatives
3,912
2,077
1,076
(2,512
)
Revenues before certain derivatives
266,688
196,234
493,291
375,644
Benefits and expenses:
Total benefits and expenses
207,162
142,510
370,355
281,987
Less:
Embedded derivatives – modco/funds withheld treaties
5,560
(405
)
8,418
2,668
Guaranteed minimum benefit riders and related free standing derivatives
540
1,694
(1,104
)
2,488
Equity-indexed annuities
8,904
983
9,546
(12,287
)
Benefits and expenses before certain derivatives
192,158
140,238
353,495
289,118
Income before income taxes:
Income before income taxes
72,694
60,840
137,652
108,102
Less:
Embedded derivatives – modco/funds withheld treaties
3,696
5,444
5,222
14,289
Guaranteed minimum benefit riders and related free standing derivatives
3,372
383
2,180
(5,000
)
Equity-indexed annuities
(8,904
)
(983
)
(9,546
)
12,287
Income before income taxes and certain derivatives
$
74,530
$
55,996
$
139,796
$
86,526
Embedded Derivatives - Modco/Funds Withheld Treaties -
Represents the change in the fair value of embedded derivatives on funds withheld at interest associated with treaties written on a modco or funds withheld basis. The fair value changes of embedded derivatives on funds withheld at interest associated with treaties written on a modco or funds withheld basis are reflected in revenues, while the related impact on deferred acquisition expenses is reflected in benefits and expenses. The Company’s utilization of a credit valuation adjustment did not have a material effect on the change in fair value of these embedded derivatives for the
six
months ended
June 30, 2019
and
2018
.
The change in fair value of the embedded derivatives - modco/funds withheld treaties increased income before income taxes by
$3.7 million
and
$5.4 million
for the
second
quarter and
$5.2 million
and
$14.3 million
for the
six
months ended
June 30, 2019
and
2018
, respectively. The decrease in income for the second quarter and first six months of 2019 was primarily the result of lower policyholder lapses and withdrawals.
Guaranteed Minimum Benefit Riders -
Represents the impact related to guaranteed minimum benefits associated with the Company’s reinsurance of variable annuities. The fair value changes of the guaranteed minimum benefits along with the changes in fair value of the free standing derivatives (interest rate swaps, financial futures and equity options), purchased by the Company to substantially hedge the liability are reflected in revenues, while the related impact on deferred acquisition expenses is reflected in benefits and expenses. The Company’s utilization of a credit valuation adjustment did not have a material effect on the change in fair value of these embedded derivatives for the
six
months ended
June 30, 2019
and
2018
.
The change in fair value of the guaranteed minimum benefits, after allowing for changes in the associated free standing derivatives, increased income before income taxes by
$3.4 million
and
$0.4 million
for the
second
quarter and increased (decreased) by
$2.2 million
and
$(5.0) million
for the
six
months ended
June 30, 2019
and
2018
, respectively. The increases in income for the second quarter and for the first six months of June 30, 2019 were primarily due to favorable hedging results. The increase in income for the second quarter of 2018 was primarily due to favorable hedging results. The decrease in income for the first six months ended June 30, 2018 was primarily the result of interest rate movements.
Equity-Indexed Annuities -
Represents changes in the liability for equity-indexed annuities in excess of changes in account value, after adjustments for related deferred acquisition expenses. The change in fair value of embedded derivative liabilities associated with equity-indexed annuities increased (decreased) income before income taxes by
$(8.9) million
and
$(1.0) million
for the
second
quarter and
$(9.5) million
and
$12.3 million
for the
six
months ended
June 30, 2019
and
2018
, respectively. The decreases in income for the second quarter and first six months of 2019 were primarily due to interest rate movements. The decrease in income for the second quarter of 2018 was primarily the result of interest rate movements. The increase in income for the first six months of 2018 was primarily due to lower policyholder lapses and withdrawals.
53
Table of Contents
The changes in derivatives discussed above are considered unrealized by management and do not affect current cash flows, crediting rates or spread performance on the underlying treaties. Fluctuations occur period to period primarily due to changing investment conditions including, but not limited to, interest rate movements (including benchmark rates and credit spreads), credit valuation adjustments, implied volatility and equity market performance, all of which are factors in the calculations of fair value. Therefore, management believes it is helpful to distinguish between the effects of changes in these derivatives and the primary factors that drive profitability of the underlying treaties, namely investment income, fee income (included in other revenues) and interest credited.
Discussion and analysis before certain derivatives:
Income before income taxes and certain derivatives increased by $18.5 million and $53.3 million for the
three and six
months ended
June 30, 2019
, as compared to the same periods in
2018
. The increases in the second quarter was primarily due to contribution from transactions executed since the second half of 2018 and favorable longevity experience. The increase in the first six months was primarily due to contributions from transactions executed since the second half of 2018.
Revenue before certain derivatives increased by $70.5 million and $117.6 million for the
three and six
months ended
June 30, 2019
, respectively, as compared to the same periods in
2018
. The increase in the second quarter was primarily due to contribution from transactions executed since the second half of 2018 and favorable longevity experience. The increase in the first six months was primarily due to contributions from transactions executed since the second half of 2018. The effect on investment income related to equity options is substantially offset by a corresponding change in interest credited.
Benefits and expenses before certain derivatives increased by $51.9 million and $64.4 million for the
three and six
months ended
June 30, 2019
, as compared to the same period in
2018
. The increase in the second quarter was primarily due to contributions from transactions executed since the second half of 2018, partially offset by favorable longevity experience. The increase in the first six months was primarily due to contributions from transactions executed since the second half of 2018. The effect on interest credited related to equity options is substantially offset by a corresponding change in investment income.
The invested asset base supporting this segment increased to $22.1 billion as of
June 30, 2019
from $15.8 billion as of
June 30, 2018
. As of
June 30, 2019
, $3.6 billion of the invested assets were funds withheld at interest, of which greater than 90% is associated with one client.
Financial Solutions - Financial Reinsurance
Financial Reinsurance within the U.S. and Latin America Financial Solutions segment income before income taxes consists primarily of net fees earned on financial reinsurance transactions. Additionally, a portion of the business is brokered business in which the Company does not participate in the assumption of risk. The fees earned from financial reinsurance contracts and brokered business are reflected in other revenues, and the fees paid to retrocessionaires are reflected in policy acquisition costs and other insurance expenses.
Income before income taxes decreased
$2.2 million
, or
10.3%
, and
$4.1 million
, or
9.7%
, for the
three and six
months ended
June 30, 2019
, as compared to the same periods in
2018
. The decreases in the second quarter and first six months were primarily due to the termination of certain agreements.
At
June 30, 2019
and
2018
, the amount of reinsurance assumed from client companies, as measured by pre-tax statutory surplus, risk based capital and other financial structures was $15.8 billion and $13.7 billion, respectively. The increase was primarily due to a number of new transactions offsetting the termination of certain agreements, as well as organic growth on existing transactions. Fees earned from this business can vary significantly depending on the size of the transactions and the timing of their completion and therefore can fluctuate from period to period.
54
Table of Contents
Canada Operations
The Company conducts reinsurance business in Canada primarily through RGA Canada. The Canada operations are primarily engaged in Traditional reinsurance, which consists mainly of traditional individual life reinsurance, and to a lesser extent creditor, group life and health, critical illness and disability reinsurance. Creditor insurance covers the outstanding balance on personal, mortgage or commercial loans in the event of death, disability or critical illness and is generally shorter in duration than traditional individual life insurance. The Canada Financial Solutions segment consists of longevity and financial reinsurance.
(dollars in thousands)
Three months ended June 30,
2019
2018
Revenues:
Traditional
Financial Solutions
Total Canada
Traditional
Financial Solutions
Total Canada
Net premiums
$
264,182
$
22,456
$
286,638
$
260,750
$
10,955
$
271,705
Investment income, net of related expenses
50,002
788
50,790
49,535
330
49,865
Investment related gains (losses), net
2,564
—
2,564
446
—
446
Other revenues
1,394
685
2,079
1,468
804
2,272
Total revenues
318,142
23,929
342,071
312,199
12,089
324,288
Benefits and expenses:
Claims and other policy benefits
206,272
19,222
225,494
223,935
7,915
231,850
Interest credited
73
—
73
21
—
21
Policy acquisition costs and other insurance expenses
57,049
447
57,496
58,541
292
58,833
Other operating expenses
8,489
447
8,936
7,897
338
8,235
Total benefits and expenses
271,883
20,116
291,999
290,394
8,545
298,939
Income before income taxes
$
46,259
$
3,813
$
50,072
$
21,805
$
3,544
$
25,349
(dollars in thousands)
Six months ended June 30,
2019
2018
Revenues:
Traditional
Financial Solutions
Total Canada
Traditional
Financial Solutions
Total Canada
Net premiums
$
519,439
$
44,445
$
563,884
$
513,473
$
22,260
$
535,733
Investment income, net of related expenses
99,695
1,506
101,201
100,119
445
100,564
Investment related gains (losses), net
9,968
—
9,968
(285
)
—
(285
)
Other revenues
1,373
1,552
2,925
1,211
2,161
3,372
Total revenues
630,475
47,503
677,978
614,518
24,866
639,384
Benefits and expenses:
Claims and other policy benefits
406,128
40,375
446,503
436,760
17,030
453,790
Interest credited
128
—
128
26
—
26
Policy acquisition costs and other insurance expenses
110,957
896
111,853
115,573
388
115,961
Other operating expenses
16,724
1,071
17,795
16,647
713
17,360
Total benefits and expenses
533,937
42,342
576,279
569,006
18,131
587,137
Income before income taxes
$
96,538
$
5,161
$
101,699
$
45,512
$
6,735
$
52,247
Income before income taxes increased by
$24.7 million
, or
97.5%
, and
$49.5 million
, or
94.7%
, for the
three and six
months ended
June 30, 2019
, as compared to the same periods in
2018
. The increases in income for the
second
quarter and first
six
months are primarily due to favorable traditional individual life mortality experience as compared to the same period in 2018. Foreign currency exchange fluctuations in the Canadian dollar resulted in a decrease in income before income taxes of
$1.7 million
and
$4.4 million
for the three and
six
months ended
June 30, 2019
, as compared to the same periods in
2018
.
Traditional Reinsurance
Income before income taxes for the Canada Traditional segment increased by
$24.5 million
, or
112.1%
, and
$51.0 million
, or
112.1%
, for the
three and six
months ended
June 30, 2019
, as compared to the same periods in
2018
. The increases in income before income taxes for the
second
quarter and first
six
months were primarily due to favorable traditional individual life mortality experience as compared to the same periods in 2018. Foreign currency exchange fluctuations in the Canadian dollar resulted in a decrease in income before income taxes of
$1.6 million
and
$4.2 million
for the
three and six
months ended
June 30, 2019
, as compared to the same periods in
2018
.
55
Table of Contents
Net premiums increased
$3.4 million
, or
1.3%
, and
$6.0 million
, or
1.2%
, for the
three and six
months ended
June 30, 2019
, as compared to the same periods in
2018
. The increases in net premiums in 2019 were primarily due to a new in force block transaction during the last quarter of 2018. Foreign currency exchange fluctuations in the Canadian dollar resulted in a decrease in net premiums of
$9.4 million
and
$22.1 million
for the
three and six
months ended
June 30, 2019
, as compared to the same periods in
2018
.
Net investment income increased
$0.5 million
, or
0.9%
, and decreased
$0.4 million
, or
0.4%
, for the
three and six
months ended
June 30, 2019
, as compared to the same periods in
2018
. The increase in net investment income for the three months ended June 30, 2019 is primarily a result of an increase in the invested asset base due to growth in the underlying business volume and an increase in investment yields, partially offset by foreign currency exchange fluctuations. The decrease in investment income in the first six months ended June 30, 2019 is primarily a result of foreign currency exchange fluctuation in the Canadian dollar partially offset by an increase in the invested asset base due to growth in the underlying business volume and an increase in investment yields. Foreign currency exchange fluctuation in the Canadian dollar resulted in a decrease in net investment income of
$1.8 million
and
$4.3 million
for the
three and six
months ended
June 30, 2019
, as compared to the same periods in
2018
.
Other revenues decreased by
$0.1 million
and increased
$0.2 million
for the
three and six
months ended
June 30, 2019
, as compared to the same periods in
2018
. These variances are primarily due to gains and losses related to foreign currency transactions.
Loss ratios for this segment were
78.1%
and
85.9%
for the
second
quarter and
78.2%
and
85.1%
for the
six
months ended
June 30, 2019
and
2018
, respectively. The decrease in the loss ratios for the three and six months ended
June 30, 2019
, as compared to the same periods in 2018, is due to favorable traditional individual life mortality experience. Loss ratios for the traditional individual life mortality business were 83.2% and 97.8% for the
second
quarter and 83.3% and 94.6% for the first
six
months ended
June 30, 2019
and
2018
, respectively. Excluding creditor business, claims as a percentage of net premiums for this segment were 67.5% and 74.7% for the second quarter and 70.3% and 75.9% for the six months ended June 30, 2019 and 2018, respectively. Excluding creditor business, claims and other policy benefits, as a percentage of net premiums and investment income were 69.4% and 77.5% for the
second
quarter and 69.7% and 76.3% for the
six
months ended
June 30, 2019
and
2018
, respectively.
Policy acquisition costs and other insurance expenses as a percentage of net premiums were
21.6%
and
22.5%
for the
second
quarter and
21.4%
and
22.5%
for the
six
months ended
June 30, 2019
and
2018
, respectively. Overall, while these ratios are expected to remain in a predictable range, they may fluctuate from period to period due to varying allowance levels and product mix. In addition, the amortization patterns of previously capitalized amounts, which are subject to the form of the reinsurance agreement and the underlying insurance policies, may vary.
Other operating expenses increased
$0.6 million
, or
7.5%
, and
$0.1 million
, or
0.5%
, for the three and
six
months ended
June 30, 2019
, respectively, as compared to the same periods in
2018
. Other operating expenses as a percentage of net premiums were
3.2%
and
3.0%
for the
second
quarter and
3.2%
and
3.2%
for the
six
month periods ended
June 30, 2019
and
2018
, respectively.
Financial Solutions Reinsurance
Income before income taxes increased by
$0.3 million
, or
7.6%
, and decreased by
$1.6 million
, or
23.4%
, for the
three and six
months ended
June 30, 2019
, as compared to the same periods in
2018
. The increase in income for the second quarter was primarily due to favorable experience on longevity business. The decrease in income for the six months ended June 30, 2019 was primarily due to more favorable experience on longevity business in 2018 compared to 2019. Foreign currency exchange fluctuations in the Canadian dollar resulted in a decrease in income before income taxes of
$0.1 million
and
$0.2 million
for the
three and six
months ended
June 30, 2019
, as compared to the same periods in
2018
.
Net premiums increased
$11.5 million
, or
105.0%
, and
$22.2 million
, or
99.7%
, for the
three and six
months ended
June 30, 2019
, as compared to the same periods in
2018
. The increases were primarily due to a new transaction completed in the first three months of 2019. Foreign currency exchange fluctuations in the Canadian dollar resulted in a decrease in net premiums of
$0.8 million
and
$1.8 million
for the
three and six
months ended
June 30, 2019
, as compared to the same periods in
2018
.
Net investment income increased
$0.5 million
, or
138.8%
, and
$1.1 million
, or
238.4%
, for the
three and six
months ended
June 30, 2019
, as compared to the same periods in
2018
primarily due to an increase in the invested asset base.
Claims and other policy benefits increased
$11.3 million
, or
142.9%
, and
$23.3 million
, or
137.1%
, for the
three and six
months ended
June 30, 2019
as compared to the same periods in
2018
. The increases for the
second
quarter and first
six
months were primarily a result of the aforementioned new transaction completed in the first three months of 2019.
Europe, Middle East and Africa Operations
The Europe, Middle East and Africa (“EMEA”) operations include business generated by its offices principally in France, Germany, Ireland, Italy, the Middle East, the Netherlands, Poland, South Africa, Spain and the United Kingdom (“UK”). EMEA consists of two major segments: Traditional and Financial Solutions. The Traditional segment primarily provides reinsurance through yearly renewable term and coinsurance agreements on a variety of life, health and critical illness products. Reinsurance agreements may
56
Table of Contents
be facultative or automatic agreements covering primarily individual risks and, in some markets, group risks. The Financial Solutions segment consists of reinsurance and other transactions associated with longevity closed blocks, payout annuities, capital management solutions and financial reinsurance.
(dollars in thousands)
Three months ended June 30,
2019
2018
Revenues:
Traditional
Financial Solutions
Total EMEA
Traditional
Financial Solutions
Total EMEA
Net premiums
$
350,884
$
56,660
$
407,544
$
354,534
$
49,135
$
403,669
Investment income, net of related expenses
17,945
46,593
64,538
17,087
40,330
57,417
Investment related gains (losses), net
112
2,550
2,662
—
5,858
5,858
Other revenues
558
8,183
8,741
917
5,352
6,269
Total revenues
369,499
113,986
483,485
372,538
100,675
473,213
Benefits and expenses:
Claims and other policy benefits
295,661
47,551
343,212
310,187
21,854
332,041
Interest credited
—
2,280
2,280
—
4,127
4,127
Policy acquisition costs and other insurance expenses
27,594
1,181
28,775
29,961
1,054
31,015
Other operating expenses
30,123
11,173
41,296
25,922
8,271
34,193
Total benefits and expenses
353,378
62,185
415,563
366,070
35,306
401,376
Income before income taxes
$
16,121
$
51,801
$
67,922
$
6,468
$
65,369
$
71,837
(dollars in thousands)
Six months ended June 30,
2019
2018
Revenues:
Traditional
Financial Solutions
Total EMEA
Traditional
Financial Solutions
Total EMEA
Net premiums
$
714,768
$
108,761
$
823,529
$
730,263
$
97,114
$
827,377
Investment income, net of related expenses
36,747
95,258
132,005
32,851
72,262
105,113
Investment related gains (losses), net
112
5,914
6,026
9
9,210
9,219
Other revenues
1,878
13,474
15,352
3,197
10,232
13,429
Total revenues
753,505
223,407
976,912
766,320
188,818
955,138
Benefits and expenses:
Claims and other policy benefits
607,796
96,429
704,225
636,989
64,325
701,314
Interest credited
—
14,622
14,622
—
1,475
1,475
Policy acquisition costs and other insurance expenses
57,547
1,812
59,359
55,513
2,134
57,647
Other operating expenses
56,617
20,353
76,970
51,929
16,351
68,280
Total benefits and expenses
721,960
133,216
855,176
744,431
84,285
828,716
Income before income taxes
$
31,545
$
90,191
$
121,736
$
21,889
$
104,533
$
126,422
Income before income taxes decreased by
$3.9 million
, or
5.4%
, and
$4.7 million
, or
3.7%
, for the
three and six
months ended
June 30, 2019
, as compared to the same periods in
2018
. The decreases in income before income taxes were primarily due to the normalization of performance on closed longevity blocks after favorable performance in 2018 and foreign exchange fluctuations partly offset by improved performance in Traditional business. Foreign currency exchange fluctuations resulted in a decrease in income before income taxes of
$3.9 million
and
$8.4 million
for the
three and six
months ended
June 30, 2019
, as compared to the same periods in
2018
.
Traditional Reinsurance
Income before income taxes increased by
$9.7 million
, or
149.2%
, and
$9.7 million
, or
44.1%
, for the
three and six
months ended
June 30, 2019
, as compared to the same periods in
2018
. The increases in income were primarily due to an improvement in morbidity experience. Foreign currency exchange fluctuations resulted in a decrease in income before income taxes of
$1.0 million
and
$2.7 million
for the
three and six
months ended
June 30, 2019
, as compared to the same periods in
2018
.
Net premiums decreased
$3.7 million
, or
1.0%
, and
$15.5 million
, or
2.1%
, for the
three and six
months ended
June 30, 2019
, as compared to the same periods in
2018
. The decrease in net premiums for the three and six months was primarily due to foreign currency exchange fluctuations. Foreign currency exchange fluctuations decreased net premiums by
$23.3 million
and
$55.9 million
for the
three and six
months ended
June 30, 2019
, as compared to the same periods in
2018
.
57
Table of Contents
A portion of the net premiums for the segment, in each period presented, relates to reinsurance of critical illness coverage, primarily in the UK. This coverage provides a benefit in the event of the diagnosis of a pre-defined critical illness. Net premiums earned from this coverage totaled $43.1 million and $47.9 million for the
second
quarter and $87.5 million and $96.7 million for the first
six
months of
2019
and
2018
, respectively.
Net investment income increased
$0.9 million
, or
5.0%
, and
$3.9 million
, or
11.9%
, for the
three and six
months ended
June 30, 2019
, as compared to the same periods in
2018
. The increase in net investment income for the three months was primarily due to an increase in the invested asset base resulting from business growth. The increase in net investment income for the six months was primarily due to an increase in the invested asset base and increased invested asset yield. Foreign currency exchange fluctuations resulted in a decrease in net investment income of
$1.4 million
and
$3.0 million
for the
three and six
months ended
June 30, 2019
, as compared to the same periods in
2018
.
Loss ratios for this segment were
84.3%
and
87.5%
for the
second
quarter and
85.0%
and
87.2%
for the first
six
months ended
June 30, 2019
and
2018
, respectively. The decreases in loss ratios were due to normal claims variability and changes in business mix.
Policy acquisition costs and other insurance expenses as a percentage of net premiums were
7.9%
and
8.5%
for the
second
quarter and
8.1%
and
7.6%
for the first
six
months ended
June 30, 2019
and
2018
, respectively. The decrease in policy acquisition cost ratio for the second quarter was primarily due to changes in the mix of business reflecting business volumes with lower allowances. The increase in the percentage for the first six months is due primarily to variations in the mixture of business.
Other operating expenses increased
$4.2 million
, or
16.2%
, and
$4.7 million
, or
9.0%
, for the
three and six
months ended
June 30, 2019
, as compared to the same periods in
2018
. The increase is in line with expected expense levels needed to support the business as well as higher incentive-based compensation. Foreign currency fluctuations resulted in a decrease in operating expenses of
$2.1 million
and
$4.4 million
for the
three and six
months ended
June 30, 2019
, as compared to the same periods in
2018
. Other operating expenses as a percentage of net premiums totaled
8.6%
and
7.3%
for the
second
quarter and
7.9%
and
7.1%
for the first
six
months ended
June 30, 2019
and
2018
, respectively.
Financial Solutions
Reinsurance
Income before income taxes decreased by
$13.6 million
, or
20.8%
, and
$14.3 million
, or
13.7%
, for the
three and six
months ended
June 30, 2019
, as compared to the same periods in
2018
. The decreases in income before income taxes were primarily due to the normalization of performance on closed longevity blocks after a positive 2018. Foreign currency exchange fluctuations resulted in a decrease in income before income taxes of
$2.9 million
and
$5.7 million
for the
three and six
months ended
June 30, 2019
, as compared to the same periods in
2018
.
Net premiums increased by
$7.5 million
, or
15.3%
, and
$11.6 million
, or
12.0%
, for the
three and six
months ended
June 30, 2019
, as compared to the same periods in
2018
. The increases in net premiums were due to higher new business volumes of closed longevity business. Foreign currency exchange fluctuations decreased net premiums by
$3.4 million
and
$7.0 million
for the
three and six
months ended
June 30, 2019
, as compared to the same periods in
2018
.
Net investment income increased
$6.3 million
, or
15.5%
, and
$23.0 million
, or
31.8%
, for the
three and six
months ended
June 30, 2019
, as compared to the same periods in
2018
. The increase in investment income for the three months was due to an increased invested asset yield and a premium received for the early redemption of a security. The increase for the six months was due to an increase in investment income associated with unit-linked policies which fluctuate with market performance, a premium received for the early redemption of a security and an increase in invested asset yield. The effect on investment income related to unit-linked products is substantially offset by a corresponding change in interest credited. Foreign currency exchange fluctuations resulted in a decrease in net investment income of
$2.6 million
and
$6.2 million
for the
three and six
months ended
June 30, 2019
, as compared to the same periods in 2018.
Other revenues increased by
$2.8 million
, or
52.9%
, and
$3.2 million
, or
31.7%
, for the
three and six
months ended
June 30, 2019
, as compared to the same periods in
2018
. The increase in other revenues for the second quarter and first six months of 2019 was primarily due to fees related to the acquisition of a new closed block annuity transaction. Foreign currency exchange fluctuations resulted in a decrease in other revenues of
$0.6 million
and
$1.2 million
for the
three and six
months ended
June 30, 2019
, as compared to the same periods in 2018.
Claims and other policy benefits increased
$25.7 million
, or
117.6%
, and
$32.1 million
, or
49.9%
, for the
three and six
months ended
June 30, 2019
, as compared to the same periods in
2018
. The increase in the second quarter and the first six months was primarily due to increased volumes of closed longevity block business as well as a normalization of performance compared to favorable performance in 2018. Foreign currency exchange fluctuations resulted in a decrease in claims and other policy benefits of
$3.0 million
and
$6.3 million
for the
three and six
months ended
June 30, 2019
, as compared to the same periods in 2018.
58
Table of Contents
Interest credited expense decreased by
$1.8 million
and increased by
$13.1 million
or the
three and six
months ended
June 30, 2019
, as compared to the same periods in
2018
. Interest credited in this segment relates to amounts credited to the contractholders of unit-linked products. The effect on interest credited related to unit-linked products is substantially offset by a corresponding change in investment income.
Other operating expenses increased
$2.9 million
, or
35.1%
, and
$4.0 million
, or
24.5%
, for the
three and six
months ended
June 30, 2019
, as compared to the same periods in
2018
due to normal growth in operations and an increase in acquisition related costs. Foreign currency exchange fluctuations resulted in a decrease in operating expenses of
$0.7 million
and
$1.4 million
for the
three and six
months ended
June 30, 2019
, as compared to the same periods in
2018
.
Asia Pacific Operations
The Asia Pacific operations include business generated by its offices principally in Australia, China, Hong Kong, India, Japan, Malaysia, New Zealand, Singapore, South Korea and Taiwan. The Traditional segment’s principal types of reinsurance include individual and group life and health, critical illness, disability and superannuation. Superannuation is the Australian government mandated compulsory retirement savings program. Superannuation funds accumulate retirement funds for employees, and, in addition, typically offer life and disability insurance coverage. The Financial Solutions segment includes financial reinsurance and asset-intensive transactions including certain disability, life and health blocks with significant investment risk. Reinsurance agreements may be facultative or automatic agreements covering primarily individual risks and in some markets, group risks.
(dollars in thousands)
Three months ended June 30,
2019
2018
Revenues:
Traditional
Financial Solutions
Total Asia Pacific
Traditional
Financial Solutions
Total Asia Pacific
Net premiums
$
606,418
$
44,453
$
650,871
$
538,799
$
30
$
538,829
Investment income, net of related expenses
24,732
10,383
35,115
24,076
10,184
34,260
Investment related gains (losses), net
—
(816
)
(816
)
—
1,904
1,904
Other revenues
2,267
5,538
7,805
7,645
5,874
13,519
Total revenues
633,417
59,558
692,975
570,520
17,992
588,512
Benefits and expenses:
Claims and other policy benefits
567,994
37,107
605,101
435,592
2,405
437,997
Interest credited
—
6,730
6,730
—
6,660
6,660
Policy acquisition costs and other insurance expenses
(11,584
)
9,530
(2,054
)
37,584
728
38,312
Other operating expenses
42,232
4,273
46,505
38,482
4,061
42,543
Total benefits and expenses
598,642
57,640
656,282
511,658
13,854
525,512
Income (loss) before income taxes
$
34,775
$
1,918
$
36,693
$
58,862
$
4,138
$
63,000
(dollars in thousands)
Six months ended June 30,
2019
2018
Revenues:
Traditional
Financial Solutions
Total Asia Pacific
Traditional
Financial Solutions
Total Asia Pacific
Net premiums
$
1,253,159
$
78,248
$
1,331,407
$
1,128,312
$
708
$
1,129,020
Investment income, net of related expenses
50,067
20,652
70,719
48,676
20,578
69,254
Investment related gains (losses), net
8
3,253
3,261
8
5,371
5,379
Other revenues
3,355
11,933
15,288
8,063
11,181
19,244
Total revenues
1,306,589
114,086
1,420,675
1,185,059
37,838
1,222,897
Benefits and expenses:
Claims and other policy benefits
1,114,448
68,826
1,183,274
930,786
6,873
937,659
Interest credited
—
13,432
13,432
—
13,054
13,054
Policy acquisition costs and other insurance expenses
38,739
14,909
53,648
96,366
1,925
98,291
Other operating expenses
82,003
8,918
90,921
76,158
7,827
83,985
Total benefits and expenses
1,235,190
106,085
1,341,275
1,103,310
29,679
1,132,989
Income before income taxes
$
71,399
$
8,001
$
79,400
$
81,749
$
8,159
$
89,908
59
Table of Contents
Income before income taxes decreased by
$26.3 million
, or
41.8%
, and
$10.5 million
, or
11.7%
, for the
three and six
months ended
June 30, 2019
, as compared to the same periods in
2018
. The decrease in income before income taxes for the second quarter was due to less favorable claims experience in Asia compared to prior year combined with unfavorable claims experience in Australia. The decrease in income before income taxes for the six months ended June 30, 2019 was due to unfavorable claims experience in Australia. Foreign currency exchange fluctuations resulted in an increase in income before income taxes of
$0.8 million
and a decrease of
$1.2 million
for the
three and six
months ended
June 30, 2019
, as compared to the same periods in
2018
.
Traditional Reinsurance
Income before income taxes decreased by
$24.1 million
, or
40.9%
, and
$10.4 million
, or
12.7%
, for the
three and six
months ended
June 30, 2019
, as compared to the same periods in
2018
. The decrease in income before income taxes for the second quarter was due to less favorable claims experience in Asia compared to prior year combined with unfavorable claims experience in Australia. The decrease in income before income taxes for the six months ended
June 30, 2019
was primarily due to unfavorable claims experience in Australia. Foreign currency exchange fluctuations resulted in an increase in income before income taxes of
$0.5 million
and a decrease of
$1.6 million
for the
three and six
months ended
June 30, 2019
, as compared to the same periods in
2018
.
Net premiums increased by
$67.6 million
, or
12.5%
, and
$124.8 million
, or
11.1%
, for the
three and six
months ended
June 30, 2019
, as compared to the same periods in
2018
. The increases were driven by new business written in Asia as well as inforce growth across the segment. Foreign currency exchange fluctuations resulted in a decrease in net premiums of
$23.2 million
and
$50.4 million
for the
three and six
months of
2019
, as compared to the same periods in
2018
.
A portion of the net premiums for the segment, in each period presented, relates to reinsurance of critical illness coverage. This coverage provides a benefit in the event of the diagnosis of a pre-defined critical illness. Reinsurance of critical illness in the segment is offered primarily in South Korea, Australia, China and Hong Kong. Net premiums earned from this coverage totaled $242.8 million and $180.9 million for the
second
quarter and $494.9 million and $416.6 million for the first
six
months ended
June 30, 2019
and
2018
, respectively.
Net investment income increased by
$0.7 million
, or
2.7%
, and
$1.4 million
, or
2.9%
, for the
three and six
months ended
June 30, 2019
, as compared to the same periods in
2018
. The increases were due to an increase in invested asset base, partially offset by a lower investment yield and foreign currency exchange fluctuations. Foreign currency exchange fluctuations resulted in a decrease in net investment income of
$1.2 million
and
$2.8 million
for the
three and six
months ended
June 30, 2019
, as compared to the same periods in
2018
.
Other revenues decreased by
$5.4 million
, or
70.3%
, and
$4.7 million
, or
58.4%
, for the
three and six
months ended
June 30, 2019
, as compared to the same periods in
2018
. The decreases primarily relate to recapture fee income recognized in the second quarter of 2018 as well as variances in foreign currency gains and losses recognized in each period. Foreign currency exchange fluctuations resulted in a decrease in other revenues of
$0.4 million
and
$0.4 million
for the
three and six
months ended
June 30, 2019
, as compared to the same periods in
2018
.
Loss ratios for this segment were
93.7%
and
80.8%
for the
second
quarter and
88.9%
and
82.5%
for the first
six months ended
June 30, 2019
and
2018
, respectively. The increase in the loss ratios for the
second
quarter was primarily due to new business mix, less favorable claims experience and experience adjustments in Asia. The increase in loss ratios for the six months ended June 30, 2019 was primarily due to new business mix and unfavorable claims experience in Australia, as well as the impact of experience adjustments in Asia.
Policy acquisition costs and other insurance expenses as a percentage of net premiums were
(1.9)%
and
7.0%
for the
second
quarter and
3.1%
and
8.5%
for the
six months ended
June 30, 2019
and
2018
, respectively. These percentages fluctuate due to timing of client company reporting, premium refunds, variations in the mixture of business and the relative maturity of the business.
In addition, as the segment grows, renewal premiums, which have lower allowances than first-year premiums, represent a greater percentage of the total net premiums. Experience adjustments in Asia resulted in reduced policy acquisition costs and other insurance expenses in the second quarter of 2019, resulting in a benefit rather than expense for the quarter. The favorable adjustment to policy acquisition costs and other insurance expenses was offset by an increase to claims and other policy benefits.
Other operating expenses increased
$3.8 million
, or
9.7%
, and
$5.8 million
, or
7.7%
, for the
three and six
months ended
June 30, 2019
, as compared to the same periods in
2018
mainly due to growth in operations in Asia and consultant expenditures. Other operating expenses as a percentage of net premiums totaled
7.0%
and
7.1%
for the
second
quarter and
6.5%
and
6.7%
for the first
six months ended
June 30, 2019
and
2018
, respectively. The timing of premium flows and the level of costs associated with the entrance into and development of new markets within the segment may cause other operating expenses as a percentage of net premiums to fluctuate over periods of time.
60
Table of Contents
Financial Solutions Reinsurance
Income before income taxes decreased by
$2.2 million
, or
53.6%
, and
$0.2 million
, or
1.9%
, for the
three and six
months ended
June 30, 2019
, as compared to the same periods in
2018
. The decrease in income before income taxes for the three months ended June 30, 2019 was primarily due to unfavorable fair value fluctuations on derivatives, partially offset by higher income from new deals in Asia. Foreign currency exchange fluctuations had a negligible effect on income before income taxes for the
three and six
months ended
June 30, 2019
, as compared to the same periods in
2018
.
Net premiums increased
$44.4 million
and
$77.5 million
for the
three and six
months ended
June 30, 2019
, as compared to the same periods in
2018
. The increase for the second quarter and first six months was due to new asset intensive deals in Asia. Foreign currency exchange fluctuations had a negligible effect on net premiums for the three months ended
June 30, 2019
, as compared to the same period in
2018
. Foreign currency exchange fluctuations decreased net premiums by
$1.3 million
for the six months ended
June 30, 2019
, as compared to the same period in
2018
.
Net investment income increased
$0.2 million
, or
2.0%
, and
$0.1 million
, or
0.4%
, for the
three and six
months ended
June 30, 2019
, as compared to the same periods in
2018
mainly due to an increase in invested asset base, partially offset by a lower investment yield and foreign currency exchange fluctuations. Foreign currency exchange fluctuations resulted in a decrease in net investment income of
$0.3 million
and
$0.8 million
for the
three and six
months ended
June 30, 2019
, as compared to the same periods in
2018
.
Other revenues increased by
$0.3 million
, or
5.7%
, and
$0.8 million
, or
6.7%
, for the
three and six
months ended
June 30, 2019
, as compared to the same periods in
2018
. At
June 30, 2019
and
2018
, the amount of reinsurance assumed from client companies, as measured by pre-tax statutory surplus, risk based capital and other financial reinsurance structures was $3.1 billion and $2.8 billion, respectively. Fees earned from this business can vary significantly depending on the size of the transactions and the timing of their completion and, therefore, can fluctuate from period to period.
Claims and other policy benefits increased by
$34.7 million
and
$62.0 million
for the
three and six
months ended
June 30, 2019
, as compared to the same periods in
2018
. The increases in the second quarter and first six months were attributable to new asset-intensive deals in Asia.
Other operating expenses increased by
$0.2 million
, or
5.2%
, and
$1.1 million
, or
13.9%
, for the
three and six
months ended
June 30, 2019
, as compared to the same periods in
2018
, respectively. The timing of transactions and the level of costs associated with the entrance into and development of new markets and new transactions within the segment may cause other operating expenses to fluctuate over periods of time.
Corporate and Other
Corporate and Other revenues primarily include investment income from unallocated invested assets, investment related gains and losses and service fees. Corporate and Other expenses consist of the offset to capital charges allocated to the operating segments within the policy acquisition costs and other insurance income line item, unallocated overhead and executive costs, interest expense related to debt, and the investment income and expense associated with the Company’s collateral finance and securitization transactions and service business expenses. Additionally, Corporate and Other includes results from certain wholly-owned subsidiaries, such as RGAX, and joint ventures that, among other activities, develop and market technology, and provide consulting and outsourcing solutions for the insurance and reinsurance industries. In the past two years, the Company has increased its investment and expenditures in this area in an effort to both support its clients and generate new future revenue streams.
61
Table of Contents
(dollars in thousands)
Three months ended June 30,
Six months ended June 30,
2019
2018
2019
2018
Revenues:
Net premiums
$
10
$
10
$
(36
)
$
20
Investment income, net of related expenses
55,402
32,727
98,026
72,873
Investment related gains (losses), net
(5,488
)
(23,281
)
(7,119
)
(32,215
)
Other revenues
13,020
6,344
39,744
14,377
Total revenues
62,944
15,800
130,615
55,055
Benefits and expenses:
Claims and other policy benefits
(111
)
108
(146
)
428
Interest credited
5,456
2,717
10,962
4,927
Policy acquisition costs and other insurance income
(28,661
)
(30,496
)
(58,035
)
(61,008
)
Other operating expenses
77,629
66,270
147,128
129,230
Interest expense
43,283
37,025
83,456
74,479
Collateral finance and securitization expense
7,151
7,440
15,568
15,042
Total benefits and expenses
104,747
83,064
198,933
163,098
Income (loss) before income taxes
$
(41,803
)
$
(67,264
)
$
(68,318
)
$
(108,043
)
Loss before income taxes decreased by
$25.5 million
and
$39.7 million
for the
three and six
months ended
June 30, 2019
, as compared to the same periods in
2018
. The decreases in loss before income taxes for the
second
quarter and the first six months are primarily due to decreased net investment related losses and higher investment income partially offset by increased other operating expenses.
Net investment income increased by
$22.7 million
, or
69.3%
, and
$25.2 million
, or
34.5%
, for the three and six months ended
June 30, 2019
, as compared to the same periods in
2018
. The increases in the second quarter and the first six months were largely attributable to increases in unallocated invested assets and a higher average investment yield.
Net investment related losses decreased by
$17.8 million
and
$25.1 million
for the
three and six
months ended
June 30, 2019
, as compared to the same periods in
2018
. The decrease in the second quarter was primarily due to an increase in net gains on the sale of fixed maturity securities of $22.1 million and an increase in the fair value of equity securities of $9.7 million, which were offset by a $2.6 million increase in investment impairments. The decrease in the first six months of 2019 was primarily due to an increase in net gains on the sale of fixed maturity securities of $27.2 million and an increase in the fair value of equity securities of $17.8 million, which were offset by a $6.4 million increase in other-than-temporary impairments on fixed maturity securities and other investments.
Other revenues increased by
$6.7 million
and
$25.4 million
for the
three and six
months ended
June 30, 2019
, as compared to the same periods in
2018
. The increase in the
second
quarter was mainly related to the Company’s RGAx operations, which contributed $3.6 million to other revenues. The increase in the first six months of 2019 was mainly due to a recapture of a collateral finance transaction, which resulted in a $12.9 million gain. In addition, the Company’s RGAX operations contributed $21.8 million to other revenues in the first six months of 2019 compared to $13.6 million in the same period in 2018.
Policy acquisition costs and other insurance income decreased by
$1.8 million
, or
6.0%
, and
$3.0 million
, or
4.9%
, for the
three and six
months ended
June 30, 2019
, as compared to the same periods in
2018
. Fluctuations period over period were attributable to the offset to capital charges allocated to the operating segments.
Other operating expenses increased by
$11.4 million
, or
17.1%
, and
$17.9 million
, or
13.8%
, for the
three and six
months ended
June 30, 2019
, as compared to the same periods in
2018
. The increases in other operating expenses, were primarily due to growth in strategic initiatives, such as RGAX, and increased incentive-based compensation.
Interest expense increased by
$6.3 million
, or
16.9%
, and
$9.0 million
, or
12.1%
, for the
three and six
months ended
June 30, 2019
, as compared to the same periods in
2018
. The increases in interest expense resulted primarily from the issuance of $600.0 million in long-term debt in May 2019 and the variability in tax-related interest expense.
Liquidity and Capital Resources
Overview
The Company believes that cash flows from the various sources of funds available to it will provide sufficient cash flows for the next twelve months to satisfy the current liquidity requirements of the Company under various scenarios that include the potential risk of early recapture of reinsurance treaties, market events and higher than expected claims. The Company performs periodic liquidity stress testing to ensure its asset portfolio includes sufficient high quality liquid assets that could be utilized to bolster its
62
Table of Contents
liquidity position under stress scenarios. These assets could be utilized as collateral for secured borrowing transactions with various third parties or by selling the securities in the open market if needed. The Company’s liquidity requirements have been and will continue to be funded through net cash flows from operations. However, in the event of significant unanticipated cash requirements beyond normal liquidity needs, the Company has multiple liquidity alternatives available based on market conditions and the amount and timing of the liquidity need. These alternatives include borrowings under committed credit facilities, secured borrowings, the ability to issue long-term debt, preferred securities or common equity and, if necessary, the sale of invested assets subject to market conditions.
Current Market Environment
The current low interest rate environment in select markets, primarily the U.S., Canada and Europe, continues to put downward pressure on the Company’s investment yield. The Company’s average investment yield, excluding spread business, for the
six
months ended
June 30, 2019
was
4.43%
, 4 basis points above the same period in 2018. The Company’s insurance liabilities, in particular its annuity products, are sensitive to changing market factors. Gross unrealized gains on fixed maturity securities available-for-sale increased from $1,858.7 million at
December 31, 2018
to
$3,828.1 million
at
June 30, 2019
. Similarly, gross unrealized losses decreased from $748.5 million at
December 31, 2018
to
$96.4 million
at
June 30, 2019
.
The Company continues to be in a position to hold any investment security showing an unrealized loss until recovery, provided it remains comfortable with the credit of the issuer. As indicated above, gross unrealized gains on fixed maturity securities of
$3,828.1 million
remain well in excess of gross unrealized losses of
$96.4 million
as of
June 30, 2019
. The Company does not rely on short-term funding or commercial paper and to date it has experienced no liquidity pressure, nor does it anticipate such pressure in the foreseeable future.
The Company projects its reserves to be sufficient, and it would not expect to write down deferred acquisition costs or be required to take any actions to augment capital, even if interest rates remain at current levels for the next five years, assuming all other factors remain constant. While the Company has felt the pressures of sustained low interest rates and volatile equity markets and may continue to do so, its business operations are not overly sensitive to these risks. Although management believes the Company’s current capital base is adequate to support its business at current operating levels, it continues to monitor new business opportunities and any associated new capital needs that could arise from the changing financial landscape.
The Holding Company
RGA is an insurance holding company whose primary uses of liquidity include, but are not limited to, the immediate capital needs of its operating companies, dividends paid to its shareholders, repurchase of common stock and interest payments on its indebtedness. The primary sources of RGA’s liquidity include proceeds from its capital-raising efforts, interest income on undeployed corporate investments, interest income received on surplus notes with RGA Reinsurance, RCM and Rockwood Re and dividends from operating subsidiaries. As the Company continues its growth efforts, RGA will continue to be dependent upon these sources of liquidity. The following tables provide comparative information for RGA (dollars in thousands):
Three months ended June 30,
Six months ended June 30,
2019
2018
2019
2018
Interest expense
$
51,548
$
47,250
$
99,998
$
92,694
Capital contributions to subsidiaries
18,268
12,000
38,768
23,000
Dividends to shareholders
37,640
32,129
75,347
64,370
Interest and dividend income
35,806
232,473
65,918
264,020
Issuance of unaffiliated debt
598,543
—
598,543
—
June 30, 2019
December 31, 2018
Cash and invested assets
$
864,100
$
658,850
See Item 15, Schedule II - “Condensed Financial Information of the Registrant” in the 2018 Annual Report for additional financial information related to RGA.
The undistributed earnings of substantially all of the Company’s foreign subsidiaries have been reinvested indefinitely in those non-U.S. operations, as described in Note 9 - “Income Tax” of the Notes to Consolidated Financial Statements in the 2018 Annual Report. As U.S. Tax Reform generally eliminates U.S. federal income taxes on dividends from foreign subsidiaries, the Company does not expect to incur material income taxes if these funds are repatriated.
RGA endeavors to maintain a capital structure that provides financial and operational flexibility to its subsidiaries, credit ratings that support its competitive position in the financial services marketplace, and shareholder returns. As part of the Company’s capital deployment strategy, it has in recent years repurchased shares of RGA common stock and paid dividends to RGA shareholders, as authorized by the board of directors. RGA’s current share repurchase program, which was approved by the board
63
Table of Contents
of directors in January 2019, authorizes the repurchase of up to $400.0 million of common stock. The pace of repurchase activity depends on various factors such as the level of available cash, an evaluation of the costs and benefits associated with alternative uses of excess capital, such as acquisitions and in force reinsurance transactions, and RGA’s stock price.
Details underlying dividend and share repurchase program activity were as follows (in thousands, except share data):
Six months ended June 30,
2019
2018
Dividends to shareholders
$
75,347
$
64,370
Repurchases of treasury stock
50,000
150,000
Total amount paid to shareholders
$
125,347
$
214,370
Number of shares repurchased
344,237
991,477
Average price per share
$
145.25
$
151.29
In July 2019, RGA’s board of directors declared a quarterly dividend of $0.70 per share. All future payments of dividends are at the discretion of RGA’s board of directors and will depend on the Company’s earnings, capital requirements, insurance regulatory conditions, operating conditions, and other such factors as the board of directors may deem relevant. The amount of dividends that RGA can pay will depend in part on the operations of its reinsurance subsidiaries. See Note 3 - “Equity” in the Notes to Condensed Consolidated Financial Statements for information on the Company’s share repurchase program.
Debt
Certain of the Company’s debt agreements contain financial covenant restrictions related to, among others, liens, the issuance and disposition of stock of restricted subsidiaries, minimum requirements of consolidated net worth, maximum ratios of debt to capitalization and change of control provisions. The Company is required to maintain a minimum consolidated net worth, as defined in the debt agreements, of $5.3 billion, calculated as of the last day of each fiscal quarter. Also, consolidated indebtedness, calculated as of the last day of each fiscal quarter, cannot exceed 35% of the sum of the Company’s consolidated indebtedness plus adjusted consolidated stockholders’ equity. A material ongoing covenant default could require immediate payment of the amount due, including principal, under the various agreements. Additionally, the Company’s debt agreements contain cross-default covenants, which would make outstanding borrowings immediately payable in the event of a material uncured covenant default under any of the agreements, including, but not limited to, non-payment of indebtedness when due for an amount in excess of the amounts set forth in those agreements, bankruptcy proceedings, or any other event that results in the acceleration of the maturity of indebtedness.
As of
June 30, 2019
and
December 31, 2018
, the Company had $3.4 billion and $2.8 billion, respectively, in outstanding borrowings under its debt agreements and was in compliance with all covenants under those agreements. As of
June 30, 2019
and
December 31, 2018
, the average net interest rate on long-term debt outstanding was 5.01% and 5.24%, respectively. The ability of the Company to make debt principal and interest payments depends on the earnings and surplus of subsidiaries, investment earnings on undeployed capital proceeds, available liquidity at the holding company, and the Company’s ability to raise additional funds.
On May 15, 2019, RGA issued 3.9% Senior Notes due May 15, 2029 with a face amount of $600.0 million. This security has been registered with the Securities and Exchange Commission. The net proceeds were approximately $593.8 million and will be used in part to repay upon maturity the Company’s $400.0 million 6.45% Senior Notes that mature in November 2019. The remainder will be used for general corporate purposes. Capitalized issue costs were approximately $4.8 million.
The Company enters into derivative agreements with counterparties that reference either the Company’s debt rating or its financial strength rating. If either rating is downgraded in the future, it could trigger certain terms in the Company’s derivative agreements, which could negatively affect overall liquidity. For the majority of the Company’s derivative agreements, there is a termination event, at the Company’s option, should the long-term senior debt ratings drop below either BBB+ (S&P) or Baa1 (Moody’s) or the financial strength ratings drop below either A- (S&P) or A3 (Moody’s).
The Company may borrow up to $850.0 million in cash and obtain letters of credit in multiple currencies on its revolving credit facility that matures in August 2023. As of
June 30, 2019
, the Company had no cash borrowings outstanding and $19.6 million in issued, but undrawn, letters of credit under this facility.
Based on the historic cash flows and the current financial results of the Company, management believes RGA’s cash flows will be sufficient to enable RGA to meet its obligations for at least the next 12 months.
64
Table of Contents
Credit and Committed Facilities
At
June 30, 2019
, the Company maintained an $850.0 million syndicated revolving credit facility and certain committed letter of credit facilities aggregating to $1,074.9 million. See Note 13 - “Debt” in the Notes to Consolidated Financial Statements in the 2018 Annual Report for further information about these facilities.
The Company has obtained bank letters of credit in favor of various affiliated and unaffiliated insurance companies from which the Company assumes business. These letters of credit represent guarantees of performance under the reinsurance agreements and allow ceding companies to take statutory reserve credits. Certain of these letters of credit contain financial covenant restrictions similar to those described in the “Debt” discussion above. At
June 30, 2019
, there were approximately $95.2 million of outstanding bank letters of credit in favor of third parties. Additionally, in accordance with applicable regulations, the Company utilizes letters of credit to secure statutory reserve credits when it retrocedes business to its affiliated subsidiaries. The Company cedes business to its affiliates to help reduce the amount of regulatory capital required in certain jurisdictions, such as the U.S. and the UK. The Company believes the capital required to support the business in the affiliates reflects more realistic expectations than the original jurisdiction of the business, where capital requirements are often considered to be quite conservative. As of
June 30, 2019
, $1.2 billion in letters of credit from various banks were outstanding, but undrawn, backing reinsurance between the various subsidiaries of the Company.
Cash Flows
The Company’s principal cash inflows from its reinsurance operations include premiums and deposit funds received from ceding companies. The primary liquidity concerns with respect to these cash flows are early recapture of the reinsurance contract by the ceding company and lapses of annuity products reinsured by the Company. The Company’s principal cash inflows from its invested assets result from investment income and the maturity and sales of invested assets. The primary liquidity concerns with respect to these cash inflows relates to the risk of default by debtors and interest rate volatility. The Company manages these risks very closely. See “Investments” and “Interest Rate Risk” below.
Additional sources of liquidity to meet unexpected cash outflows in excess of operating cash inflows and current cash and equivalents on hand include selling short-term investments or fixed maturity securities and drawing funds under a revolving credit facility, under which the Company had availability of $830.4 million as of
June 30, 2019
. The Company also has $865.9 million of funds available through collateralized borrowings from the FHLB as of
June 30, 2019
. As of
June 30, 2019
, the Company could have borrowed these additional amounts without violating any of its existing debt covenants.
The Company’s principal cash outflows relate to the payment of claims liabilities, interest credited, operating expenses, income taxes, dividends to shareholders, purchases of treasury stock and principal and interest under debt and other financing obligations. The Company seeks to limit its exposure to loss on any single insured and to recover a portion of benefits paid by ceding reinsurance to other insurance enterprises or reinsurers under excess coverage and coinsurance contracts (See Note 2, “Significant Accounting Policies and Pronouncements” in the Notes to Consolidated Financial Statements in the 2018 Annual Report). The Company performs annual financial reviews of its retrocessionaires to evaluate financial stability and performance. The Company has never experienced a material default in connection with retrocession arrangements, nor has it experienced any difficulty in collecting claims recoverable from retrocessionaires; however, no assurance can be given as to the future performance of such retrocessionaires nor to the recoverability of future claims. The Company’s management believes its current sources of liquidity are adequate to meet its cash requirements for the next 12 months.
65
Table of Contents
Summary of Primary Sources and Uses of Liquidity and Capital
The Company’s primary sources and uses of liquidity and capital are summarized as follows:
For the six months ended June 30,
2019
2018
(Dollars in thousands)
Sources:
Net cash provided by operating activities
$
970,331
$
583,588
Proceeds from long-term debt issuance
598,524
—
Exercise of stock options, net
2,590
1,252
Change in cash collateral for derivative positions and other arrangements
—
17,578
Effect of exchange rate changes on cash
6,759
—
Total sources
1,578,204
602,418
Uses:
Net cash used in investing activities
764,403
100,615
Dividends to stockholders
75,347
64,370
Repayment of collateral finance and securitization notes
52,644
53,102
Debt issuance costs
4,750
—
Principal payments of long-term debt
1,387
1,331
Purchases of treasury stock
67,744
165,069
Change in cash collateral for derivatives and other arrangements
80,214
—
Cash used for changes in universal life and other
investment type policies and contracts
133,922
104,023
Effect of exchange rate changes on cash
—
19,753
Total uses
1,180,411
508,263
Net change in cash and cash equivalents
$
397,793
$
94,155
Cash Flows from Operations
- The principal cash inflows from the Company’s reinsurance activities come from premiums, investment and fee income, annuity considerations and deposit funds. The principal cash outflows relate to the liabilities associated with various life and health insurance, annuity and disability products, operating expenses, income tax payments and interest on outstanding debt obligations. The primary liquidity concern with respect to these cash flows is the risk of shortfalls in premiums and investment income, particularly in periods with abnormally high claims levels.
Cash Flows from Investments
- The principal cash inflows from the Company’s investment activities come from repayments of principal on invested assets, proceeds from maturities of invested assets, sales of invested assets and settlements of freestanding derivatives. The principal cash outflows relate to purchases of investments, issuances of policy loans and settlements of freestanding derivatives. The Company typically has a net cash outflow from investing activities because cash inflows from insurance operations are reinvested in accordance with its asset/liability management discipline to fund insurance liabilities. The Company closely monitors and manages these risks through its credit risk management process. The primary liquidity concerns with respect to these cash flows are the risk of default by debtors and market disruption, which could make it difficult for the Company to sell investments.
Financing Cash Flows
- The principal cash inflows from the Company’s financing activities come from issuances of RGA debt and equity securities, and deposit funds associated with universal life and other investment type policies and contracts. The principal cash outflows come from repayments of debt, payments of dividends to stockholders, purchases of treasury stock, and withdrawals associated with universal life and other investment type policies and contracts. A primary liquidity concern with respect to these cash flows is the risk of early contractholder and policyholder withdrawal.
Contractual Obligations
The Company’s obligation for long-term debt, including interest, increased by $755.9 million since December 31, 2018 primarily related to the May 2019 issuance of senior notes as previously discussed. There were no other material changes in the Company’s contractual obligations from those reported in the 2018 Annual Report.
Asset / Liability Management
The Company actively manages its cash and invested assets using an approach that is intended to balance quality, diversification, asset/liability matching, liquidity and investment return. The goals of the investment process are to optimize after-tax, risk-adjusted investment income and after-tax, risk-adjusted total return while managing the assets and liabilities on a cash flow and duration basis.
66
Table of Contents
The Company has established target asset portfolios for its operating segments, which represent the investment strategies intended to profitably fund its liabilities within acceptable risk parameters. These strategies include objectives and limits for effective duration, yield curve sensitivity and convexity, liquidity, asset sector concentration and credit quality.
The Company’s asset-intensive products are primarily supported by investments in fixed maturity securities reflected on the Company’s balance sheet and under funds withheld arrangements with the ceding company. Investment guidelines are established to structure the investment portfolio based upon the type, duration and behavior of products in the liability portfolio so as to achieve targeted levels of profitability. The Company manages the asset-intensive business to provide a targeted spread between the interest rate earned on investments and the interest rate credited to the underlying interest-sensitive contract liabilities. The Company periodically reviews models projecting different interest rate scenarios and their effect on profitability. Certain of these asset-intensive agreements, primarily in the U.S. and Latin America Financial Solutions operating segment, are generally funded by fixed maturity securities that are withheld by the ceding company.
The Company’s liquidity position (cash and cash equivalents and short-term investments) was
$2,446.3 million
and
$2,032.3 million
at
June 30, 2019
and
December 31, 2018
, respectively. Liquidity needs are determined from valuation analyses conducted by operational units and are driven by product portfolios. Periodic evaluations of demand liabilities and short-term liquid assets are designed to adjust specific portfolios, as well as their durations and maturities, in response to anticipated liquidity needs.
See “Securities Borrowing, Lending and Other” in Note 4 - “Investments” in the Notes to Condensed Consolidated Financial Statements for information related to the Company’s securities borrowing, lending and repurchase/reverse repurchase programs. In addition to its security agreements with third parties, certain RGA’s subsidiaries have entered into intercompany securities lending agreements to more efficiently source securities for lending to third parties and to provide for more efficient regulatory capital management.
The Company is a member of the FHLB and holds $83.7 million of FHLB common stock, which is included in other invested assets on the Company’s condensed consolidated balance sheets.
The Company has entered into funding agreements with the FHLB under guaranteed investment contracts whereby the Company has issued the funding agreements in exchange for cash and for which the FHLB has been granted a blanket lien on the Company’s commercial and residential mortgage-backed securities and commercial mortgage loans used to collateralize the Company’s obligations under the funding agreements. The Company maintains control over these pledged assets, and may use, commingle, encumber or dispose of any portion of the collateral as long as there is no event of default and the remaining qualified collateral is sufficient to satisfy the collateral maintenance level. The funding agreements and the related security agreements represented by this blanket lien provide that upon any event of default by the Company, the FHLB’s recovery is limited to the amount of the Company’s liability under the outstanding funding agreements. The amount of the Company’s liability for the funding agreements with the FHLB under guaranteed investment contracts was $1.7 billion at
June 30, 2019
and
December 31, 2018
, respectively, which is included in interest sensitive contract liabilities on the Company’s condensed consolidated balance sheets. The advances on these agreements are collateralized primarily by commercial and residential mortgage-backed securities, commercial mortgage loans, and U.S. Treasury and government agency securities. The amount of collateral exceeds the liability and is dependent on the type of assets collateralizing the guaranteed investment contracts.
Investments
Management of Investments
The Company’s investment and derivative strategies involve matching the characteristics of its reinsurance products and other obligations and to seek to closely approximate the interest rate sensitivity of the assets with estimated interest rate sensitivity of the reinsurance liabilities. The Company achieves its income objectives through strategic and tactical asset allocations, security and derivative strategies within an asset/liability management and disciplined risk management framework. Derivative strategies are employed within the Company’s risk management framework to help manage duration, currency, and other risks in assets and/or liabilities and to replicate the credit characteristics of certain assets. For a discussion of the Company’s risk management process see “Market and Credit Risk” in the “Enterprise Risk Management” section of the Company’s 2018 Annual Report.
The Company’s portfolio management groups work with the Enterprise Risk Management function to develop the investment policies for the assets of the Company’s domestic and international investment portfolios. All investments held by the Company, directly or in a funds withheld at interest reinsurance arrangement, are monitored for conformance with the Company’s stated investment policy limits as well as any limits prescribed by the applicable jurisdiction’s insurance laws and regulations. See Note 4 – “Investments” in the Notes to Condensed Consolidated Financial Statements for additional information regarding the Company’s investments.
67
Table of Contents
Portfolio Composition
The Company had total cash and invested assets of
$63.3 billion
and
$56.1 billion
at
June 30, 2019
and
December 31, 2018
, respectively, as illustrated below (dollars in thousands):
June 30, 2019
% of Total
December 31, 2018
% of Total
Fixed maturity securities, available-for-sale
$
46,189,305
72.9
%
$
39,992,346
71.3
%
Equity securities
146,755
0.2
82,197
0.1
Mortgage loans on real estate
5,405,422
8.5
4,966,298
8.8
Policy loans
1,319,722
2.1
1,344,980
2.4
Funds withheld at interest
5,696,217
9.0
5,761,471
10.3
Short-term investments
158,788
0.3
142,598
0.3
Other invested assets
2,121,406
3.4
1,915,297
3.4
Cash and cash equivalents
2,287,526
3.6
1,889,733
3.4
Total cash and invested assets
$
63,325,141
100.0
%
$
56,094,920
100.0
%
Investment Yield
The following table presents consolidated average invested assets at amortized cost, net investment income and investment yield, excluding spread related business. Spread related business is primarily associated with contracts on which the Company earns an interest rate spread between assets and liabilities. To varying degrees, fluctuations in the yield on other spread related business is generally subject to corresponding adjustments to the interest credited on the liabilities (dollars in thousands).
Three months ended June 30,
Six months ended June 30,
2019
2018
Increase/
(Decrease)
2019
2018
Increase/
(Decrease)
Average invested assets at amortized cost
$
28,486,745
$
26,899,416
5.9
%
$
28,137,502
$
26,816,599
4.9
%
Net investment income
306,805
285,832
7.3
%
617,034
582,305
6.0
%
Investment yield (ratio of net investment income to average invested assets)
4.38
%
4.32
%
6 bps
4.43
%
4.39
%
4 bps
Investment yield increased for the three and six months ended
June 30, 2019
in comparison to the same periods in the prior year primarily due to increased income from limited partnerships, which is included in other invested assets on the condensed consolidated balance sheets.
Fixed Maturity Securities Available-for-Sale
See “Fixed Maturity Securities Available-for-Sale” in Note 4 – “Investments” in the Notes to Condensed Consolidated Financial Statements for tables that provide the amortized cost, unrealized gains and losses, estimated fair value of these securities, and the other-than-temporary impairments in AOCI by sector as of
June 30, 2019
and
December 31, 2018
.
The Company holds various types of fixed maturity securities available-for-sale and classifies them as corporate securities (“Corporate”), Canadian and Canadian provincial government securities (“Canadian government”), residential mortgage-backed securities (“RMBS”), asset-backed securities (“ABS”), commercial mortgage-backed securities (“CMBS”), U.S. government and agencies (“U.S. government”), state and political subdivisions, and other foreign government, supranational and foreign government-sponsored enterprises (“Other foreign government”). As of
June 30, 2019
and
December 31, 2018
, approximately
95.8%
and
95.6%
, respectively, of the Company’s consolidated investment portfolio of fixed maturity securities were investment grade.
Important factors in the selection of investments include diversification, quality, yield, call protection and total rate of return potential. The relative importance of these factors is determined by market conditions and the underlying reinsurance liability and existing portfolio characteristics. The Company owns floating rate securities that represent approximately
16.6%
and 16.0% of the total fixed maturity securities at
June 30, 2019
and
December 31, 2018
, respectively. These investments have a higher degree of income variability than the other fixed income holdings in the portfolio due to the floating rate nature of the interest payments. The Company holds these investments to match specific floating rate liabilities primarily reflected in the condensed consolidated balance sheets as collateral finance notes, as well as to enhance asset management strategies.
The largest asset class in which fixed maturity securities were invested was corporate securities, which represented approximately
59.8%
and
59.9%
of total fixed maturity securities as of
June 30, 2019
and
December 31, 2018
, respectively. See “Corporate Fixed Maturity Securities” in Note 4 – “Investments” in the Notes to Condensed Consolidated Financial Statements for tables showing the major industry types, which comprise the corporate fixed maturity holdings at
June 30, 2019
and
December 31, 2018
.
68
Table of Contents
As of
June 30, 2019
, the Company’s investments in Canadian government securities represented
9.9%
of the fair value of total fixed maturity securities compared to
9.7%
of the fair value of total fixed maturities at
December 31, 2018
. These assets are primarily high quality, long duration provincial strips, the valuation of which is closely linked to the interest rate curve. These assets are longer in duration and held primarily for asset/liability management to meet Canadian regulatory requirements. See “Fixed Maturity Securities Available-for-Sale” in Note 4 – “Investments” in the Notes to Condensed Consolidated Financial Statements for tables showing the various sectors as of
June 30, 2019
and
December 31, 2018
.
The Company references rating agency designations in some of its investments disclosures. These designations are based on the ratings from nationally recognized statistical rating organizations, primarily Moody’s, S&P and Fitch. Structured securities held by the Company’s insurance subsidiaries that maintain the NAIC statutory basis of accounting utilize the NAIC rating methodology. The NAIC assigns designations to publicly traded as well as privately placed securities. The designations assigned by the NAIC range from class 1 to class 6, with designations in classes 1 and 2 generally considered investment grade (BBB or higher rating agency designation). NAIC designations in classes 3 through 6 are generally considered below investment grade (BB or lower rating agency designation).
The quality of the Company’s available-for-sale fixed maturity securities portfolio, as measured at fair value and by the percentage of fixed maturity securities invested in various ratings categories, relative to the entire available-for-sale fixed maturity security portfolio, at
June 30, 2019
and
December 31, 2018
was as follows (dollars in thousands):
June 30, 2019
December 31, 2018
NAIC
Designation
Rating Agency
Designation
Amortized Cost
Estimated
Fair Value
% of Total
Amortized Cost
Estimated
Fair Value
% of Total
1
AAA/AA/A
$
27,571,234
$
30,513,833
66.1
%
$
24,904,526
$
26,180,440
65.5
%
2
BBB
12,941,492
13,705,079
29.7
12,141,601
12,023,426
30.1
3
BB
1,389,207
1,407,595
3.0
1,409,235
1,371,328
3.4
4
B
489,829
495,219
1.1
395,694
385,670
1.0
5
CCC and lower
15,120
15,890
—
13,183
12,860
—
6
In or near default
50,736
51,689
0.1
17,929
18,622
—
Total
$
42,457,618
$
46,189,305
100.0
%
$
38,882,168
$
39,992,346
100.0
%
The Company’s fixed maturity portfolio includes structured securities. The following table shows the types of structured securities the Company held at
June 30, 2019
and
December 31, 2018
(dollars in thousands):
June 30, 2019
December 31, 2018
Amortized Cost
Estimated
Fair Value
Amortized Cost
Estimated
Fair Value
RMBS:
Agency
$
893,169
$
928,931
$
811,044
$
814,568
Non-agency
1,321,794
1,347,584
1,061,192
1,054,653
Total RMBS
2,214,963
2,276,515
1,872,236
1,869,221
CMBS
1,687,024
1,747,285
1,428,115
1,419,034
ABS
2,482,012
2,494,664
2,171,254
2,149,204
Total
$
6,383,999
$
6,518,464
$
5,471,605
$
5,437,459
The Company’s RMBS include agency-issued pass-through securities and collateralized mortgage obligations. A majority of the agency-issued pass-through securities are guaranteed or otherwise supported by the Federal Home Loan Mortgage Corporation, the Federal National Mortgage Association, or the Government National Mortgage Association. The principal risks inherent in holding mortgage-backed securities are prepayment and extension risks, which will affect the timing of when cash will be received and are dependent on the level of mortgage interest rates. Prepayment risk is the unexpected increase in principal payments from the expected, primarily as a result of owner refinancing. Extension risk relates to the unexpected slowdown in principal payments from the expected. In addition, non-agency mortgage-backed securities face credit risk should the borrower be unable to pay the contractual interest or principal on their obligation. The Company monitors its mortgage-backed securities to mitigate exposure to the cash flow uncertainties associated with these risks.
The Company’s ABS portfolio primarily consists of collateralized loan obligations among other collateral types. The principal risks in holding asset-backed securities are structural, credit, capital market and interest rate risks. Structural risks include the securities’ cash flow priority in the capital structure and the inherent prepayment sensitivity of the underlying collateral. Credit risks include the adequacy and ability to realize proceeds from the collateral. Credit risks are mitigated by credit enhancements that include excess spread, over-collateralization and subordination. Capital market risks include general level of interest rates and the liquidity for these securities in the marketplace.
69
Table of Contents
The Company monitors its fixed maturity securities to determine impairments in value and evaluates factors such as financial condition of the issuer, payment performance, the length of time and the extent to which the market value has been below amortized cost, compliance with covenants, general market and industry sector conditions, current intent and ability to hold securities, and various other subjective factors. Based on management’s judgment, securities determined to have an other-than-temporary impairment in value are written down to fair value. See “Investments – Other-than-Temporary Impairment” in Note 2 – “Significant Accounting Policies and Pronouncements” in the Notes to Consolidated Financial Statements in the 2018 Annual Report for additional information. The table below summarizes other-than-temporary impairments and changes in the mortgage loan provision for the
three and six
months ended
June 30, 2019
and
2018
(dollars in thousands).
Three months ended June 30,
Six months ended June 30,
2019
2018
2019
2018
Impairment losses on fixed maturity securities
$
—
$
3,350
$
9,453
$
3,350
Other impairment losses
5,139
512
7,071
1,340
Change in mortgage loan provision
470
845
397
329
Total
$
5,609
$
4,707
$
16,921
$
5,019
There were no fixed maturity securities impairments for the three months ended
June 30, 2019
. The fixed maturity securities impairments for the six months ended
June 30, 2019
were primarily related to a U.S. utility company. The fixed maturity securities impairments for the three and six months ended June 30, 2018 were primarily related to high-yield corporate securities. In addition, other impairment losses for the three months ended
June 30, 2019
were primarily due to impairments on limited partnerships. Other impairment losses for the six months ended
June 30, 2019
were primarily due to impairments on real estate joint ventures and limited partnerships. Other impairment losses for the
three and six
months ended June 30, 2018 were primarily due to impairments on real estate joint ventures.
At
June 30, 2019
and
December 31, 2018
, the Company had
$96.4 million
and $748.5 million, respectively, of gross unrealized losses related to its fixed maturity securities. The distribution of the gross unrealized losses related to these securities is shown below.
June 30, 2019
December 31, 2018
Sector:
Corporate
73.4
%
74.2
%
Canadian government
0.1
0.3
RMBS
3.2
3.4
ABS
13.6
4.4
CMBS
0.5
2.4
U.S. government
0.4
7.7
State and political subdivisions
1.6
1.2
Other foreign government
7.2
6.4
Total
100.0
%
100.0
%
Industry:
Finance
20.0
%
27.5
%
Asset-backed
13.6
4.4
Industrial
47.4
38.2
Mortgage-backed
3.7
5.8
Government
9.3
15.6
Utility
6.0
8.5
Total
100.0
%
100.0
%
See “Unrealized Losses for Fixed Maturity Securities Available-for-Sale” in Note 4 – “Investments” in the Notes to Condensed Consolidated Financial Statements for a table that presents the total gross unrealized losses for these securities at
June 30, 2019
and
December 31, 2018
, where the estimated fair value had declined and remained below amortized cost by less than 20% or more than 20%.
70
Table of Contents
The Company’s determination of whether a decline in value is other-than-temporary includes analysis of the underlying credit and the extent and duration of a decline in value. The Company’s credit analysis of an investment includes determining whether the issuer is current on its contractual payments, evaluating whether it is probable that the Company will be able to collect all amounts due according to the contractual terms of the security and analyzing the overall ability of the Company to recover the amortized cost of the investment.
See “Unrealized Losses for Fixed Maturity Securities Available-for-Sale” in Note 4 – “Investments” in the Notes to Condensed Consolidated Financial Statements for tables that present the estimated fair values and gross unrealized losses, including other-than-temporary impairment losses reported in AOCI, for these securities that have estimated fair values below amortized cost, by class and grade security, as well as the length of time the related market value has remained below amortized cost as of
June 30, 2019
and
December 31, 2018
.
As of
June 30, 2019
and
December 31, 2018
, the Company classified approximately
5.4%
and 5.0%, respectively, of its fixed maturity securities in the Level 3 category (refer to Note 6 – “Fair Value of Assets and Liabilities” in the Notes to Condensed Consolidated Financial Statements for additional information). These securities primarily consist of private placement corporate securities, bank loans, and Canadian provincial strips with inactive trading markets.
See “Securities Borrowing, Lending and Other” in Note 4 - “Investments” in the Notes to Condensed Consolidated Financial Statements for information related to the Company’s securities borrowing, lending, repurchase and repurchase/reverse repurchase programs.
Mortgage Loans on Real Estate
Mortgage loans represented approximately
8.5
% and 8.8% of the Company’s cash and invested assets as of
June 30, 2019
and
December 31, 2018
, respectively. The Company’s mortgage loan portfolio consists of U.S., Canada and United Kingdom based investments primarily in commercial offices, light industrial properties and retail locations. The mortgage loan portfolio is diversified by geographic region and property type. The mortgage loan portfolio was diversified by geographic region and property type discussed further under “Mortgage Loans on Real Estate” in Note 4 – “Investments” in the Notes to Condensed Consolidated Financial Statements.
As of
June 30, 2019
and
December 31, 2018
, the Company’s mortgage loans, gross of unamortized deferred loan origination fees and expenses and valuation allowances, were distributed geographically as follows (dollars in thousands):
June 30, 2019
December 31, 2018
Recorded
Investment
% of Total
Recorded
Investment
% of Total
U.S. Region:
Pacific
$
1,389,504
25.5
%
$
1,396,346
28.0
%
South Atlantic
993,143
18.3
964,174
19.3
Mountain
772,054
14.2
693,281
13.9
East North Central
694,241
12.8
605,608
12.2
West North Central
296,537
5.5
288,949
5.8
West South Central
751,789
13.9
567,541
11.4
Middle Atlantic
200,513
3.7
202,235
4.1
East South Central
138,580
2.6
117,588
2.4
New England
5,554
0.1
5,609
0.1
Subtotal - U.S.
5,241,915
96.6
4,841,331
97.2
Canada
155,651
2.9
135,394
2.7
United Kingdom
26,579
0.5
6,629
0.1
Total
$
5,424,145
100.0
%
$
4,983,354
100.0
%
Valuation allowances on mortgage loans are established based upon inherent losses expected by management to be realized in connection with future dispositions or settlement of mortgage loans, including foreclosures. The valuation allowances are established after management considers, among other things, the value of underlying collateral and payment capabilities of debtors. Any subsequent adjustments to the valuation allowances will be treated as investment gains or losses. See “Mortgage Loans on Real Estate” in Note 4 – “Investments” in the Notes to Condensed Consolidated Financial Statements for information regarding valuation allowances and impairments.
71
Table of Contents
Policy Loans
Policy loans comprised approximately
2.1
% and
2.4%
of the Company’s cash and invested assets as of
June 30, 2019
and
December 31, 2018
, respectively, the majority of which are associated with one client. These policy loans present no credit risk because the amount of the loan cannot exceed the obligation due the ceding company upon the death of the insured or surrender of the underlying policy. The provisions of the treaties in force and the underlying policies determine the policy loan interest rates. The Company earns a spread between the interest rate earned on policy loans and the interest rate credited to corresponding liabilities.
Funds Withheld at Interest
Funds withheld at interest comprised approximately
9.0
% and
10.3%
of the Company’s cash and invested assets as of
June 30, 2019
and
December 31, 2018
, respectively. For reinsurance agreements written on a modified coinsurance basis and certain agreements written on a coinsurance basis, assets equal to the net statutory reserves are withheld and legally owned and managed by the ceding company, and are reflected as funds withheld at interest on the Company’s condensed consolidated balance sheets. In the event of a ceding company’s insolvency, the Company would need to assert a claim on the assets supporting its reserve liabilities. However, the risk of loss to the Company is mitigated by its ability to offset amounts it owes the ceding company for claims or allowances against amounts owed by the ceding company. Interest accrues to the total funds withheld at interest assets at rates defined by the treaty terms. The Company is subject to the investment performance on the withheld assets, although it does not directly control them. These assets are primarily fixed maturity investment securities and pose risks similar to the fixed maturity securities the Company owns. To mitigate this risk, the Company helps set the investment guidelines followed by the ceding company and monitors compliance. Ceding companies with funds withheld at interest had an average financial strength rating of “A” at
June 30, 2019
and
December 31, 2018
. Certain ceding companies maintain segregated portfolios for the benefit of the Company.
Other Invested Assets
Other invested assets include limited partnership interests, joint ventures (other than operating joint ventures), equity release mortgages, derivative contracts, FVO contractholder-directed unit-linked investments and FHLB common stock. Other invested assets represented approximately
3.4
% of the Company’s cash and invested assets as of both
June 30, 2019
and
December 31, 2018
. See “Other Invested Assets” in Note 4 – “Investments” in the Notes to Condensed Consolidated Financial Statements for a table that presents the carrying value of the Company’s other invested assets by type as of
June 30, 2019
and
December 31, 2018
.
The Company utilizes derivative financial instruments to protect the Company against possible changes in the fair value of its investment portfolio as a result of interest rate changes, to hedge liabilities associated with the reinsurance of variable annuities with guaranteed living benefits and to manage the portfolio’s effective yield, maturity and duration. In addition, the Company utilizes derivative financial instruments to reduce the risk associated with fluctuations in foreign currency exchange rates. The Company uses exchange-traded, centrally cleared, and customized over-the-counter derivative financial instruments.
See Note 5 - “Derivative Instruments” in the Notes to Condensed Consolidated Financial Statements for a table that presents the notional amounts and fair value of investment related derivative instruments held at
June 30, 2019
and
December 31, 2018
.
The Company may be exposed to credit-related losses in the event of non-performance by counterparties to derivative financial instruments. Generally, the credit exposure of the Company’s derivative contracts is limited to the fair value at the reporting date plus or minus any collateral posted or held by the Company. The Company had no credit exposure related to its derivative contracts, excluding futures and mortality swaps, at
June 30, 2019
and
December 31, 2018
, as the net amount of collateral pledged to the Company from counterparties exceeded the fair value of the derivative contracts.
The Company manages its credit risk related to over-the-counter derivatives by entering into transactions with creditworthy counterparties, maintaining collateral arrangements and through the use of master agreements that provide for a single net payment to be made by one counterparty to another at each due date and upon termination. As exchange-traded futures are affected through regulated exchanges, and positions are marked to market on a daily basis, the Company has minimal exposure to credit-related losses in the event of nonperformance by counterparties. See Note 5 - “Derivative Instruments” in the Notes to Condensed Consolidated Financial Statements for more information regarding the Company’s derivative instruments.
The Company holds beneficial interests in equity release mortgages in the United Kingdom. Equity release mortgages represent loans provided to individuals 55 years of age and older secured by the borrower’s residence. Equity release mortgages are comparable to a home equity loan by allowing the borrower to utilize the equity in their home as collateral. The amount of the loan is dependent on the appraised value of the home at the time of origination, the borrower's age and interest rate. Unlike a home equity loan, no payment of principal or interest is required until the death of the borrower or sale of the home. Equity release mortgages may be fully funded at origination, or the borrower can request periodic funding similar to a line of credit. Equity release mortgages are subject to risks, including market, credit, interest rate, liquidity, operational, reputational and legal risks.
72
Table of Contents
Other invested assets include
$641.6 million
and $475.9 million of equity release mortgages as of June 30, 2019 and December 31, 2018, respectively. Equity release mortgage investment income was $8.4 million and $3.9 million for the three months ended June 30, 2019 and 2018, respectively, and $15.7 million and $7.2 million for the six months ended June 30, 2019 and 2018, respectively.
New Accounting Standards
See Note 14 — “New Accounting Standards” in the Notes to Condensed Consolidated Financial Statements.
ITEM 3. Quantitative and Qualitative Disclosures About Market Risk
Market risk is the risk of fluctuations in the value of financial instruments as a result of absolute or relative changes in interest rates, foreign currency exchange rates, equity prices or commodity prices. To varying degrees, the Company products and services, and the investment activities supporting them, generate exposure to market risk. The market risk incurred, and the Company’s strategies for managing this risk, vary by product. As of
June 30, 2019
, there have been no material changes in the Company’s economic exposure to market risk or the Company’s Enterprise Risk Management function from December 31, 2018, a description of which may be found in its Annual Report on Form 10-K, for the year ended December 31, 2018, Item 7A, “Quantitative and Qualitative Disclosures about Market Risk,” filed with the Securities and Exchange Commission.
ITEM 4. Controls and Procedures
The Chief Executive Officer and the Chief Financial Officer have evaluated the effectiveness of the design and operation of the Company’s disclosure controls and procedures as defined in Exchange Act Rule 13a-15(e) as of the end of the period covered by this report. Based on that evaluation, the Chief Executive Officer and the Chief Financial Officer concluded that these disclosure controls and procedures were effective.
There was no change in the Company’s internal control over financial reporting as defined in Exchange Act Rule 13a-15(f) during the quarter ended
June 30, 2019
, that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.
PART II - OTHER INFORMATION
ITEM 1. Legal Proceedings
The Company is subject to litigation in the normal course of its business. The Company currently has no material litigation. A legal reserve is established when the Company is notified of an arbitration demand or litigation or is notified that an arbitration demand or litigation is imminent, it is probable that the Company will incur a loss as a result and the amount of the probable loss is reasonably capable of being estimated.
ITEM 1A. Risk Factors
There were no material changes from the risk factors disclosed in the 2018 Annual Report.
73
Table of Contents
ITEM 2. Unregistered Sales of Equity Securities and Use of Proceeds
Issuer Purchases of Equity Securities
The following table summarizes RGA’s repurchase activity of its common stock during the quarter ended
June 30, 2019
:
Total Number of Shares
Purchased (1)
Average Price Paid per
Share
Total Number of Shares
Purchased as Part of
Publicly Announced Plans
or Programs (1)
Maximum Number (or
Approximate Dollar
Value) of Shares that May
Yet Be Purchased Under
the Plan or Program
April 1, 2019 -
April 30, 2019
6,746
$
150.39
—
$
39,579,388
May 1, 2019 -
May 31, 2019
97,139
$
149.46
—
$
39,579,388
June 1, 2019 -
June 30, 2019
1,154
$
151.66
—
$
39,579,388
(1)
RGA had no repurchases of common stock under its share repurchase program for the second quarter of 2019. The Company net settled - issuing 19,838, 266,451 and 3,714 shares from treasury and repurchased from recipients 6,746, 97,139 and 1,154 shares in April, May and June 2019, respectively, in settlement of income tax withholding requirements incurred by the recipients of equity incentive awards.
On January 24, 2019, RGA’s board of directors authorized a share repurchase program, with no expiration date, for up to $400.0 million of RGA’s outstanding common stock.
ITEM 6. Exhibits
See index to exhibits.
74
Table of Contents
INDEX TO EXHIBITS
Exhibit
Number
Description
3.1
Amended and Restated Articles of Incorporation, as amended by Amendment of Articles of Incorporation, effective as of May 23, 2018, incorporated by reference to Exhibit 3.1 to Quarterly Report on Form 10-Q for the period ended June 30, 2018, filed on August 3, 2018.
3.2
Amended and Restated Bylaws, effective as of May 23, 2018, incorporated by reference to Exhibit 3.2 to Current Report on Form 8-K filed on May 24, 2018.
10.1
First Amendment to Letter of Credit Reimbursement Agreement, dated as of June 14, 2019, by and between Reinsurance Group of America, Incorporated and Crédit Agricole Corporate and Investment Bank, incorporated by reference to Exhibit 10.1 to Current Report on Form 8-K filed on June 18, 2019.
31.1
Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to section 302 of the Sarbanes-Oxley Act of 2002.
31.2
Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to section 302 of the Sarbanes-Oxley Act of 2002.
32.1
Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002.
32.2
Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002.
101.INS
XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document
101.SCH
XBRL Taxonomy Extension Schema Document
101.CAL
XBRL Taxonomy Extension Calculation Linkbase Document
101.LAB
XBRL Taxonomy Extension Label Linkbase Document
101.PRE
XBRL Taxonomy Extension Presentation Linkbase Document
101.DEF
XBRL Taxonomy Extension Definition Linkbase Document
75
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Reinsurance Group of America, Incorporated
Date: August 2, 2019
By:
/s/ Anna Manning
Anna Manning
President & Chief Executive Officer
(Principal Executive Officer)
Date: August 2, 2019
By:
/s/ Todd C. Larson
Todd C. Larson
Senior Executive Vice President & Chief Financial Officer
(Principal Financial and Accounting Officer)
76